<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Microbiol</journal-id><journal-id journal-id-type="iso-abbrev">Front Microbiol</journal-id><journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id><journal-title-group><journal-title>Frontiers in Microbiology</journal-title></journal-title-group><issn pub-type="epub">1664-302X</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">8121174</article-id><article-id pub-id-type="doi">10.3389/fmicb.2021.638609</article-id><article-categories><subj-group subj-group-type="heading"><subject>Microbiology</subject><subj-group><subject>Review</subject></subj-group></subj-group></article-categories><title-group><article-title>Mechanistic Understanding of <italic>Candida albicans</italic> Biofilm Formation and Approaches for Its Inhibition</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Atriwal</surname><given-names>Tanu</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/1169034/overview"/></contrib><contrib contrib-type="author"><name><surname>Azeem</surname><given-names>Kashish</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/1287380/overview"/></contrib><contrib contrib-type="author"><name><surname>Husain</surname><given-names>Fohad Mabood</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/232973/overview"/></contrib><contrib contrib-type="author"><name><surname>Hussain</surname><given-names>Afzal</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/414473/overview"/></contrib><contrib contrib-type="author"><name><surname>Khan</surname><given-names>Muhammed Nadeem</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Alajmi</surname><given-names>Mohamed F.</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="corresp" rid="c001"><sup>*</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/605291/overview"/></contrib><contrib contrib-type="author"><name><surname>Abid</surname><given-names>Mohammad</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="c002"><sup>*</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/425453/overview"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Medicinal Chemistry Laboratory, Department of Biosciences, Jamia Millia Islamia</institution>, <addr-line>New Delhi</addr-line>, <country>India</country></aff><aff id="aff2"><sup>2</sup><institution>Department of Food Science and Nutrition, College of Food and Agriculture Science, King Saud University</institution>, <addr-line>Riyadh</addr-line>, <country>Saudi Arabia</country></aff><aff id="aff3"><sup>3</sup><institution>Department of Pharmacognosy, College of Pharmacy, King Saud University</institution>, <addr-line>Riyadh</addr-line>, <country>Saudi Arabia</country></aff><aff id="aff4"><sup>4</sup><institution>Department of Tashreehul Badan, Faculty of Unani Medicine, Aligarh Muslim University</institution>, <addr-line>Aligarh</addr-line>, <country>India</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Miguel Cacho Teixeira, University of Lisbon, Portugal</p></fn><fn fn-type="edited-by"><p>Reviewed by: Suman Saha, Priyamvada Birla Aravind Eye Hospital, India; Shanmugaraj Gowrishankar, Alagappa University, India</p></fn><corresp id="c001">*Correspondence: Mohamed F. Alajmi, <email>malajmii@ksu.edu.sa</email></corresp><corresp id="c002">Mohammad Abid, <email>mabid@jmi.ac.in</email></corresp><fn fn-type="other" id="fn004"><p>This article was submitted to Antimicrobials, Resistance and Chemotherapy, a section of the journal Frontiers in Microbiology</p></fn></author-notes><pub-date pub-type="epub"><day>30</day><month>4</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>12</volume><elocation-id>638609</elocation-id><history><date date-type="received"><day>07</day><month>12</month><year>2020</year></date><date date-type="accepted"><day>30</day><month>3</month><year>2021</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2021 Atriwal, Azeem, Husain, Hussain, Khan, Alajmi and Abid.</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Atriwal, Azeem, Husain, Hussain, Khan, Alajmi and Abid</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>In recent years, the demand for novel antifungal therapies has increased several- folds due to its potential to treat severe biofilm-associated infections. Biofilms are made by the sessile microorganisms attached to the abiotic or biotic surfaces, enclosed in a matrix of exopolymeric substances. This results in new phenotypic characteristics and intrinsic resistance from both host immune response and antimicrobial drugs. <italic>Candida albicans</italic> biofilm is a complex association of hyphal cells that are associated with both abiotic and animal tissues. It is an invasive fungal infection and acts as an important virulent factor. The challenges linked with biofilm-associated diseases have urged scientists to uncover the factors responsible for the formation and maturation of biofilm. Several strategies have been developed that could be adopted to eradicate biofilm-associated infections. This article presents an overview of the role of <italic>C. albicans</italic> biofilm in its pathogenicity, challenges it poses and threats associated with its formation. Further, it discusses strategies that are currently available or under development targeting prostaglandins, quorum-sensing, changing surface properties of biomedical devices, natural scaffolds, and small molecule-based chemical approaches to combat the threat of <italic>C. albicans</italic> biofilm. This review also highlights the recent developments in finding ways to increase the penetration of drugs into the extracellular matrix of biofilm using different nanomaterials against <italic>C. albicans</italic>.</p></abstract><kwd-group><kwd><italic>Candida albicans</italic></kwd><kwd>biofilm</kwd><kwd>resistance</kwd><kwd>antifungal drugs</kwd><kwd>prostaglandins</kwd><kwd>small molecule inhibitors</kwd><kwd>naturally occurring compounds</kwd></kwd-group><counts><fig-count count="3"/><table-count count="9"/><equation-count count="0"/><ref-count count="190"/><page-count count="34"/><word-count count="0"/></counts></article-meta></front><body><sec id="S1"><title>Introduction</title><p>Biofilms are structurally organized microbial communities attached to the surfaces of implanted devices encapsulated within a solid protective extracellular matrix (<xref rid="B156" ref-type="bibr">Spormann et al., 2004</xref>). Approximately, 65% of all human microbial infections embroil biofilm formation. Therefore, identifying its role, composition, and impact of microbial biofilms on human medication is an attractive proposition (<xref rid="B41" ref-type="bibr">Douglas, 2003</xref>). Biofilm &#x0201c;inhabitants,&#x0201d; fungi and bacteria, are less sensitive or insensitive to antimicrobial agents. The property of the microorganisms to adhere to different surfaces facilitates the formation of biofilm in clinical settings such as catheters, prosthetic heart valves, joints, and various tissues in the host leading to effective colonization and this results in persistent drug-resistant.</p><p>In recent years, the prevalence of fungal infection has increased. These mycotic diseases account for over 10 lakhs of human deaths annually, which has become a delinquent health issue across the world. In today&#x02019;s scenario, these opportunistic fungal infections have affected immunosuppressed or immunocompromised patients, and folks proclaimed for administration in the intensive care unit. These mycotic infections are classified from non-life-threatening mucocutaneous illnesses to intrusive infections which can affect any organ (<xref rid="B124" ref-type="bibr">Pfaller and Diekema, 2007</xref>; <xref rid="B183" ref-type="bibr">Yapar, 2014</xref>). This kind of fungal infection is often connected with the other mild to lethal fungal or bacterial infections involving species such as <italic>Aspergillus</italic> (<xref rid="B178" ref-type="bibr">Williams et al., 2016</xref>; <xref rid="B139" ref-type="bibr">Richardson and Rautemaa-Richardson, 2019</xref>) different species of <italic>Candida</italic>, <italic>Staphylococcus aureus</italic>, and <italic>Pseudomonas aeruginosa</italic> (<xref rid="B75" ref-type="bibr">Kaplan, 2014</xref>; <xref rid="B128" ref-type="bibr">Pleszczy&#x00144;ska et al., 2015</xref>; <xref rid="B49" ref-type="bibr">Fleming et al., 2017</xref>) and <italic>Cryptococcus neofornams</italic> (<xref rid="B9" ref-type="bibr">Aslanyan et al., 2017</xref>). Of the several known and frequently studied <italic>Candida</italic> species, <italic>C. albicans</italic> is the one most commonly recorded and encountered fungal pathogen in the human race (<xref rid="B157" ref-type="bibr">Su et al., 2018</xref>). Systemic candidiasis, caused by <italic>C. albicans</italic>, is known to be the reason for death in nosocomial and opportunistically abysmal fungal infection in patients (<xref rid="B157" ref-type="bibr">Su et al., 2018</xref>). followed by <italic>Candida glabrata. Candida tropicalis</italic> is commonly found in urinary tract infections (UTI) whereas <italic>Candida parapsilosis</italic> is mostly located on the epidermis of a healthy individual. The latter is also the causative agent of catheter-related infections. Likewise, all <italic>Candida</italic> species depict differences in terms of their biofilm formation, structure, changes in the morphology extracellular matrix (ECM), and potential to resist antifungal drugs (<xref rid="B24" ref-type="bibr">Cavalheiro and Teixeira, 2018</xref>).</p><p>National Nosocomial Infection Survey (NNIS) indicated that <italic>Candida</italic> spp. were the fourth most common cause of nosocomial bloodstream infections during the 1990s. However, in more recent studies, it has been discovered that <italic>Candida</italic> spp. are the third most frequent nosocomial bloodstream isolates (<xref rid="B123" ref-type="bibr">Perlroth et al., 2007</xref>; <xref rid="B89" ref-type="bibr">Lohse et al., 2018</xref>). Additionally, <italic>Candida</italic> is the third mainstream infection of central-line-associated bloodstream infections (CLABSIs) and the second most prominent reason for catheter-associated urinary tract infections in the United States. <xref rid="B88" ref-type="bibr">Lockhart (2014)</xref> Subsequently, the incidence of disseminated candidiasis which broadly refers to the mucosal, cutaneous, and deep-seated organ infection caused by <italic>Candida</italic> genus has increased 15 to 20-fold in the last two decades (<xref rid="B88" ref-type="bibr">Lockhart, 2014</xref>; <xref rid="B121" ref-type="bibr">Pappas et al., 2018</xref>). It has been reported that systemic candidiasis, caused by <italic>C. albicans</italic> is one of the major reasons for death in nosocomial as well as opportunistically abysmal fungal infection in patients because of its ability to form a biofilm which decreases the susceptibility of fungal cells toward drug treatment. Consequently, it has been reported each year that up to 50% of systemic candidiasis adults patients and approximately 30% of the young population die due to candidiasis co-related with biofilms. Moreover, there is an estimation of 100 thousand deaths because of the infection initiated by biofilm formation. Approximately, $6500 millions are spent per year in the United States toward its treatment causing a high fiscal impact on the state (<xref rid="B57" ref-type="bibr">Gulati and Nobile, 2016</xref>; <xref rid="B152" ref-type="bibr">Silva et al., 2017</xref>). The five most widespread species, <italic>C. albicans</italic>, <italic>C. glabrata</italic>, <italic>C. parapsilosis</italic>, <italic>C. tropicalis</italic>, and <italic>C. krusei</italic> are the reason behind 92 to 95% of Intensive Care Unit (ICU) cases in the United States, although, distribution of all five species might vary (<xref rid="B78" ref-type="bibr">Kojic and Darouiche, 2004</xref>; <xref rid="B164" ref-type="bibr">Ten Cate et al., 2009</xref>). According to National Institute of Health (NIH) reports, pathogenic biofilms account for more than 80% of all microbial infections (<xref rid="B134" ref-type="bibr">Ramage et al., 2006</xref>; <xref rid="B123" ref-type="bibr">Perlroth et al., 2007</xref>; <xref rid="B170" ref-type="bibr">Tsui et al., 2016</xref>; <xref rid="B89" ref-type="bibr">Lohse et al., 2018</xref>), of which 75% cases are of vaginal yeast infection in women once or more than once in their lifetime (<xref rid="B123" ref-type="bibr">Perlroth et al., 2007</xref>; <xref rid="B183" ref-type="bibr">Yapar, 2014</xref>).</p><p><italic>Candida albicans</italic> is a commensal fungi, asymptomatically associated with normal microflora of the host, but becomes invasive and virulent when converted to hyphal form covered by an extracellular polymeric substance (EPS), which is a dimorphic nature of <italic>C. albicans</italic> (<xref rid="B57" ref-type="bibr">Gulati and Nobile, 2016</xref>). It is the most stereotypical fungal pathogen in humans, causing disease ranging from apparent mucosal to lethal disseminated bloodstream infections which make a considerable contribution of more than 40% of mortality rates (<xref rid="B89" ref-type="bibr">Lohse et al., 2018</xref>).</p><p>The three stages of the development of <italic>C. albicans</italic> comprise adhesion of the yeast cells on the medical devices (early stage), differentiation of the yeast cells to hyphal cells (intermediate stage), and an increase in the matrix which is the maturation phase (<xref rid="B4" ref-type="bibr">Alim et al., 2018</xref>). The mature biphasic structure of <italic>C. albicans</italic> is promoted by the adhesive hydrophobic nature of indwelling devices with the proper growing environment. Biomedical devices inserted during transplantation catheter are the favorable ones as they provide nutrition like glucose from the excreted products (<xref rid="B134" ref-type="bibr">Ramage et al., 2006</xref>; <xref rid="B4" ref-type="bibr">Alim et al., 2018</xref>).</p><p><italic>Candida albicans</italic> colonizes the skin, intestinal mucosa and/or genital mucosa of 30&#x02013;70% of healthy individuals. Therefore, under normal circumstances, the fungus does not cause any significant disease (<xref rid="B135" ref-type="bibr">Ramage et al., 2014</xref>). Furthermore, about 15% of sepsis cases acquired in a hospital due to medical devices occur due to the predominant fungi <italic>Candida</italic> (<xref rid="B89" ref-type="bibr">Lohse et al., 2018</xref>). According to some recent reports, 63.5% of patients out of 224 patients suffering from septic shock showed a positive result for <italic>Candida</italic> and were found dead. Thus, it is the leading cause of death in hospital procured diseases (<xref rid="B135" ref-type="bibr">Ramage et al., 2014</xref>). In India, just 6-18% of cases of Candidemia are reported. A study exhibits 53 repeated episodes of Candidemia in 48 patients in 1.5 years. Different species made their contribution, like 45% of infections were due to <italic>C. tropicalis</italic>, while 23% of cases by <italic>C. albicans</italic> and the rest 32% by other <italic>Candida</italic> spp. (<xref rid="B80" ref-type="bibr">Kothari and Sagar, 2009</xref>). Western countries&#x02019; trend on candidemia differs from India as <italic>C. albicans</italic> is related to more than 50% of all candidemia incidences (<xref rid="B76" ref-type="bibr">Kaur et al., 2014</xref>).</p></sec><sec id="S2"><title>Recent Challenge-Drug Resistance</title><p>The extensive use of antimicrobials medicaments in a well-connected global human population has increased the cases of antimicrobial resistance (<xref rid="B104" ref-type="bibr">Michael et al., 2014</xref>). According to the UN <italic>ad hoc</italic> Interagency Coordinating Group on Antimicrobial Resistance, drug-resistant diseases by 2050 can bring around 10 million deaths per year and cause an economic catastrophe similar to that of the 2008-2009 global financial recession. By 2030, antimicrobial resistance could affect approximately 24 million people plunging them into severe poverty (<xref rid="B181" ref-type="bibr">World Health Organisation [WHO], 2019</xref>). According to the Center for disease control and prevention, around 7% of all the blood samples from patients suffering from <italic>Candida</italic> is resistant to fluconazole. However, this resistance to azole is persistent for the last 20 years, but resistance toward echinocandins and other drugs is a huge concern. Thus, this situation will prove to be lethal because of the ever -growing human population.</p><p>Owing to its inappropriate use, antifungal drug resistance has emerged as a major challenge that needs immediate attention. This is further aggravated because of the overuse of antibiotics, which affects the normal microflora of humans, providing a favorable environment for <italic>C. albican</italic> to grow (<xref rid="B13" ref-type="bibr">Ben-Ami et al., 2012</xref>). Currently, available drugs are categorized into four major classes which include azoles, polyenes, pyrimidine analogs, and echinocandins. The primary targets of these antifungal drugs are the biosynthetic pathway of ergosterol, the cell wall of fungal cells, or the DNA/RNA of fungi (<xref rid="B19" ref-type="bibr">Borghi et al., 2016</xref>; <xref rid="B142" ref-type="bibr">Sagatova et al., 2016</xref>; <xref rid="B152" ref-type="bibr">Silva et al., 2017</xref>; <xref ref-type="fig" rid="F1">Figure 1</xref>).</p><fig id="F1" position="float"><label>FIGURE 1</label><caption><p>A different mechanism of actions of commonly known antifungal drugs adapted from <xref rid="B155" ref-type="bibr">Spampinato and Leonardi (2013)</xref>.</p></caption><graphic xlink:href="fmicb-12-638609-g001"/></fig><p>Azoles are widely recommended antifungal drugs to treat superficial and invasive fungal infections. The first generation azoles include clotrimazole, bifonazole, econazole, and ketoconazole containing imidazole in their ring system. Fluconazole and itraconazole are some of the renowned examples of second- generation azoles., containing triazole moiety. Voriconazole and posaconazole are the FDA- approved broad -spectrum third generation azole- based antifungal drugs. They exhibit their antifungal effects by inhibiting cytochrome P450-dependent 14&#x003b1;-lanosterol demethylase (Cyp51) encrypted by the ERG11 gene which converts lanosterol to ergosterol (<xref rid="B162" ref-type="bibr">Taff et al., 2013</xref>; <xref rid="B152" ref-type="bibr">Silva et al., 2017</xref>). The ancient class of fungicidal drugs, polyenes, is used to treat severe infections. It intercalates with the steroids ergosterol, found in the cell membrane, creating pores that obliterate the proton gradient of the cell, destabilizing the cell membrane causing leakage of the ions in the process. Another fungicidal drug, Echinocandins (e.g., Caspofungin), is the newest class of antifungals that acts against <italic>Candida spp.</italic> and is administered intravenously. It interferes with the production of &#x003b2;-1,3- glucans, critical polysaccharides and the major constituent of fungal cell walls (<xref rid="B122" ref-type="bibr">Perfect, 2017</xref>; <xref rid="B129" ref-type="bibr">Pristov and Ghannoum, 2019</xref>).</p><p>Analogs of nucleosides like 5-flucytosine (5-FC) are antimetabolites that imitate nucleotide bases in the course of the synthesis of nucleosides. The 5-Flucytosine acts as a pyrimidine correspondent disturbing the synthesis of fungal RNA, DNA, and protein leading to cell cycle arrest. The 5-FC in itself does not act as an antifungal agent but becomes active when changed into 5-fluorouracil. This conversion of 5-FC into 5-FU is catalyzed by the enzyme cytosine deaminase, residing in fungal cells but not present inside the host cells. Even with a vast diversity of antifungal drugs, the problem of resistance persists against the drug sequestration, making it challenging to fight. The classic inventions, polyenes and azoles, are also ineffective against <italic>C</italic>. <italic>albicans</italic> biofilms, thereby limiting the range of treatment. Thus, the indispensable development of new antifungal therapies with high efficiency against the biofilm mode of growth is required. Biofilms are the major contributors and intensifiers of antifungal resilience. As yet, none of these factors works alone. Instead, this antifungal resilience is a multifactorial phenomenon, which is still unexplored. Various factors of intrinsic resilience which alter normal vegetative cell to more virulent form have been listed briefly. These include an increase in the density of cells within the biofilm, complex association extracellular matrix, the existence of persister cells, gene expression of the antifungal resistance genes, and the proliferation of sterols on the membrane of biofilm cells (<xref rid="B140" ref-type="bibr">Romo et al., 2017</xref>; <xref rid="B152" ref-type="bibr">Silva et al., 2017</xref>; <xref rid="B157" ref-type="bibr">Su et al., 2018</xref>).</p></sec><sec id="S3"><title>Fungal Biofilms</title><p>Fungal biofilms are the complex association of hyphal cells which in turn are associated with both abiotic and animal tissues. They are important virulence factors and correlated with invasive fungal infection (<xref rid="B20" ref-type="bibr">Borghi et al., 2015</xref>). They are the sessile microorganisms that, when attached to the abiotic or biotic surfaces, lead to new phenotypic characteristic features (<xref rid="B60" ref-type="bibr">Hawser and Douglas, 1995</xref>; <xref rid="B89" ref-type="bibr">Lohse et al., 2018</xref>). Implantable medical devices are the favorable sites where <italic>C. albicans</italic> form a complex association forming the biofilms, thus becoming responsible for a proportion of clinical candidiasis (<xref rid="B40" ref-type="bibr">Douglas, 2002</xref>).</p><p>Furthermore, adherence of the fungal cell to the available biomaterial and its relatedness to bloodstream infections might be due to hematogenous spread. Medical devices provide a perfect niche to yeast cells because of their structure to chemical properties ranging from hydrophobicity to surface roughness. These devices are surrounded by body fluids like urine, blood, saliva, and synovial fluid, which condition them with glycoproteinaceous film (<xref rid="B55" ref-type="bibr">Gristina et al., 1988</xref>; <xref rid="B158" ref-type="bibr">Subbiahdoss et al., 2010</xref>). This acclimatizing film can accord chemical properties entirely different from its origin. The mature biphasic structure of C. <italic>albicans</italic> is promoted by non-specific factors (cell surface hydrophobicity and electrostatic forces) and specific adhesins on the fungal surface recognizing ligands in the conditioning films, such as serum proteins (fibrinogen and fibronectin) and salivary factors (<xref rid="B25" ref-type="bibr">Chaffin et al., 1998</xref>; <xref rid="B38" ref-type="bibr">Demuyser et al., 2014</xref>). Also, <italic>C. albicans</italic> cells can co-aggregate to interact with bacterial cells/colonies already vested in these devices (<xref rid="B25" ref-type="bibr">Chaffin et al., 1998</xref>; <xref rid="B134" ref-type="bibr">Ramage et al., 2006</xref>). Nevertheless, the preliminary focal attachment of the fungal cell to a substratum is accompanied by multiplication and propagation of cells followed by biofilm development (<xref rid="B154" ref-type="bibr">Soll and Daniels, 2016</xref>; <xref rid="B152" ref-type="bibr">Silva et al., 2017</xref>).</p><sec id="S3.SS1"><title>Pathogenesis of Biofilm</title><sec id="S3.SS1.SSS1"><title>Stages of Biofilm Development</title><p>It has been observed that biofilm development follows sequential steps over a period of 24&#x02013;48 h (<xref rid="B100" ref-type="bibr">Math&#x000e9; and Van Dijck, 2013</xref>; <xref rid="B162" ref-type="bibr">Taff et al., 2013</xref>; <xref ref-type="fig" rid="F2">Figure 2</xref>). Initially, a single yeast cell adheres to the substratum making a foundation for the layer of a yeast cell (<italic>adherence step</italic>) (<xref rid="B48" ref-type="bibr">Finkel and Mitchell, 2011</xref>; <xref rid="B100" ref-type="bibr">Math&#x000e9; and Van Dijck, 2013</xref>; <xref rid="B179" ref-type="bibr">Williams et al., 2013</xref>). Following this initial phase is the phase of cell proliferation where cells project out and continue to grow into the filamentous structure of hyphal cells through the surface (<italic>initiation step</italic>). The assembly of hyphae marks the beginning of biofilm formation accompanied by the accretion of an extracellular matrix (ECM) on maturation biofilm (<italic>maturation step</italic>). Lastly, non-adhering yeast cells detach themselves from the biofilm into the environment to find a favorable site of attachment (<italic>dispersal step</italic>).</p><fig id="F2" position="float"><label>FIGURE 2</label><caption><p>Schematic diagram of different stages of biofilm development.</p></caption><graphic xlink:href="fmicb-12-638609-g002"/></fig><p>Spreading of biofilm-associated yeast cells has tremendous clinical significance as they can start the formation of new biofilms or circulate throughout the host cell and tissues leading to disseminated invasive diseases or candidemia. Various factors promoting the pathogenesis of <italic>C. albicans</italic> biofilm (<xref ref-type="fig" rid="F3">Figure 3</xref>) have been reported, which are discussed in the following section.</p><fig id="F3" position="float"><label>FIGURE 3</label><caption><p>Different factors promoting the pathogenesis of the <italic>C. albicans</italic> biofilm.</p></caption><graphic xlink:href="fmicb-12-638609-g003"/></fig></sec><sec id="S3.SS1.SSS2"><title>Extracellular Matrix Formation (ECM)</title><p>The extracellular matrix is a critically important feature of biofilms that guards the adherent cells against the host immune system and antifungal agents by forming an extensive structure of the matrix (<xref rid="B19" ref-type="bibr">Borghi et al., 2016</xref>). In some of the pioneer works, it was shown that <italic>Candida</italic> species biofilm&#x02019;s matrices increase when highly dynamic flow environments influence biofilm, and its quantity extensively depends upon strain and the species. Moreover, the chemical composition of <italic>C. albicans</italic> ECM suggests that the extracellular matrix is composed of approximately 55% of a combination of glycoproteins with carbohydrates contributing to only 25% of the total composition. Carbohydrates consist largely of &#x003b1;-mannan and &#x003b2;-1, 6-glucan polysaccharides with &#x003b2;-1, 3-glucans making a very little contribution. ECM also consists of 15% of lipids and only 5% of nucleic acids. &#x003b2;- 1, 3- glucan plays a major role in azole resilience by specific binding. Additionally, the biofilm is two times thicker than planktonic cells. Upon comparison of the chemical composition of planktonic cells with biofilm cells, it was observed that there is a difference in carbohydrate and &#x003b2; 1, 3 glucan composition (<xref rid="B92" ref-type="bibr">Mah and O&#x02019;Toole, 2001</xref>; <xref rid="B111" ref-type="bibr">Nett et al., 2010</xref>; <xref rid="B152" ref-type="bibr">Silva et al., 2017</xref>; <xref rid="B89" ref-type="bibr">Lohse et al., 2018</xref>; <xref rid="B121" ref-type="bibr">Pappas et al., 2018</xref>).</p></sec><sec id="S3.SS1.SSS3"><title>Extracellular DNA and Genetic Factors</title><p>Extracellular DNA (e-DNA) present inside the extracellular matrix is a major contributor to the stability of the <italic>C. albicans</italic> biofilm. The e-DNA is present both in bacterial and fungal biofilms; hence, when these biofilm-forming microorganisms are treated with DNAase enzyme in combination with the respective drugs, they exhibit a decrease in the biofilm matrix (<xref rid="B99" ref-type="bibr">Martins et al., 2014</xref>). Various genetic factors like Bcr1 (a transcription factor required for the attachment of fungal cells to the abiotic surfaces), Rlmp, Brg1, Efg1, Ndt80, Rob1, and Tec1, Fsk1p, Smi1p (which works in unification with Fsk1p and Rlmp), Gcr1, Mnn4 are under study. All these factors work together and interact with different genes to regulate and generate biofilms, thus, has given new insight to biofilm formation (<xref rid="B48" ref-type="bibr">Finkel and Mitchell, 2011</xref>; <xref rid="B112" ref-type="bibr">Nett et al., 2011</xref>; <xref rid="B114" ref-type="bibr">Nobile et al., 2011</xref>).</p></sec><sec id="S3.SS1.SSS4"><title>Quorum Sensing (QS)</title><p>Another mechanism related to extracellular properties of the matrix of the <italic>C. albicans</italic> is quorum sensing, which plays a significant role in the growth of biofilms. It is a density-dependent cell-cell communication mechanism in which autoinducers (signal molecules) are released in response to the increasing density, which enhances or represses the activation of certain genes or factors. This density-dependent mechanism affects different aspects of microorganisms like pathogenesis, morphology, competence, etc. Importantly, it also makes its contribution to biofilm formation. Earlier, QS was thought to be an exclusive feature of a certain bacterial system, but the recent discovery of farnesol, a quorum-sensing molecule inhibiting <italic>C. albicans</italic> biofilms, has publicized QS (<xref rid="B136" ref-type="bibr">Ramage et al., 2002</xref>). Genetic regulation of virulent genes in pathogenic microorganisms by QS has shown an indirect connection with the emergence of multi-drug resistant pathogens. Thus, it necessitates the finding of alternative strategies to target QS and restrain the same (<xref rid="B48" ref-type="bibr">Finkel and Mitchell, 2011</xref>; <xref rid="B162" ref-type="bibr">Taff et al., 2013</xref>).</p></sec><sec id="S3.SS1.SSS5"><title>Evasion of Host Immune Responses</title><p>The immune system plays a crucial role in the recognition and elimination of the <italic>C. albicans</italic>. The innate immune system, which is the first line of defense, recognizes pathogen-associated molecular patterns of a pathogenic strain of <italic>C. albicans</italic> leading to the activation signaling channels of a host organism resulting in the extermination of the <italic>C. albicans</italic> cells.</p><p>According to recent studies, ten diverse surface receptors participate in this recognition pattern. They are Toll-like receptors -TLR4 and TLR2, TLR9, and NLR Family Pyrin Domain Containing 3 (NLRP3) the internal receptors, C-type lectin receptors, Dectin-1and 2, Dendritic Cell-Specific Intercellular adhesion molecule-3-Grabbing Non-integrin (DCSIGN), Mincle, and Mannose-binding lectin. Usually, these receptors recognize and bind to sugar moieties (&#x003b2;-1, 3-glucans, and mannose derivatives) present on the cell surface of <italic>C. albicans</italic>. Due to this binding, the cytokine complement system gets activated, phagocytizing the fungal cells. Internal uptake of these fungal cells by APCs (antigen-presenting cells) expedites the activation of internal receptors; thus, resultant activation of TLR9 or NLRP3 inflammasome occurs. This non-specific immune response (innate response) has a significant role in preventing <italic>C. albicans</italic> infection. Besides, the adaptive immune response also makes its contribution by producing antibodies against some specific extracellular proteins, obstructing the <italic>C. albicans</italic> growth.</p><p>On the other hand, there are many strategies employed by <italic>C. albicans</italic> to evade the immune response. Mature biofilms escape immune responses owing to the presence of a top layer of biofilm composed of hyphal cells which mask the &#x003b2;-glucans component of biofilm. Subsequently, these hyphal cells escape the neutrophil killing either by penetrating the epithelial cell layers in the course of invasive growth or by escaping immune response by physical penetrating inside the cell. The variance in the degree of expression of genes in planktonic cells concerning biofilms cells has a connection with a mechanism of immune evasion. There are several proteins that are highly expressed and they also restrict the stimulation of the host complement system. For example, Zinc binding cell surface protein Pra1, a cell surface glycerol-3-phosphate dehydrogenase protein (Gpd2), and all the secretory proteins of aspartyl protease (Sap) family. Another well-known protein that functions as a sensor for cell wall damage with high expression in biofilms is Msb2. This protein secretes and blocks the antimicrobial peptides preventing complement activation.</p><p>Neutrophils are the first foot soldiers of the immune system which are altered during biofilm formation. Neutrophils work with different modes of action like phagocytosis, oxidative response, and non-oxidative response against the emerging pathogen. Another known novel mechanism that was discovered in 2004, is the Neutrophil extracellular trap &#x0201c;NETosis.&#x0201d; It is a complex structure that comprises neutrophil chromatin, DNA, and protein. NETosis degranulates neutrophils and releases a lytic enzyme, which is different from necrosis and apoptosis. It has killing properties against planktonic yeast cells; however, it is seemingly ineffective against <italic>C. albicans</italic> biofilms (<xref rid="B21" ref-type="bibr">Branzk and Papayannopoulos, 2013</xref>; <xref rid="B71" ref-type="bibr">Johnson et al., 2016</xref>, <xref rid="B72" ref-type="bibr">2017</xref>; <xref rid="B170" ref-type="bibr">Tsui et al., 2016</xref>). Some studies also suggest that the peripheral mononuclear cells (PBMCs) -due to some unknown factors- thicken the <italic>C. albicans</italic> biofilms rather than phagocytizing them. Furthermore, mature biofilms do not evoke a vigorous oxidative response, a primary mechanism of neutrophil killing microbes (<xref rid="B89" ref-type="bibr">Lohse et al., 2018</xref>; <xref rid="B121" ref-type="bibr">Pappas et al., 2018</xref>).</p></sec><sec id="S3.SS1.SSS6"><title>Polymicrobial Species</title><p>Humans provide an immediate small- scale environment to a varied population of microbial species. The human microbiota embraces members from three kingdoms of life: Archaea, Bacteria, and fungi. They usually exist in a symbiotic relationship leading to a complex association of ecosystems. Imbalance in this symbiotic association due to genetic or environmental factors of the host - like changes in pH, shifts in host immunity, and transient viscosity of mucosal layers, and indiscriminate usage of broad-spectrum antimicrobial agents- lead to the disproportionate infection by the overgrowth of specific microbial species over others.</p><p><italic>Candida albicans</italic> is the most frequent fungal pathogen present in commensalism with bacteria. Furthermore, there is incremental progress in the dual-species biofilms formation between common bacterial species and <italic>C. albicans</italic> that usually interact in human beings to cause infection. These kinds of interaction which lead to diseases are studied and concluded based on observational studies, arising mainly in immunocompromised patients. It is difficult to establish a clinical prognosis of polymicrobial interaction from immunocompromised individuals as they are highly vulnerable to other infections. Hence, it is tough to evaluate the degree of polymicrobial interactions and molecular mechanisms from such studies. <italic>In vitro</italic> studies suggest that bacterial species and <italic>Candida spp.</italic> isolated from different parts, like the vagina, oral cavity, etc., interact with each other in different ways. This includes exudation of signaling molecules which influences species behavior toward each other, physical interaction between microbial cells (e.g., hyphal cells provides an attachment site to bacterial cells contained within polymicrobial biofilms), biochemical alterations of the local environment like change in oxygen content and pH. For instance, in the case of the vaginal microbiota, <italic>C. albicans</italic> interacts with Lactobacillus species which produces lactic acid that changes local pH, thus hindering C. <italic>albicans</italic> growth on the mucosal surface of the vagina. Some hyphal cell wall proteins (E.g., Hwp1), transcription regulators (Tec1 and Bcr1, Efg1, Cph1, etc.) and adhesive proteins (E.g., Als1, Als2, and Als3) show a pivotal role in enhancing the expression of virulent genes and hence the resistance in bacterial species such as <italic>Staphylococcus aureus</italic>, <italic>Streptococcus gordonii</italic> and <italic>Staphylococcus epidermidis</italic> (<xref rid="B59" ref-type="bibr">Harriott and Noverr, 2010</xref>; <xref rid="B120" ref-type="bibr">Pammi et al., 2013</xref>; <xref rid="B29" ref-type="bibr">Chinnici et al., 2019</xref>). However, deletion or mutation of these proteins results in a decrease in the number of bacterial cells and weakens their interaction with <italic>C. albicans</italic>. Although biofilms are formed in an oxygen-rich environment, some anaerobic bacteria can easily grow under <italic>C. albicans</italic> biofilms. These biofilms provide bacteria with a positive anaerobic environment to grow. In return, the bacteria augments the formation of <italic>C. albicans</italic> &#x0201c;mini biofilms&#x0201d; which can easily float and grow under the toxic condition (<xref rid="B41" ref-type="bibr">Douglas, 2003</xref>; <xref rid="B48" ref-type="bibr">Finkel and Mitchell, 2011</xref>; <xref rid="B57" ref-type="bibr">Gulati and Nobile, 2016</xref>; <xref rid="B4" ref-type="bibr">Alim et al., 2018</xref>).</p></sec><sec id="S3.SS1.SSS7"><title>Efflux Pumps</title><p>Overexpression of efflux pumps is one of the major contributors to antifungal drug resistance in <italic>C. albicans</italic> as they lead to drug sequestration by pumping out the antifungal drugs given as a treatment. Subsequently, these are primarily concerned with first-generation azoles but ineffective toward Echinocandins resistance. During usual antifungal treatment toward planktonic cells, efflux pumps prevent the intracellular accumulation of antifungal drugs by up-regulating their expression (<xref rid="B19" ref-type="bibr">Borghi et al., 2016</xref>; <xref rid="B154" ref-type="bibr">Soll and Daniels, 2016</xref>; <xref rid="B170" ref-type="bibr">Tsui et al., 2016</xref>). The Cdr1, 2 (ATP binding cassette transporter superfamily), and Mdr1 (Major facilitator transporter superfamily) are the two major classes of efflux pumps that control drug exportation in <italic>C. albicans.</italic> Moreover, initially, after a few hours of up-regulation in biofilms, they persist in being up-regulated all through the biofilm growth even in the absence of the antifungal drug. Rapid upregulation of efflux pumps happens during the primary stage of biofilm formation.</p></sec><sec id="S3.SS1.SSS8"><title>Persister Cell and Stress Response</title><p>Another major contributing element toward resistance is persister cells, which are the inconsequential subset of yeast cells with minimum metabolic activity assumed to be raised as a phenotypic variant but not a mutant type. They are highly resistant cells within biofilms. Amphotericin B treatment upon <italic>C. albicans</italic> led to the discovery of persister cells. These cells are acknowledged to be persister as they maintain themselves in a dormant stage. Still, in a stressful situation, they reactivate themselves to a state of active metabolism and reinstate as biofilms. Subsequently, drug sequestration by persister cells occurs due to some virulent traits like hyphal growth rather than an expression of efflux pumps and cell membrane structure (<xref rid="B92" ref-type="bibr">Mah and O&#x02019;Toole, 2001</xref>; <xref rid="B170" ref-type="bibr">Tsui et al., 2016</xref>; <xref rid="B152" ref-type="bibr">Silva et al., 2017</xref>; <xref rid="B89" ref-type="bibr">Lohse et al., 2018</xref>).</p></sec></sec></sec><sec id="S4"><title>Antibiofilm Strategies</title><p>The social burden of fungal disease is massive with approximately more than 1.5 billion people affected by the fungal disease worldwide per annum. However, these invasive fungal infections are estimated to be the cause of about 1.5 million deaths per year, making this a noteworthy health problem (<xref rid="B17" ref-type="bibr">Bongomin et al., 2017</xref>). While flourishing in its most usual mode of growth, a biofilm of <italic>C. albicans</italic> biofilm displays increased resistance to the available antifungal drugs. These persistent groups of cells are difficult to eradicate and, ever so often, accountable for treatment failures. There is a necessity to develop new strategies to exterminate and treat these emerging <italic>C. albicans</italic> biofilm infections in the medical setting.</p><p>Different targets have gained attention aiming to tackle this growing antifungal resistance problem. Treating these biofilms is a big hurdle in medical mycology; thus, there is a vast exigency for the development of new antifungal agents and identification of novel targets.</p><p>Considering the efforts undertaken to find solutions to the fungal biofilm infections, the reader may acknowledge the complicated mechanisms that impede the path to reach the panacea. The research was done while managing the patients so far has led to the conclusion that the study of biofilm phenotype is inevitable to restrict fungal biofilms. Besides, the counter effect of fungus on the drug should be examined not just against the planktonic cells but also against the biofilm. Since fully established mature biofilms are much more challenging to treat and eradicate, preemptive practices targeting planktonic cells further inhibiting the early development of biofilms are the need of the hour. Nonetheless, strategies to combat mature biofilms should also be kept in mind. We discuss specific strategies that are under scrutiny, globally, against the problem of drug resistance (<xref rid="B127" ref-type="bibr">Pierce et al., 2015b</xref>; <xref rid="B140" ref-type="bibr">Romo et al., 2017</xref>).</p><sec id="S4.SS1"><title>Prostaglandins</title><p>Molecular studies on biofilms have revealed the important role of lipids on antifungal resistance. The lipid profile of planktonic cells differs from that of biofilms, making lipids a censorious modulator of resistance. This change in the sphingolipids and sterol profile promotes biofilm formation affects cells morphology and physiology altering the adhesion properties in <italic>C. albicans</italic> (<xref rid="B4" ref-type="bibr">Alim et al., 2018</xref>; <xref rid="B157" ref-type="bibr">Su et al., 2018</xref>). Thus exploiting these prostaglandins adaptation and their properties could be targeted for treatment. The signaling cascade of Arachidonic acid (AA) is pivotal for both biology of humans and fungi morphology and growth. Very nearly each of the following enzymes of the AA cascade can be subjected to the pharmacological investigation: Cyclooxygenase (COX), Cytochrome P 450 (CYP), and Lipoxygenase (LOX) (<xref rid="B87" ref-type="bibr">Liu et al., 2016</xref>). Arachidonic acid could be processed into different types of eicosanoids.</p><p>Prostaglandins are synthesized by cyclooxygenase enzymes in human cells as well as pathogenic fungi. Prostaglandin E2 is the profusely synthesized prostaglandin that transfers immune responses of humans in the direction which endorses fungal establishment and chronic illness (<xref rid="B43" ref-type="bibr">Erb-Downward and Noverr, 2007</xref>; <xref rid="B4" ref-type="bibr">Alim et al., 2018</xref>). PGE<sub>2</sub> inhibits T- helper cells (Type-1) &#x02013;Th-1 and stimulates the progression of T-helper cells (Type II)-Th-2. These cells are responsible for maintaining the inflammatory responses as Th-1 is accountable for pro-inflammatory responses, while Th-2 for producing anti-inflammatory responses (<xref rid="B15" ref-type="bibr">Berger, 2000</xref>). PGE<sub>2</sub> also down-regulates the production of chemokine and TNF&#x003b1;, thus augmenting the fungal colonization and germ tube formation.</p><p>Arachidonic acid, when used along with antifungal drugs, affects the level of prostaglandin E2 in a variety of <italic>Candida</italic> spp. The above-mentioned study suggests that lipid plays a specific role in the structural aspects, signaling cascade, fungal pathogenicity, and metabolic activity of biofilm development in <italic>C. albicans.</italic> However, the defined part of lipid-dependent processes in the development of <italic>C. albicans</italic> biofilm is still not known. Genetic modulation and pharmacological inflection of biosynthetic pathways of lipids are the two stratagems that have been browbeaten in linking lipid alterations with <italic>C. albicans</italic> biofilm morphology- its formation and function in this fungi. Modulating the lipid composition of the cell membrane by comprehensively targeting genes that encode enzymes for lipid biosynthesis regulates endogenic lipid levels (<xref rid="B116" ref-type="bibr">Noverr and Huffnagle, 2004</xref>; <xref rid="B43" ref-type="bibr">Erb-Downward and Noverr, 2007</xref>; <xref rid="B148" ref-type="bibr">Sherry et al., 2012</xref>; <xref rid="B50" ref-type="bibr">Fourie et al., 2016</xref>; <xref rid="B87" ref-type="bibr">Liu et al., 2016</xref>).</p></sec><sec id="S4.SS2"><title>Modification of the Surface of Biomedical Devices</title><p>Biomaterial-associated-infection (BAI) is the major cause of dereliction of biomaterial implants. Microbial contamination of biomaterial devices during implant surgery (peri-operative contamination) or hospitalization (<xref rid="B55" ref-type="bibr">Gristina et al., 1988</xref>), causes the onset of BAI. Microorganisms present in BAI are resistant due to the biofilm mode of growth. The extensive use of indwelling catheters in recent medicine, particularly central venous and hemodialysis catheters, has contributed significantly to the increasing incidence of fungal bloodstream infections, in particular, candidiasis (<xref rid="B127" ref-type="bibr">Pierce et al., 2015b</xref>).</p><p>Traditionally, to decrease the cases of nosocomial infection, which occurs due to central line-associated bloodstream infections (CLABSIs), removal of the devices and providing systemic antimicrobial therapy was performed to eradicate these microorganisms.</p><p>These biomedical-assisted devices with a wide range of biomaterials are utilized by a wide range of pathogenic fungi like <italic>C. albicans</italic> to support adhesion, colonization, and subsequent biofilm formation (<xref rid="B134" ref-type="bibr">Ramage et al., 2006</xref>; <xref rid="B163" ref-type="bibr">Talsma, 2007</xref>). Thus, to preclude these contagious microorganisms on the surface of implanted devices with biofilms, there is an inquisitiveness in the development and improvement of unconventional biomaterials which are unfavorable to microbial (both fungal and bacterial) adhesion and colonization. Another modification strategy from some studies suggests that modifying the surface chemistry of the biomaterials could be an approach to prevent or reduce biofilm formation. This could be achieved by adding surface-modifying end groups (SMEs) or by altering the chemical composition of substrates. For example, SME Polyetherurethane when added to Elasthane 80A, a biomaterial, decreased the <italic>C. albicans</italic> ability to form biofilm significantly (<xref rid="B26" ref-type="bibr">Chandra et al., 2005</xref>).</p></sec><sec id="S4.SS3"><title>Antibiotic Lock Therapy (ALT)</title><p>Antibiotic lock therapy is, in general, a combination of an antibacterial solution that has minimum inhibitory concentrations (MIC) 100-1000 times greater than the antibiotic used for planktonic cells in combination with the anticoagulant instilled into the lumen of a catheter. The solution is allowed to dwell or is &#x0201c;locked&#x0201d; while the Central Venous Catheter (CVC) is not used to prevent colonization or sterilize a previously infected catheter (<xref rid="B18" ref-type="bibr">Bookstaver et al., 2013</xref>; <xref rid="B74" ref-type="bibr">Justo and Bookstaver, 2014</xref>; <xref rid="B115" ref-type="bibr">Norris et al., 2017</xref>). The study suggests that only 10% of the patients subjected to ALT needed conventional replacement therapy compared to 33% of the patients treated with systemic antimicrobial drugs (<xref rid="B117" ref-type="bibr">O&#x02019;Horo et al., 2011</xref>). Ethanol Lock solution at more than 40% dwelled onto catheter with <italic>C. albicans</italic> biofilm cleansed the catheter within 30 minutes (<xref rid="B118" ref-type="bibr">&#x000d6;nc&#x000fc;, 2014</xref>). Interestingly, an <italic>in vitro</italic> study of 40% ethanol lock solution in combination with 60IU heparin showed a significant decrease in &#x02265;90% of <italic>C. albicans</italic> biofilm metabolism (<xref rid="B6" ref-type="bibr">Alonso et al., 2018</xref>).</p></sec><sec id="S4.SS4"><title>Small Molecular Inhibitors and Natural Products</title><p>Microbiological resistance depends on various fungal factors that have been established due to genetic alteration in the fungi. Clinical resistance is due to host- or drug-related factors. All these factors may cause fungal resistance individually or in tandem. In addition to standardized susceptibility testing and appropriate drug dosing, one way to avoid resistance is the use of combinational antifungal therapy. Combination therapy also offers advantages in increased synergistic action with enhanced spectrum activity. Newer insights into mechanisms of drug resistance will help in the development of appropriate antifungal therapy.</p><p>For dealing with this problem of resistance, there are two ways: (i) finding of the novel anti-biofilm molecules and (ii) repurposing of the known drug to increase the activity of antifungal agents by combinational therapy. Due to the scarcity of known molecular scaffolds that inhibit/disperse fungal biofilms, high throughput screening (HTS) has been employed in an attempt to discover leads for new anti-biofilm modulators. Intending to identify novel small molecules that possessed anti-biofilm activity, screening of an extensive chemical library of compounds took a new start. It was observed that clinical isolates of <italic>C. albicans</italic> have varied abilities to respond to different growth media to form hyphae and also biofilms, and this variability is not associated with specific host conditions or characteristics. A high-content screen has identified many new structural series of antifungal compounds with the mode of action, namely inhibition of biofilm formation and filamentation. Many compounds among them represent a promising candidate for the development of novel anti-virulence approaches against <italic>C. albicans</italic> infections, aimed at minimizing the development of resistance.</p><sec id="S4.SS4.SSS1"><title>Different Targets of Small Molecule Inhibitors</title><p>Small molecular inhibitors have been identified specifically for various targets along with their MIC/IC50 values which are summarized in the tables mentioned below.</p><sec id="S4.SS4.SSS1.Px1"><title>Inhibitors of budded to hyphal transition</title><p>The pathogenic yeast <italic>C. albicans</italic> can exist in multiple morphological states, including budded, pseudohyphal, and true hyphal forms. The ability to change between the budded and hyphal forms, termed as the budded-to-hyphal-form transition, is important for virulence and is regulated by multiple environmental and cellular signals (<xref rid="B168" ref-type="bibr">Toenjes et al., 2005</xref>).</p><p>Filastatin <bold>1,</bold> inhibits yeast to hyphal transition, impedes the adhesion of fungal cells to different biomaterials by inhibiting the hyphal specific <italic>HWP1</italic> promoter. Interestingly, in the <italic>in vivo</italic> studies, filastatin in the presence of fluconazole protected <italic>C. elegans</italic> against <italic>C. albicans</italic> infection. Moreover, it also inhibited biofilm formation in a mouse model of vulvovaginal candidal infection (<xref rid="B46" ref-type="bibr">Fazly et al., 2013</xref>). Similarly, Johnson and the group identified several small molecular inhibitors. This includes Buhytrin A <bold>2</bold>, CGP-37157 <bold>3</bold> (affecting the calcium metabolism of bud to hyphal transition), and ETYA <bold>4</bold> (inhibiting multiple signaling pathways) and Clozapine <bold>5</bold> (FDA approved antipsychotic drug inhibiting Efg1 pathway at Gpr1 G-protein-coupled receptor level). These molecules restrict the bud to hyphal growth in <italic>C. albicans</italic> and affect multiple signaling pathways that are intricate in the filamentation process which regulates the biofilm formation (<xref rid="B105" ref-type="bibr">Midkiff et al., 2011</xref>; <xref rid="B54" ref-type="bibr">Grald et al., 2012</xref>; <xref rid="B127" ref-type="bibr">Pierce et al., 2015b</xref>). By screening a library of 50,240 small molecules of inhibitors for yeast-to-hypha transition, Sm21 <bold>6</bold> was identified as a novel small antifungal molecule that showed its efficacy in both <italic>in vivo</italic> oral candidiasis mouse model and <italic>in vitro</italic> system. The study also revealed that compound <bold>6</bold> when given to <italic>C. albicans</italic> strain led to reactive oxygen species (ROS) accumulation and mitochondrial dysfunction (<xref rid="B180" ref-type="bibr">Wong et al., 2014</xref>; <xref rid="B169" ref-type="bibr">Truong et al., 2018</xref>). In another study, Chrysazin <bold>7</bold> (1, 8-dihydroxyanthraquinone) and Alizarin <bold>8</bold> (1, 2-dihydroxyanthraquinone) an anthraquinone derivative, effectively inhibits biofilm formation in <italic>C. albicans.</italic> Their anti-biofilm activity was mainly due to a hydroxyl group (-OH) at C1 position. Unlike other commercially available drugs, alizarin was found to be a non-toxic compound. It downregulates the expression of various hyphal-specific and biofilm related genes like <italic>ALS3, ECE1, ECE2</italic>, and <italic>RBT1</italic>. Additionally, Chrysazin and Alizarin at 2 &#x003bc;g/ml adequately inhibited yeast to hyphal formation and increased the survivability of <italic>C. albicans</italic> infected <italic>C. elegans</italic>, thus, proving to be a strong candidate for future investigation as an antifungal agent (<xref rid="B96" ref-type="bibr">Manoharan et al., 2017b</xref>).</p><p>While performing high throughput screening in a chemical library (NOVACore<sup>TM</sup>), about 20,000 small molecules were identified as a novel series of a Diazaspiro-decane and its structural analogs (9a-d). These molecules inhibit progressions of the virulence-associated with <italic>C. albicans</italic>, especially biofilm formation and filamentation, without affecting the overall growth or prompting the resistance in <italic>C. albicans.</italic> These compounds displayed a potent inhibitory activity when tested against murine models of oral candidiasis (<xref rid="B125" ref-type="bibr">Pierce et al., 2015a</xref>). In addition to all these, when 678 small molecules were screened from the chemical library by the group scientist against the invasive hyphal growth of the opportunistic human yeast <italic>C. albicans</italic>, it led to the discovery of two halogenated compounds (N1-(3,5-dichlorophenyl)-5-chloro-2-hydroxybenzamide) 10 and Niclosamide 11 which is the analog of salicylanilide, an FDA-approved anthelmintic in humans, both exhibiting an anti-filamentation and anti-biofilm activities against <italic>C. albicans</italic> (<xref rid="B51" ref-type="bibr">Garcia et al., 2018</xref>).</p><p>Another compound N-[3-(allyloxy)-phenyl]-4-methoxyben zamide <bold>12</bold> was recognized as the lead one showing inhibition against C. <italic>albicans</italic> filamentation and was found effective in both <italic>in vitro</italic> and <italic>in vivo</italic> study of <italic>C. albicans</italic> infected murine model. The whole transcriptomic analysis revealed a total of 618 genes that were up-regulated and 702 were down-regulated. It was observed that most of the down-regulated genes such as SAP5, ECE1, and ALS3 already well-characterized were associated with filamentation and virulency. In addition, some genes affect metal chelation and utilization (<xref rid="B141" ref-type="bibr">Romo et al., 2019</xref>).</p><p>Homology studies using <italic>Candida</italic> Genome Database showed that <italic>Candida</italic> accounts for type III 5-&#x003b1;-reductase, Dfg10p, and shares a 27% sequence identity and 41% similarity to the human type III 5-&#x003b1;-reductase, which were identified as a target for benign prostatic hyperplasia. Finasteride <bold>13</bold> was recognized as one of the potent inhibitors against type III 5-&#x003b1;-reductase. Studying its activity showed some promising results at dose &#x02265;16 mg/liter. Finasteride alone was highly efficient in preventing filamentation of <italic>C. albicans</italic> and demonstrated synergy with FLC against <italic>in vitro</italic> urinary biofilm (<xref rid="B27" ref-type="bibr">Chavez-Dozal et al., 2014</xref>).</p><p>LaFleur group, while filtering through 120,000 small compounds from the NIH Molecular Libraries Small Molecule Repository, identified 1,3-benzothiazole <bold>14, 14(a-c)</bold> and its scaffolds as an anti-filamentation drug which acts as an potentiate a known antifungal drug Clotrimazole by increasing its activity to &#x0003e;100 fold against <italic>C. albican</italic> biofilm isolates (<xref rid="B81" ref-type="bibr">LaFleur et al., 2011</xref>).</p></sec><sec id="S4.SS4.SSS1.Px2"><title>Enzymes</title><p>Potent inhibitors of essential microbial enzymes are significant growth inhibitors of <italic>C. albicans</italic>, a pathogenic fungi. The enzyme aspartate semialdehyde dehydrogenase (ASADH) is critical for the functioning of the biosynthetic pathway of aspartate in microbes and plants, an important step for the biosynthesis of other essential amino acids. Because the aspartate pathway is absent in humans, ASADH can be a promising new target for antifungal research. Deleting the ASD gene encoding for ASADH significantly decreases the survival of <italic>C</italic>. <italic>albicans</italic>, establishing this enzyme as essential for this organism (<xref rid="B34" ref-type="bibr">Dahal and Viola, 2018</xref>; <xref rid="B33" ref-type="bibr">Dahal et al., 2020</xref>).</p><p>The 1,4-Napthoquinone and its derivatives <bold>15, 15 (c-e)</bold> did possess activity against clinical isolates of <italic>C. albicans</italic> derived from gynecological patients by inhibiting phenotypic changes in <italic>C. albicans</italic>. Additionally, some other studies also establish that dichloro-derivatives of 1,4 naphthoquinone i.e., 2-chloro 1,4-Naphthoquinone <bold>15a</bold> and 2,3-dichloro naphthoquinone <bold>15b</bold> are the inhibitors of ASADH (aspartate dehydrogenase) (<xref rid="B67" ref-type="bibr">Janeczko et al., 2018</xref>).</p><p>Secreted Aspartic Protease-2 enzymes (SAP2) of the <italic>C. albicans</italic> are one of the known classes of the virulent factor for localized and systemic infection. In <italic>C. albicans</italic>, ten distinct SAP genes (SAP1-10) were expressed <italic>in vitro</italic> and <italic>in vivo</italic>. The SAPs are essential for the fungal nutrition process and contribute to the fungal pathogenicity due to their critical participation in several stages of the infective process, including adhesion, invasion, and tissue damage and so on. Pepstatin and peptidomimetic are the known peptide inhibitors, but it is challenging to clinically synthesize them due to pharmacokinetic characteristics. So from the studies, compound <bold>16,</bold> one of the derivatives of pepstatin, came out to be a potent inhibitor against 3 of the SAP2 present in fungi. Moreover, compound <bold>16</bold> and fluconazole when administered to FLC resistant mouse model infected with <italic>C. albicans</italic> showed synergistic effect by increasing the survival rate of the mouse by 50% (<xref rid="B22" ref-type="bibr">Cadicamo et al., 2013</xref>).</p><p>Targeting proteinases and phospholipases, which are vital to fungal invasion of host tissues and immunosuppression, <xref rid="B8" ref-type="bibr">Aneja et al. (2016)</xref> developed an s triazole series&#x02013;amino acid hybrids. It was found that compounds <bold>17</bold> and <bold>18</bold> significantly reduce the secretion of proteinases and phospholipases in <italic>Candida</italic> spp. which are vital to fungal invasion of host tissues and immunosuppression. The study showed that on treatment with compound <bold>17</bold>, proteinase secretion was decreased by 29, 22 and 23.5% in standard, FLC-sensitive and resistant strains of <italic>C. albicans</italic>, respectively, while at the same concentration, compound 18 decreased the proteinase secretion by 30, 33 and 17% against the respective strains. At similar concentrations in the same strains, compound <bold>17</bold> caused 40, 38, and 38% inhibition in phopholipase secretion whereas compound <bold>18</bold> decreased the secretions by 36, 27 and 38% respectively.</p></sec><sec id="S4.SS4.SSS1.Px3"><title>Efflux pump</title><p>One of the structural derivatives of cyclobutene-dione [3-(phenylamino)-4-{[1,3,3-trimethyl-2,3-dihydro-1H-indol-2-ylidene]methyl}-cyclobut-3-ene-1,2-dione] <bold>19</bold> was chemically synthesized and was identified as the puissant inhibitor of the efflux pumps residing in plasma membrane - Major Facilitator Superfamily (MFS) and ATP-binding cassette (ABC) transporters accountable for efflux pump-mediated drug resistance in the fungal pathogen <italic>C. albicans</italic> (<xref rid="B77" ref-type="bibr">Keniya et al., 2015</xref>).</p></sec></sec><sec id="S4.SS4.SSS2"><title>Quorum Sensing Molecules</title><p>As already mentioned, quorum sensing plays an important role in mediating the formation of biofilm of <italic>C. albicans</italic>. One of the known quorum-sensing molecules released from <italic>Candida</italic> itself, &#x0201c;Farnesol&#x0201d; <bold>20,</bold> is known to inhibit filamentation in <italic>C. albicans</italic>, which is a known virulence factor enhancing biofilm formation. From the previous studies it is known that the upregulation of the sterol biosynthetic pathway gene <italic>ERG</italic> and the efflux pump genes <italic>CDR</italic> and <italic>MDR</italic> are one of the major contributors to the azole tolerance in <italic>C. albicans</italic>. Therefore, through northern blot studies, it was examined that Farnesol down-regulates the expression of partial gene expression in ergosterol biosynthesis, Ras1-cAMP-Efg1 signaling cascade, <italic>HWP1</italic> promoter, which encodes for hyphal &#x02013;specific cell wall protein (<xref rid="B136" ref-type="bibr">Ramage et al., 2002</xref>; <xref rid="B187" ref-type="bibr">Yu et al., 2012</xref>; <xref rid="B39" ref-type="bibr">Di&#x0017e;ov&#x000e1; and Bujd&#x000e1;kov&#x000e1;, 2017</xref>). Further, it was observed that compound <bold>20</bold> is in synergism with already known antifungal drugs augmenting the accumulation of ROS, leading to early apoptosis in fungal cells (<xref rid="B146" ref-type="bibr">Sharma and Prasad, 2011</xref>). In a recent study, a bacterial quorum sensing quencher S8- Thiazolidinedione-8 <bold>21</bold> has been identified as an effective small molecular inhibitor which significantly decreases biofilm formation by <italic>C. albicans.</italic> Additionally, it shows, anti-filamentation, as well as anti-adhesion activity at four to eight fold decreased MIC concentrations. Nevertheless, it down-regulates <italic>HWP1, ALS3, EAP1</italic>, <italic>HST7</italic> and <italic>CPH</italic> transcription factors that play a key role in biofilm formation (<xref rid="B47" ref-type="bibr">Feldman et al., 2014</xref>). Another newly discovered Thiazolidinedione molecule- N-(oxazolylmethyl)-thiazolidinedione <bold>22</bold> scaffolds has been identified as a novel compound that inhibits <italic>C. albicans</italic> Als surface protein (<xref rid="B97" ref-type="bibr">Marc et al., 2018</xref>; <xref rid="T1" ref-type="table">Table 1</xref>).</p><table-wrap id="T1" position="float"><label>TABLE 1</label><caption><p>Chemical structures and MIC/IC<sub>50</sub> values of small molecule inhibitors (1&#x02013;22).</p></caption><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><tbody><tr><td rowspan="1" colspan="1"><inline-graphic xlink:href="fmicb-12-638609-t001.jpg"/></td></tr></tbody></table></table-wrap></sec><sec id="S4.SS4.SSS3"><title>High Throughput Screening of the Libraries</title><p>Around 400 heterogeneous drugs like molecules assembled by Medicines for Malaria Venture [MMV], Switzerland was screened with the motto to hasten the identification of medicinal molecules <italic>C. albicans</italic> biofilm. Three confirmed hits were obtained- MMV688768, MMV687807, and MMV687273, which exhibited activity against pre- biofilms. However, by additional exploration, it was observed that compound MMV688768- 2-methyl-3-[(4-methylpiperazin-1-yl)-thiophen-2-ylmethyl]-1H- indole <bold>23</bold> an anti-<italic>Schistosoma</italic> drugs are the best showing anti-biofilm activity against <italic>C. albicans</italic>, with concentrations as low as 3.12 &#x003bc;M (<xref rid="B173" ref-type="bibr">Vila and Lopez-Ribot, 2017</xref>).</p><p>Ebselen <bold>24</bold> an organoselenium compound, was screened out from the off-patent drugs using the Prestwick Chemical Library, a repurposing library of about 1,280 small molecules. Out of nine molecules, Ebselen illustrated 100% inhibition against multi-drug resistant species, <italic>Candida auris</italic> at concentration &#x02264; 2.5 &#x003bc;M (<xref rid="B174" ref-type="bibr">Wall et al., 2018</xref>). Furthermore, it elucidates its antifungal activity by accumulating reactive oxygen species (ROS) inside the fungal cells. Further, <italic>in vivo</italic> study of <italic>C. elegan</italic> model infected with <italic>C. albicans</italic> showed complete eradication of fungal load when treated with 8 &#x003bc;g/ml of ebselen (<xref rid="B166" ref-type="bibr">Thangamani et al., 2017</xref>). Additional screening of New Prestwick Chemical Library comprised of FDA-approved 1,200 off-patent drugs. Alexidine dihydrochloride <bold>25</bold> (AXD) and Thimerosal <bold>26</bold> showed more than 80% of inhibition mature biofilms. Subsequently, AXD showed antibiofilm potency <italic>C. albicans</italic> mouse model disseminated with fungal infection (<xref rid="B94" ref-type="bibr">Mamouei et al., 2018</xref>; <xref rid="T2" ref-type="table">Table 2</xref>).</p><table-wrap id="T2" position="float"><label>TABLE 2</label><caption><p>Chemical structures and MIC/IC<sub>50</sub> values of small molecule inhibitors (23&#x02013;26).</p></caption><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><tbody><tr><td rowspan="1" colspan="1"><inline-graphic xlink:href="fmicb-12-638609-t002.jpg"/></td></tr></tbody></table></table-wrap></sec><sec id="S4.SS4.SSS4"><title>Phenotypic Screening</title><p>Phenotypic screening refers to the nascent methodology for the biological screening of the chemical entities to assess their therapeutic effects. It is not a target- based strategy but involves detailed cell-based studies (<xref rid="B10" ref-type="bibr">Aulner et al., 2019</xref>). The phenotypic screening was done to identify different small molecules which depict antibiofilm and antifilamentation activity against <italic>C. albicans.</italic> This study leads to the identification of about 2293 compounds from the chemical library of the National Cancer Institute which were categorized into three sets- (i) NCI Natural set, Out of all the compounds present in this set six hits were confirmed against <italic>C. albicans</italic> biofilm formation. These include -Trichoderonin <bold>27</bold>; Nanaomycin <bold>28</bold>; Rapamycin <bold>29</bold>; Anisomycin <bold>30</bold>; Valinomycin <bold>31</bold> and Bacitracin <bold>32</bold>. Three of these molecules (Trichoderonin, Nanaomycin, Rapamycin) showed inhibition of both filamentation and biofilm formation while the rest three showed inhibition against biofilm formation.</p><p>Furthermore in the next (ii)-NCI-Structural diversity set, in total, there were 12 hits out of which eight were identified as biofilm inhibitor. These compounds were-Phenanthroline Hydrochloride <bold>33</bold>; 2-isoquinolin-2-ium-2-yl-1-phenanthren-3- ylethanone, iodide <bold>34</bold>;Metanilamide (3-aminobenzenesul fonamide) <bold>35</bold>; Mercury, (4-amino phenyl)(6-thioguano sinato- N7,S6)- <bold>36</bold>; 2-[7-[3-(carboxymethyl)-5,10-dihydroxy-1-methyl- 6,9-dioxo-3,4-dihydro-1H-benzo[g] isochromen-7-yl]-5,10-dihy droxy-1-methyl-6,9-dioxo-3,4-dihydro-1H-benzo [g]isochro men-3-yl]acetic acid <bold>37</bold> are only biofilm inhibitors while Mercury,(2-aminio-1,9-dihydro-6H-purine-6-thionato-N7,S6) hexyl-,2-benzo[a]phenothiazin-12-yl-N,N-diethylethanamine <bold>38</bold>; 17-[1-[2(dimethylamino)ethylamino]ethyl]-13-methyl-6,7,8, 9,11,12,14,15,16,17 decahydrocyclopenta[a]phenanthren-3-ol <bold>39</bold>. Three of these compounds inhibited both filamentation and biofilm formation. From all these compounds related to 17- aminoestradiols, a Mercury containing organometallic was the most potent compound with IC<sub>50</sub> value in the range of nanomolar concentration.</p><p>Next and last was (iii)-NCI-Challenge Set. In this, there were total 11 hits, of which 10 showed inhibition against <italic>C. albicans</italic> biofilm formation whereas only one compound inhibited filamentation transformation. Ten hits which were identified from these compounds displayed common inhibition against both biofilm and filament formation. These include Biofilm Inhibitor- Trichopolyn-B<bold>40</bold>, Vengicide (Unamycin B, Toyocamycin)<bold>41</bold>, 4Z-4-[[4-(dimethylamino)phenyl]methyli dene]-1-methyl-2-phenylpyrazolo[1,5-a]indol-1-ium-6-ol;trifluo romethanesulfonate<bold>42</bold>, Anisomycin<bold>43</bold>, Azetidinecarbo thioic acid, [1-(2-pyridinyl) ethylidene] hydrazide<bold>4</bold>. Additionally, compounds with both antifilamentation and antibiofilm activity are.- 6-Hydroxy-3-((methanesulfonyloxy) Methyl)-1- ((5,6,7-tri methoxyindol-2-yl) carbonyl)indoline<bold>45</bold>, Hydrazineca rbothioamide, N, N-dipropyl-2-(2-pyridinemethylene)-,(N,N,S) copper(II)chloridecomplex(SP-4-3)3;3-Azabicyclo[3.22]nonane-3-carboselenoicacid,[1-(2pyridinyl)ethyidene] hydrazide<bold>46</bold>, 2- hydroxyethyl-[(2R)-2-hydroxyheptadecyl]-dimethylazanium iodide <bold>47</bold>, 1H-Azepine-1-carbothioic acid, hexa hydro-, [1-(2-pyridinyl) ethylidene]hydrazide<bold>48</bold> (<xref rid="B126" ref-type="bibr">Pierce et al., 2014</xref>; <xref rid="T3" ref-type="table">Table 3</xref>).</p><table-wrap id="T3" position="float"><label>TABLE 3</label><caption><p>Chemical structures and MIC/IC<sub>50</sub> values of small molecule inhibitors (27&#x02013;48).</p></caption><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><tbody><tr><td rowspan="1" colspan="1"><inline-graphic xlink:href="fmicb-12-638609-t003.jpg"/></td></tr></tbody></table></table-wrap></sec><sec id="S4.SS4.SSS5"><title>Repurposing FDA Approved Drug Showing Synergistic Effect</title><p>Haloperidol <bold>49</bold> and its derivative (Benzocyclane derivative B10 <bold>49a)</bold> (<xref rid="B69" ref-type="bibr">Ji et al., 2020</xref>) and Bromoperidol <bold>50</bold> and its derivative are some of the known antipsychotic drugs that were repurposed and were utilized as anti-biofilm molecules. Haloperidol&#x02019;s derivative exhibited inhibition of yeast to hyphal transition in resistant strain of <italic>C. albicans</italic> in synergism with FLC while it also down-regulated the expression of ERG11, and MDR1 genes are leading to cell membrane damage. Moreover, compound <bold>49a</bold> showed significant decrease in the CFU/g from 7.63 to 7.29 in murine model of invasive candidiasis. Similarly, Bromoperidol and its derivative showed a synergistic effect in combination with different azoles. The mechanism of action is unknown but it does decrease the amount of azole administered at the time of treatment (<xref rid="B63" ref-type="bibr">Holbrook et al., 2017</xref>).</p><p>While looking for different antibiofilm drug groups, scientists looked for the Hsp 90 and Calcineruin inhibitors as it chemo sensitizes the fungal strains toward azole- as the first line of antifungal drugs. Piperazinyl quinolone <bold>51</bold> screened from MLPCN library had no antifungal activity alone, but, in combination with Azoles, it selectively inversed the fluconazole resistance in the clinical isolates of <italic>C. albicans</italic> (<xref rid="B185" ref-type="bibr">Youngsaye et al., 2011</xref>). Similarly, FK506 <bold>52</bold> and Cyclosporine A <bold>53</bold>, the other potential calcineruin inhibitors also illustrated the increase in the susceptibility of <italic>C. albicans</italic> toward antifungal drugs (<xref rid="B171" ref-type="bibr">Uppuluri et al., 2008</xref>; <xref rid="B31" ref-type="bibr">Cordeiro et al., 2014</xref>; <xref rid="B70" ref-type="bibr">Jia et al., 2016</xref>). Ribavirin <bold>54,</bold> already known antiviral drug, was screened through Prestwick Chemical Library against FLC-resistant strains. It illustrated a fungistatic effect against MDR species of <italic>C. albicans</italic> and acted synergistically with MIC &#x0003c; 24.4 &#x003bc;g/mL (<xref rid="B186" ref-type="bibr">Yousfi et al., 2019</xref>).</p><p>While going through 1,600 compounds present in the drug-repositioning library, 8 hits were obtained. These are Hexachlorophene <bold>55</bold> (anti- topical anti-infective drug) (<xref rid="B150" ref-type="bibr">Siles et al., 2013</xref>), Pyrvinium pamoate <bold>56</bold> (an anti-helminthic drug), Artesunate <bold>57</bold> (antimalarial drug), Broxyquinoline <bold>58</bold> (antiseptic drug), Dihydroartemisinin <bold>59</bold> (antimalarial drug), Gentian violet <bold>60</bold> (antibacterial and antihelminthic drug), Bithionate disodium <bold>61</bold> (antiseptic), and Nitroxoline (Antibacterial). Out of these 8 hits, the first seven hits showed inhibition of mature <italic>C. albicans</italic> biofilm in combination with miconazole at sub-inhibitory concentrations. Further, studies were performed on the best-acknowledged potentiators, Hexachlorophene, pyrvinium pamoate, and artesunate. Mechanistic synergy was most pronounced for artesunate, an artemisinin homolog, which prompted the study of different structural homologs of Artemisinia. Thus, it was observed that biofilm inhibition in combination with Micanazole was not specific only to artesunate but also applicable to dihydroartemisinin and other artemisinin derivatives, indicating artemisinin as a potential antifungal molecule that can be further investigated to establish its overall potentials in the human health care system (<xref rid="B36" ref-type="bibr">De Cremer et al., 2015</xref>).</p><p>In another study, the library comprehending 1600 off-patent drugs was sifted for the compound that enhances <italic>in vitro</italic> activity of amphotericin B when used in combination against <italic>C. albicans</italic> biofilms. Out of 1600 compounds, the team found 50 hits, and from these 50 hits, only seven of them illustrated BIC<sub>50</sub> &#x0003c; 100 &#x003bc;M for biofilm inhibition. Those compounds are as follow: Prochlorperazine edisylate 5.2 &#x003bc;M <bold>(62)</bold>, Danthron 12 &#x003bc;M <bold>(63)</bold>, Chlorprothixene hydrochloride 17 &#x003bc;M <bold>(64),</bold> Toremifene citrate 19.5 &#x003bc;M <bold>(65)</bold>, Clorgiline hydrochloride 24 &#x003bc;M <bold>(66)</bold>; Perhexiline maleate 39 &#x003bc;M <bold>(67)</bold> Dicyclomine hydrochloride 60 &#x003bc;M<bold>(68)</bold>. Subsequently, all of these compounds showed a synergistic effect with caspofungin. Additionally, while studying tormifene citrate <bold>(65)</bold> for its synergistic effect on <italic>C. elegans</italic> infection model, it showed strong antifungal potency (<xref rid="B37" ref-type="bibr">Delattin et al., 2014</xref>). Diclofenac <bold>69</bold> a non -steroidal anti-inflammatory drug, increased the susceptibility of caspofungin toward the <italic>in vitro C. albicans</italic> biofilm. Furthermore, catheter retrieved from the animal model-rat when treated with combination therapy of caspofungin and diclofenac showed a significant reduction in the number of biofilm cells (<xref rid="B16" ref-type="bibr">Bink et al., 2012</xref>). Further, an off-patent antipsychotic drug Aripiprazole <bold>70</bold> was identified as a potent inhibitor of <italic>C. albicans</italic> which inhibited the early formation of pseudohyphal cells and mimicked standard azoles at higher concentrations showing different mechanisms of action (<xref rid="B131" ref-type="bibr">Rajasekharan et al., 2019</xref>; <xref rid="T4" ref-type="table">Table 4</xref>).</p><table-wrap id="T4" position="float"><label>TABLE 4</label><caption><p>Chemical structures and MIC/IC<sub>50</sub> values of small molecule inhibitors (49&#x02013;70).</p></caption><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><tbody><tr><td rowspan="1" colspan="1"><inline-graphic xlink:href="fmicb-12-638609-t004.jpg"/></td></tr></tbody></table><table-wrap-foot><attrib><italic><sup><italic>b</italic></sup>means that the unit of IC<sub>50</sub> value is &#x003bc;g/ml.</italic></attrib></table-wrap-foot></table-wrap></sec></sec><sec id="S4.SS5"><title>Natural Products</title><p>Arising fungal resistance ascribed to mutational changes has diversified the complexity fueling the thought processes along this line. To overcome this issue, we need to find some substantial solutions. For the past few decades, natural products have emerged as an essential source of antibacterial, antimalarial, and chemotherapeutic agents. Presently, around 60% of used drugs for cancer treatment are procured from natural products. Furthermore, the modification of natural products is one of the most common and productive methodologies to obtain novel therapeutic agents using medicinal chemistry (<xref rid="B189" ref-type="bibr">Zaki et al., 2019</xref>). Thus, targeting fungal biofilms by either natural derivatives or synthetic analogs could be a novel approach. Natural product screening has proved to be one of the promising strategies. Although anti-biofilm agents themselves might not kill the bacteria, they can make them more susceptible to conventional antibiotics and the action of the host immune system. The search for biofilm inhibitors has led to identifying a significant number of compounds of potential therapeutic use as biofilm inhibitors. A literature survey reveals that some of the most active anti-biofilm compounds discovered to date have been based upon the molecular scaffolds of natural products isolated from marine natural products and plant products (<xref rid="B46" ref-type="bibr">Fazly et al., 2013</xref>). As compiled by the World Health Organization, more than 21,000 plant species containing a vast array of biologically active compounds have been used worldwide in herbal medicines (<xref rid="B105" ref-type="bibr">Midkiff et al., 2011</xref>). Naturally occurring alcohols magnolol <bold>71</bold> and its isomer honokiol <bold>72</bold>, carvacrol <bold>73</bold>, thymol <bold>74,</bold> and geraniol <bold>75</bold> have been identified as a potent inhibitor of both bacterial and <italic>C. albicans</italic> biofilms (<xref rid="B35" ref-type="bibr">de Castro et al., 2015</xref>; <xref rid="B91" ref-type="bibr">Magi et al., 2015</xref>; <xref rid="B160" ref-type="bibr">Sun et al., 2015</xref>; <xref rid="B147" ref-type="bibr">Sharma et al., 2016</xref>; <xref rid="B12" ref-type="bibr">Behbehani et al., 2017</xref>). Furthermore, when <italic>C. elegan</italic> was treated with 16 &#x003bc;g/ml of magnolol and honokiol, there was a decrease in the number of colony forming units (CFU) of <italic>C. albicans</italic> in the nematode which enhances its survival. Additionally, antibiofilm activity of these compounds <bold>69</bold> and <bold>70</bold> were related to Ras1-cAMP-Efg1 pathway of <italic>C. albicans</italic> (<xref rid="B160" ref-type="bibr">Sun et al., 2015</xref>). A Recent study shows that compound <bold>70</bold> and <bold>71</bold> are antifungal and induce ROS mediated programmed cell death in <italic>C. albicans</italic> (<xref rid="B161" ref-type="bibr">Sun et al., 2017</xref>; <xref rid="B113" ref-type="bibr">Niu et al., 2020</xref>). Saponins are one of the known natural products that bind to the ergosterol rather than cholesterol of <italic>C. albicans.</italic> This increases the susceptibility to photodynamic inactivation due to an increase in the permeability of photosensitizers by sapnonin. In one study, a total of 12 different saponins were identified as potential antifungal agents, but out of those 12, only two were selected. One was <bold>76,</bold> which belongs to the aginoside family of saponins and the secone one <bold>77</bold> to the barrgeniol family of the saponins. Both of these compounds were potent antifungal agents with MIC 16 and 32 &#x003bc;g/ml, respectively. Furthermore, to study toxicity and efficacy of the compound, <italic>C. elegans</italic> and <italic>C. albicans</italic> models were used. In an <italic>in vivo</italic> study, compound <bold>76</bold> and <bold>77</bold> showed no sign of toxicity and conferred high percentage of nematode survival from upto 73% to 80%, respectively (<xref rid="B30" ref-type="bibr">Coleman et al., 2010</xref>).</p><p>Occasionally, other known naturally occurring compounds are found to be useful. The Carvone <bold>78</bold> and perillaledhyde <bold>79</bold> (<xref rid="B101" ref-type="bibr">McGeady et al., 2002</xref>; <xref rid="B167" ref-type="bibr">Tian et al., 2017</xref>; <xref rid="B109" ref-type="bibr">Moro et al., 2018</xref>) at very low concentration inhibit the filamentous formation of <italic>C. albicans</italic>. Furthermore, it was observed that at MIC of 4 &#x003bc;l/mL compound <bold>77</bold> increased the level of ROS, which activated the programmed cell death in <italic>C. albicans</italic>. Additionally, it equalizes the level of E-cadherins the epithelial barriers preventing which decreases in number due to invasion of pathogenic fungi (<xref rid="B167" ref-type="bibr">Tian et al., 2017</xref>; <xref rid="B130" ref-type="bibr">Qu et al., 2019</xref>). The Riccardin D<bold>80, 80a</bold> - macrocyclic bisbibenzyl isolated from <italic>Dumortiera hirsute</italic> chinese liverwort, exhibited an inhibitory effect on the biofilm formation of <italic>C. albicans</italic> by downregulating HWP1, ASL3, and EFG1 genes thus, inhibiting hyphal formation. Additionally, one of the semi-synthetic derivative of Riccardin D with a bromine atom attached to the arene ring showed better antifungal activity with MIC-2 &#x003bc;g/ml in comparison to Riccardin with MIC-16 &#x003bc;g/ml (<xref rid="B86" ref-type="bibr">Li et al., 2012</xref>; <xref rid="B159" ref-type="bibr">Sun et al., 2016</xref>). Another known compound is Emodin <bold>81</bold> (1, 3, 8&#x02212;trihydroxy&#x02212;6&#x02212;methyl&#x02212;anthraquinone) which is a natural secondary plant product, originally isolated from the rhizomes of <italic>Rheum palmatum</italic>. This compound suppressed the growth of the cells of reference and clinical <italic>C. albicans</italic> strains with minimal inhibitory and minimal fungicidal concentration values between 12.5 and 200 &#x003bc;g/mL, respectively, showing anti-virulent potential. Research showed that emodin added to <italic>C. albicans</italic> culture inhibited the phosphorylation of many cellular proteins, presumably, owing to the inhibition of protein kinase CK2. Notably, the enzyme isolated from the <italic>C. albicans</italic> cells was found to be susceptible to emodin with IC50 of 2.8 &#x003bc;g/mL, revealing that emodin was able to occupy the ATP&#x02212;binding pocket of CK2 (<xref rid="B68" ref-type="bibr">Janeczko et al., 2017</xref>). In another finding, <italic>M. sylvestris</italic> root was also shown to inhibit <italic>C. albicans</italic> biofilm formation (<xref rid="B5" ref-type="bibr">Alizadeh et al., 2017</xref>). Studies on quorum sensing inhibition and the quest for QS inhibitors have shown plants to produce anti-QS substances. Several anti-QS methods have been used, including natural products from plant-based secondary metabolites (<xref rid="B14" ref-type="bibr">Berde et al., 2019</xref>). Carbohydrate derived fulvic acid (CHD-FA) <bold>82</bold> from pure form of fulvic acid is obtained from humic substances, also exhibits anti-biofilm activity against <italic>C. albicans</italic> (<xref rid="B148" ref-type="bibr">Sherry et al., 2012</xref>; <xref rid="B20" ref-type="bibr">Borghi et al., 2015</xref>). Plant alkaloid berberine <bold>83</bold> showed 91% biofilm inhibition against <italic>C. albicans</italic> in combination with Miconazole. Furthermore, it reduces the metabolic activity of early- stage biofilm formation in <italic>C. albicans.</italic> Individually, Berberine inactivates fungal biofilm at MIC range 0.98-31.25mg/mL (<xref rid="B177" ref-type="bibr">Wei et al., 2011</xref>). Resveratrol (3, 4, 5 -trihydroxystilbene) <bold>84</bold> is a phytoalexin, a known antimicrobial agent present in a wide range of dietary sources, including peanuts, plums, grapes and in red wines. A semisynthetic compound -EB487 <bold>84a</bold> was synthesized from resveratrol, which showed an antibiofilm and anti-preformed biofilm activity against <italic>C. albicans</italic> strain. Subsequently, the study revealed that resveratrol regulates its antifungal activity from early to late apoptosis stage. Furthermore, it increases the ROS concentration in fungal cells of <italic>C. albicans</italic> and modulates the activation of metacaspase release in response to mitochondrial dysfunction (<xref rid="B84" ref-type="bibr">Lee and Lee, 2015</xref>; <xref rid="B73" ref-type="bibr">Juin et al., 2019</xref>; <xref rid="T5" ref-type="table">Table 5</xref>).</p><table-wrap id="T5" position="float"><label>TABLE 5</label><caption><p>Chemical structures and MIC/IC<sub>50</sub> values of small molecule inhibitors (71&#x02013;84).</p></caption><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><tbody><tr><td rowspan="1" colspan="1"><inline-graphic xlink:href="fmicb-12-638609-t005.jpg"/></td></tr></tbody></table></table-wrap><sec id="S4.SS5.SSS1"><title>Natural Extracts and Essential Oils</title><p>Ethanol extract of <italic>Tovomita krukovii</italic> led to the identification of few new xanthones like 1,3,5-trihydroxy-8-isoprenylxanthone <bold>85a</bold>, 1,5,7-trihydroxy-8-isoprenylxanthone <bold>85b</bold>, betulinic acid <bold>86,</bold> and 3,4-dihydroxybenzoic acid <bold>87</bold> targeting secreted aspartic protease SAP2 of <italic>C. albicans</italic> with IC<sub>50</sub> values 15 &#x003bc;g/ml, 25 &#x003bc;g/ml, 40 &#x003bc;g/ml, and 6.5 &#x003bc;g/ml, respectively (<xref rid="B190" ref-type="bibr">Zhang et al., 2002</xref>). Crude hydro alcoholic extract prepared through peel extract of <italic>Punica grantum</italic> presented strong inhibitory activity against <italic>C. albicans</italic> at MIC 3.9 &#x003bc;g/mL and led to the two-fold decrease in the concentration of FLC when used in combination (<xref rid="B42" ref-type="bibr">Endo et al., 2010</xref>). In certain studies, essential oils from plants and their compounds have been scrutinized as antifungal agents. The essential oil of <italic>Coriandrum sativum</italic> delineates fungicidal activity in a combination of amphotericin B, mainly targeting germ tube formation in <italic>C. albicans</italic> (<xref rid="B151" ref-type="bibr">Silva et al., 2011</xref>). According to the studies, <italic>Rumex</italic> root extract and Nepodin <bold>88,</bold> a compound extracted from <italic>Rumex</italic> roots, were defined as anti-biofilm agents against <italic>C. albicans.</italic> It also increased the survivability in nematode infection model. Further, Nepodin also showed repressed expression of several genes related to bud to hyphal transition Like <italic>ECE1</italic>, <italic>UME6, HWP1</italic>, and <italic>HGT10</italic>, while the increase in the expression of quite a few transport genes (<italic>CDR4</italic>, <italic>TPO2</italic>, and <italic>CDR11</italic>) essential for phenotypic expression (<xref rid="B85" ref-type="bibr">Lee et al., 2019</xref>). Additionally while screening compounds from the crude extract of aerial parts of <italic>Waltheria indica</italic>, 10 quinoline alkaloids were identified as a potential molecule which inhibit biofilm formation in <italic>C. albicans</italic>: These include Waltherione N <bold>89</bold>, (R)-Vanessine <bold>90</bold>, Waltherione Q <bold>91</bold>, 8-deoxoantidesmone <bold>92</bold>, Antidesmone <bold>93</bold>, Waltherione E <bold>94</bold>, Waltherione G <bold>95</bold>, Waltherione I <bold>96</bold>, Waltherione J <bold>97</bold>, Waltherione F <bold>98</bold> (<xref rid="B32" ref-type="bibr">Cretton et al., 2016</xref>; <xref rid="T6" ref-type="table">Table 6</xref>).</p><table-wrap id="T6" position="float"><label>TABLE 6</label><caption><p>Chemical structures and MIC/IC<sub>50</sub> values of small molecule inhibitors (85&#x02013;98).</p></caption><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><tbody><tr><td rowspan="1" colspan="1"><inline-graphic xlink:href="fmicb-12-638609-t006.jpg"/></td></tr></tbody></table></table-wrap><p>The Unexplored Brazilian Organic Propolis &#x02013;BOP6 crude extract was characterized as an anti-inflammatory and anti-biofilm agent. It reduces the mortality rate by 30% in <italic>C. albicans</italic> infected sample with MIC ranging from 50 to 100 &#x003bc;g/mL while in combination with Amphotericin B, it decreases to 0.25 to 1.0 &#x003bc;g/mL (<xref rid="B110" ref-type="bibr">Nani et al., 2019</xref>). Through library screening with the information regarding fungal extract, it was revealed that <italic>Bionectria ochroleuca</italic>, an endophytic fungus. when cultivated on cereals, lead to the production of certain secondary metabolites-Polyketide glycosides <bold>99</bold>. These Polyketide glycosides exhibited anti-biofilm activity against <italic>C. albicans</italic> and correspondingly showed a synergistic effect with Amphotericin B (<xref rid="B175" ref-type="bibr">Wang et al., 2014</xref>).</p><p>From HPLC, a different set of compounds were extracted from the crude dichloromethane extract from the roots of <italic>Swartzia simplex.</italic> In total 14 compounds were identified out of which only six compounds such as Simplexene A <bold>100</bold>, (5S,10S)-11,15(R)-Dihydroxy,12 methoxyswartziarboreol G <bold>101</bold>, Simplexene B <bold>102</bold>, Simplexene D <bold>103</bold>, 11,12-Dihydroxy-15, 16-dihydroswartziarboreol C<bold>104</bold>,11,12-Dihydroxy-8,11,13,15- cassatetraen-17,16-olide(11,12 Dihydroxyswartziarboreol C) <bold>105</bold> depicted strong biofilm inhibition against <italic>C. albicans</italic> (<xref rid="B45" ref-type="bibr">Favre-Godal et al., 2015</xref>; <xref rid="T7" ref-type="table">Table 7</xref>).</p><table-wrap id="T7" position="float"><label>TABLE 7</label><caption><p>Chemical structures and MIC/IC<sub>50</sub> values of small molecule inhibitors (99&#x02013;105).</p></caption><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><tbody><tr><td rowspan="1" colspan="1"><inline-graphic xlink:href="fmicb-12-638609-t007.jpg"/></td></tr></tbody></table></table-wrap><p>The crude extract of eucalyptus oil and its component 1, 8- cineole <bold>106</bold> showed antimicrobial activity against different microbes including <italic>C. albicans</italic> biofilm. It showed inhibitory effect alone and also in combination with chlorhexidine (<xref rid="B61" ref-type="bibr">Hendry et al., 2009</xref>; <xref rid="B153" ref-type="bibr">Simsek and Duman, 2017</xref>). While studying different components of essential oils as a treatment against invasive candidiasis, some terpenic derivatives showed promising results. These include carvacrol <bold>73</bold>, geraniol <bold>75</bold>, carvone <bold>78</bold>, terpinen-4-ol<bold>107</bold>, linalool <bold>108</bold>, menthol <bold>109</bold>, &#x003b1;-terpineol <bold>110</bold>, nerol <bold>111</bold>, isopulegol <bold>112</bold>, menthone <bold>113,</bold> and &#x003b1;-thujone <bold>114.</bold> On further study, tyrosol <bold>115</bold> &#x02013;(a phenethyl alcohol), tyrosine derivative and eugenol- phenylpropanoid <bold>116</bold> both showed a strong inhibitory effect against <italic>C. albicans</italic> biofilm (<xref rid="B98" ref-type="bibr">Marcos-Arias et al., 2011</xref>; <xref rid="B138" ref-type="bibr">Raut et al., 2013</xref>). Furthermore, tyrosol <bold>115</bold> showed antibiofilm activity when applied exogenously at millimolar concentration. However, at micromolar concentration this compound stimulates hyphal production during the intial stage of <italic>C. albicans</italic> biofilm formation. This inhibition of biofilm formation by the exogenous addition of quorum sensing molecule usually occurs due to disruption in the qurom sensing mechanisms or due to the limitation of yeast adhesion on medical devices (<xref rid="B107" ref-type="bibr">Monteiro et al., 2015</xref>; <xref rid="B144" ref-type="bibr">Sebaa et al., 2019</xref>).</p><p>Epigallocatechin-3-gallate <bold>117</bold>-a Polyphenol compound from green tea extract and its analogs depicted a 75% reduction in the mature <italic>C. albicans</italic> biofilm (<xref rid="B44" ref-type="bibr">Evensen and Braun, 2009</xref>).</p><p>The &#x003b1;-Longipinene <bold>118,</bold> a significant component of <italic>Helichrysum</italic> oil and <italic>Cascarilla</italic> bark oil, inhibited the <italic>C</italic>. <italic>albicans</italic> biofilm formation without affecting planktonic cell growth and also exhibited a decrease in the virulence in <italic>C. elegans</italic> model (<xref rid="B95" ref-type="bibr">Manoharan et al., 2017a</xref>). Further, the compounds Glabridin <bold>119</bold>, Licochalcone A <bold>120</bold>, and Glycyrrhizic acid <bold>121</bold> derived from Licorice- a natural compound extracted from the root of the plant <italic>Glycyrrhiza glabra</italic> showed biofilm inhibition against <italic>C. albicans.</italic> It was found that Glabridin, Licochalcone A showed 35-60% of biofilm inhibition while they inhabited more than 80% hyphal growth. Furthermore, they displayed a synergistic effect with Nystatin at sub-inhibitory concentration (<xref rid="B103" ref-type="bibr">Messier and Grenier, 2011</xref>). Another successful study on the essential oils obtained from Thyme species &#x02013; <italic>T. camphoratus</italic> and <italic>T. carnosus</italic>, earlier used in Portuguese as an antimicrobial therapy, lead to the discovery of different molecules.</p><p>In <italic>Thymus carnosus</italic> oil, high aggregates of Camphene and Borneol were present while <italic>Thymus camphoratus</italic> oil <italic>was rich in</italic> 1,8-cineole and &#x003b1;-pinene. Both the oils were highly effective against <italic>C. albicans</italic> biofilm and germ tube formation with very little toxicity (<xref rid="B7" ref-type="bibr">Alves et al., 2019</xref>). Another category of essential oils <italic>Syzygium aromaticum</italic> and <italic>Cymbopogon citratus</italic>, largely used in Asia, especially in India, for the treatment of inflammation and skin infection, displayed a potent anti-biofilm activity against <italic>C. albicans</italic> strain (<xref rid="B143" ref-type="bibr">Sajjad et al., 2012</xref>). Furthermore, Safranal <bold>122</bold> and its thiosemicarbazone <bold>122a</bold> derivative, the bioactive compounds obtained from <italic>Crocus sativa</italic> when added together in <italic>C. albicans</italic> culture, acted as a potent inhibitor of biofilm and germ tube formation at 32 times less concentration than MIC (<xref rid="B23" ref-type="bibr">Carradori et al., 2016</xref>; <xref rid="T8" ref-type="table">Table 8</xref>).</p><table-wrap id="T8" position="float"><label>TABLE 8</label><caption><p>Chemical structures and MIC/IC<sub>50</sub> values of small molecule inhibitors (106&#x02013;122).</p></caption><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><tbody><tr><td rowspan="1" colspan="1"><inline-graphic xlink:href="fmicb-12-638609-t008.jpg"/></td></tr></tbody></table></table-wrap><p>Work on small molecular inhibitors of plant origin, several molecules showed high to moderate activity toward <italic>C. albicans</italic> biofilm. These compounds like Cinnamaldehyde<bold>123</bold>, Piperidine <bold>124</bold>, Citral <bold>125</bold>, Furfuradehyde <bold>126</bold>, and Indole <bold>127</bold> showed inhibitory activity toward ergosterol biosynthesis at varying concentrations (<xref rid="B133" ref-type="bibr">Rajput and Karuppayil, 2013</xref>). A recent study revealed that compound <bold>123</bold> and <bold>124</bold> regulated antifungal activity against <italic>C. albicans</italic> by ROS mediated apoptosis (<xref rid="B28" ref-type="bibr">Chen et al., 2019</xref>; <xref rid="B165" ref-type="bibr">Thakre et al., 2020</xref>). Similarly, another set of <italic>C. albicans</italic> biofilm inhibitor Shearinines D and E <bold>(128,129)</bold> derived from <italic>Penicillum species</italic> showed yeast to hyphal blockage. However, it was observed that these compounds are more potent against early biofilm formation than the mature biofilm (<xref rid="B184" ref-type="bibr">You et al., 2013</xref>). Gymnemic acid <bold>130,</bold> a small molecular inhibitor obtained from the leaves of the plant <italic>Gymnema sylvestre</italic>, showed its activity against dual-species <italic>S. gordonii</italic> and <italic>C. albicans</italic> together, leading to biofilm formation in the mouth. It decreases the amount of e-DNA present in biofilm. It also inhibits the adhesive property of <italic>C. albicans</italic> by inhibiting an enzyme glyceraldehyde-3-phosphate dehydrogenase, which is thought to be responsible for the display of adhesion property in <italic>C</italic>. <italic>albicans</italic> (<xref rid="B172" ref-type="bibr">Veerapandian and Vediyappan, 2019</xref>). Similarly, Waikiloid A <bold>131</bold>- a prenylated indole alkaloid and polyketide metabolite Waikialide A<bold>132</bold> obtained from a Hawaiian <italic>Aspergillus spp.</italic> both acted as a potent biofilm inhibitor against <italic>C. albicans</italic> with a IC<sub>50</sub> - 1.4 &#x003bc;M and 32.4 &#x003bc;M, respectively (<xref rid="B176" ref-type="bibr">Wang et al., 2012</xref>).</p><p>Myriocin <bold>133</bold> is a metabolite of the <italic>Isaria sinclairii - a pathogenic insect</italic> fungus. It disrupts the formation of sphingolipids as it is a structural analog of sphingosine precursors. It works very effectively in combination with known antifungal drugs like amphotericin and fluconazole, reducing the mortality rate from 26% to 0%, respectively. Additionally, <italic>G.mellonella</italic> larva infected with <italic>C. albicans</italic> showed a decrease in mortality rate when treated with myriocin. Furthermore, study of compound <bold>133</bold> indicated that it regulates <italic>C. albicans</italic> pathogenesis through NF-&#x003ba;B pathway, G protein coupled receptor and immunity (<xref rid="B102" ref-type="bibr">Melo et al., 2013</xref>). Acetylcholine <bold>134,</bold> a known soluble protein that has a neuronal function, also displays strong anti-biofilm activity against <italic>C. albicans</italic>. Along with this, it also reduces the damage induced due to inflammation in the host. Additionally, <italic>in vivo</italic> study of acetylcholine on <italic>G. mellonella</italic> larvae showed robust antifungal potency with a decrease in mortality rate from 80 to 100% to 25%. Further, compound <bold>134</bold> acts by promoting the rapid cellular immune response in host cells (<xref rid="B132" ref-type="bibr">Rajendran et al., 2015</xref>).</p><p>Garcinol <bold>135</bold> and Xanthochymol <bold>136</bold>, isoprenylated benzophenones obtained from <italic>Garcinia xanthochymus</italic> fruits, show antibiofilm activity against <italic>C. albicans</italic> by inducing programmed cell death in early biofilms without actually affecting the growth and viability of planktonic cells. Sampangine B <bold>137, 137(a-b)</bold> a naturally derived azaoxoporphine alkaloid and its derivatives showed potent activity against <italic>C. albicans</italic> biofilms and yeast to hyphal formation. It was found to show antifungal activity by inducing the accumulation of ROS and subsequent heme dysfunction. Moreover, it showed strong <italic>in vivo</italic> antifungal activity with low cytotoxicity in nematode model of <italic>C. albicans</italic> (<xref rid="B182" ref-type="bibr">Wu et al., 2017</xref>; <xref rid="T9" ref-type="table">Table 9</xref>).</p><table-wrap id="T9" position="float"><label>TABLE 9</label><caption><p>Chemical structures and MIC/IC<sub>50</sub> values of small molecule inhibitors (123&#x02013;137).</p></caption><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><tbody><tr><td rowspan="1" colspan="1"><inline-graphic xlink:href="fmicb-12-638609-t009.jpg"/></td></tr></tbody></table></table-wrap></sec></sec></sec><sec id="S5"><title>Recent Advances to Inhibit <italic>C. albicans</italic> Biofilm Formation</title><p>Throughout this article, we have seen different strategies and methods to combat antifungal drug resistance. However, after all the efforts and attempts we are still stuck at a point where biofilm formation is difficult to treat with both non-antifungal and antifungal drugs because of the poor penetration and non-specificity of the drugs. Therefore, to address this issue, researchers are working on finding ways to increase the penetration of drugs into the extracellular matrix of biofilm. Over the last few years, different metal nanoparticles have emerged as prospective candidates to treat microbial infections pertaining to their strong potential as antimicrobial agents. In this context, different research groups have initiated the exploration to identify the antibiofilm activity of different nanomaterials against <italic>C. albicans</italic> (<xref rid="B149" ref-type="bibr">Shukla, 2020</xref>).</p><p>The usage of silver as an antimicrobial agent spans a century. Silver was used as a disinfectant by Greeks and Romans to decontaminate their water and food supplies. Silver was also used in ancient times to treat burns and wounds (<xref rid="B3" ref-type="bibr">Alexander, 2009</xref>; <xref rid="B11" ref-type="bibr">Barillo and Marx, 2014</xref>; <xref rid="B1" ref-type="bibr">Adhya et al., 2015</xref>). Studying silver nanoparticles against biofilms has gained immense recognition. Silver nanoparticles exert an inhibitory effect against fungal biofilms by damaging cell wall mostly by distortion and disruption of the outer surface of the fungal cell wall (<xref rid="B83" ref-type="bibr">Lara et al., 2015</xref>). In subsequent experiments, AgNPs when used to functionalize medical and environmental surfaces, demonstrated biofilm inhibition (&#x0003e;50%) at relatively low concentrations (2.3 to 0.28 ppm) (<xref rid="B82" ref-type="bibr">Lara et al., 2020</xref>). Combination therapy of Fluconazole with silver nanoparticles has also shown a substantial decrease in the MIC (<xref rid="B90" ref-type="bibr">Longhi et al., 2016</xref>). The resistance to fluconazole (FLC) in <italic>C. albicans</italic> is strongly associated with overexpression of genes encoding efflux pumps or lanosterol 14&#x003b1;-demethylase (<xref rid="B142" ref-type="bibr">Sagatova et al., 2016</xref>). Subsequently, with the disruption of the cell wall and cytoplasmic membrane of <italic>C. albicans</italic> by AgNPs, these silver particles cause an increase in reactive oxygen species and hydroxyl radical production, which can also contribute to cell membrane damage (<xref rid="B65" ref-type="bibr">Hwang et al., 2012</xref>; <xref rid="B108" ref-type="bibr">Monteiro et al., 2012</xref>). Recently, researchers have identified bismuth oxide (BiO<sub>3</sub>) nanoparticles with potent antimycotic activity against <italic>C. albicans</italic> growth. Moreover, when these nanoparticles were compared to commercially available antifungal drugs like chlorhexidine, nystatin, they completely eradicated the biofilm formation (<xref rid="B62" ref-type="bibr">Hernandez-Delgadillo et al., 2013</xref>). In another study, magnesium oxide nanoparticles (MgO NP) were used to investigate their antifungal and antibiofilm property against <italic>C. albican</italic>s. The study revealed that MgO nanoparticles effectively inhibited <italic>C. albicans</italic> biofilm formation. Furthermore, adhesion experiments showed that MgO NPs repressed the preliminary adhesion of <italic>Candida albicans</italic> (<xref rid="B79" ref-type="bibr">Kong et al., 2020</xref>). In another study, when gold nanoparticles (Au-NP) were tested on the biofilms formed due to <italic>C. albicans</italic>, these particles showed robust inhibitory activity. Additionally, these Au-NPs increased the host immune response activity against these pathogenic organisms (<xref rid="B188" ref-type="bibr">Yu et al., 2016</xref>; <xref rid="B110" ref-type="bibr">Nani et al., 2019</xref>). From previous studies, chitostan and its nanoparticle (ChNPs) were already known for their antifungal property (<xref rid="B66" ref-type="bibr">Ing et al., 2012</xref>; <xref rid="B106" ref-type="bibr">Mohammed et al., 2017</xref>; <xref rid="B53" ref-type="bibr">Gondim et al., 2018</xref>). Therefore, to establish its antibiofilm activity, ChNPs were investigated, and it was found that ChNPs significantly inhibited the biofilm formation causing very less changes in the acrylic resin surface (<xref rid="B53" ref-type="bibr">Gondim et al., 2018</xref>). Likewise, another study conducted with selenium nanoparticles (Se-NP) showed strong inhibition on <italic>Candida</italic> biofilm formation as these particles out compete sulfur in biological process due to their similar chemical properties. Also, these nanoparticles enter into the cell to shrink and disrupt the outer membrane structure of <italic>C. albicans</italic> cell (<xref rid="B56" ref-type="bibr">Guisbiers et al., 2017</xref>).</p><p>The titanium oxide nanoparticles (Ti-NP) when scrutinized for their antifungal property showed strong antifungal activity against planktonic form of <italic>C. albicans.</italic> They also depicted robust potential against biofilm formation (<xref rid="B58" ref-type="bibr">Haghighi et al., 2013</xref>). In addition, zinc oxide nanoparticles (ZnO-NPs) used on <italic>Candida</italic> biofilm showed a decrease in the biofilm formation by abot 62%-85% at varied concentration of 125 ppm to 250 ppm respectively. The ZnO-NPs suggested to inhibit hyphae formation in <italic>C. albicans</italic> by production of reactive oxygen species in a dose-dependent manner (<xref rid="B64" ref-type="bibr">Hosseini et al., 2018</xref>; <xref rid="B52" ref-type="bibr">Golipour et al., 2019</xref>; <xref rid="B93" ref-type="bibr">Mahamuni-Badiger et al., 2020</xref>). Additionally, another study involving copper oxide nanoparticles (Cu<sub>2</sub>ONP and CuONP) showed potent inhibitory action against biofilm formation by <italic>C. albicans.</italic> The study revealed that copper oxide nanoparticles constrain the yeast for hypae transformation. Also CuO-NP elicited the reactive oxygen species while Cu<sub>2</sub>ONP pronounced the membrane damage in <italic>C. albicans.</italic> In comparison to both types of copper oxide nanoparticles, CuONP was more stable and depicted better antifungal activity in comparison to Cu<sub>2</sub>O-NP (<xref rid="B137" ref-type="bibr">Rasool, 2019</xref>; <xref rid="B119" ref-type="bibr">Padmavathi et al., 2020</xref>). In another study, iron-oxide nanoparticles (Fe<sub>3</sub>O<sub>4</sub> NPs) were investigated on <italic>C. albicans</italic> biofilm which showed 87.2-100% inhibition based on their particle size which was 100 ppm to 200 pm respectively (<xref rid="B145" ref-type="bibr">Seddighi et al., 2017</xref>).</p><p>The nitric oxide nanoparticles (NO-NP) showed strong potential as an antifungal agent by hindering the extracellular matrix and biofilm formation on the surface of biomaterials. It was found that NO-NPs also decrease the metabolic activity of <italic>Candida</italic> cells both <italic>in vitro</italic> and <italic>in vivo</italic> (<xref rid="B2" ref-type="bibr">Ahmadi et al., 2016</xref>).</p></sec><sec id="S6"><title>Concluding Remarks and Future Perspective</title><p>The high mortality and morbidity rate owing to <italic>C. albicans</italic> biofilm infection is a big challenge in medical mycology. Since the formation of biofilm and biomaterial infections is a progressively alarming problem, this warrants the development of new antifungal agents and the search for newer targets. This review elucidates the pathogenic foundation and molecular mechanism of <italic>C. albicans</italic> biofilms over antifungal drug resistance. A plethora of studies by several scientific groups and investigators have delivered essential knowledge regarding the pathogenesis associated with biofilm formation. These useful insights can represent an optimal starting point to find new therapeutic strategies related to drug resistance and mechanistic signals that govern <italic>C. albicans</italic> biofilm formation. Recent advances on different transcription factors, quorum sensing molecules, host response to adhesion, change in efflux pumps, enzymes, bud to hyphal transition, and change in lipid profile have broadened the knowledge of the complex mechanism underlying the biofilm resistance. Moreover, the development of new biomaterials with anti-adhesive properties, anti- infective lock therapies, high throughput phenotypic screening of small-molecule inhibitors, discovery and repurposing of naturally known compounds are under scrutiny. For medical instruments, a fine coating of nanomaterial may inhibit bacterial accumulation and biofilm formation. Recently, different metal nanoparticles have also emerged as antibiofilm agents against <italic>C. albicans</italic> and gaining momentum. Furthermore, different combinational therapies are harnessed for antibiofilm activity. Yet, the target-based approach is the need of the hour. For this multifaceted biofilm, the complex should be extensively studied to target different loops of phenotypic character change as they play a major role in biofilm formation. The detailed electron microscopic studies using both transmission electron microscopy (TEM) and scanning electron microscope (SEM) with much greater resolution may add additional repertoire to our knowledge. Yet another approach may be the use of some engineered enzymes that do not allow colony formation and inhibit in turn the biofilm formation. Any compound used for this purpose may be empirically optimized for its dose, sensitivity, and efficacy before a search for a target is mounted.</p><p>Given the diverse strategies to combat antifungal resistance, there is a hope that specific target-based drugs will be added to the arsenal in our fight against <italic>C. albicans</italic> biofilm formation in the not too distant future.</p></sec><sec id="S7"><title>Author Contributions</title><p>All authors contributed equally and approved the final version of the manuscript.</p></sec><sec sec-type="COI-statement" id="conf1"><title>Conflict of Interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body><back><ack><p>MFA and AH acknowledge the generous support from Research Supporting Project (No. RSP-2021-122) by King Saud University, Riyadh, Kingdom of Saudi Arabia.</p></ack><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adhya</surname><given-names>A.</given-names></name><name><surname>Bain</surname><given-names>J.</given-names></name><name><surname>Dutta</surname><given-names>G.</given-names></name><name><surname>Hazra</surname><given-names>A.</given-names></name><name><surname>Majumdar</surname><given-names>B.</given-names></name><name><surname>Ray</surname><given-names>O.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Healing of burn wounds by topical treatment: a randomized controlled comparison between silver sulfadiazine and nano-crystalline silver.</article-title>
<source><italic>J. Basic Clin. Pharm.</italic></source>
<volume>6</volume>:<issue>29</issue>. <pub-id pub-id-type="doi">10.4103/0976-0105.145776</pub-id>
<?supplied-pmid 25538469?><pub-id pub-id-type="pmid">25538469</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmadi</surname><given-names>M. S.</given-names></name><name><surname>Lee</surname><given-names>H. H.</given-names></name><name><surname>Sanchez</surname><given-names>D. A.</given-names></name><name><surname>Friedman</surname><given-names>A. J.</given-names></name><name><surname>Tar</surname><given-names>M. T.</given-names></name><name><surname>Davies</surname><given-names>K. P.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Sustained nitric oxide-releasing nanoparticles induce cell death in <italic>Candida albicans</italic> yeast and hyphal cells, preventing biofilm formation in vitro and in a rodent central venous catheter model.</article-title>
<source><italic>Antimicrob. Agents Chemother.</italic></source>
<volume>60</volume>
<fpage>2185</fpage>&#x02013;<lpage>2194</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.02659-15</pub-id>
<?supplied-pmid 26810653?><pub-id pub-id-type="pmid">26810653</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alexander</surname><given-names>J. W.</given-names></name></person-group> (<year>2009</year>). <article-title>History of the medical use of silver.</article-title>
<source><italic>Surg. Infect.</italic></source>
<volume>10</volume>
<fpage>289</fpage>&#x02013;<lpage>292</lpage>. <pub-id pub-id-type="doi">10.1089/sur.2008.9941</pub-id>
<?supplied-pmid 19566416?><pub-id pub-id-type="pmid">19566416</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alim</surname><given-names>D.</given-names></name><name><surname>Sircaik</surname><given-names>S.</given-names></name><name><surname>Panwar</surname><given-names>S. L.</given-names></name></person-group> (<year>2018</year>). <article-title>The significance of lipids to biofilm formation in <italic>Candida albicans</italic>: an emerging perspective.</article-title>
<source><italic>J. Fungi</italic></source>
<volume>4</volume>:<issue>140</issue>. <pub-id pub-id-type="doi">10.3390/jof4040140</pub-id>
<?supplied-pmid 30567300?><pub-id pub-id-type="pmid">30567300</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alizadeh</surname><given-names>F.</given-names></name><name><surname>Khodavandi</surname><given-names>A.</given-names></name><name><surname>Faraji</surname><given-names>F. S.</given-names></name></person-group> (<year>2017</year>). <article-title>Malva sylvestris inhibits <italic>Candida albicans</italic> biofilm formation.</article-title>
<source><italic>J. Herbmed. Pharmacol.</italic></source>
<volume>6</volume>
<fpage>62</fpage>&#x02013;<lpage>68</lpage>.</mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alonso</surname><given-names>B.</given-names></name><name><surname>P&#x000e9;rez-Granda</surname><given-names>M. J.</given-names></name><name><surname>Rodr&#x000ed;guez-Huerta</surname><given-names>A.</given-names></name><name><surname>Rodr&#x000ed;guez</surname><given-names>C.</given-names></name><name><surname>Bouza</surname><given-names>E.</given-names></name><name><surname>Guembe</surname><given-names>M.</given-names></name></person-group> (<year>2018</year>). <article-title>The optimal ethanol lock therapy regimen for treatment of biofilm-associated catheter infections: an in-vitro study.</article-title>
<source><italic>J. Hosp. Infect.</italic></source>
<volume>100</volume>
<fpage>e187</fpage>&#x02013;<lpage>e195</lpage>. <pub-id pub-id-type="doi">10.1016/j.jhin.2018.04.007</pub-id>
<?supplied-pmid 29653134?><pub-id pub-id-type="pmid">29653134</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alves</surname><given-names>M.</given-names></name><name><surname>Gon&#x000e7;alves</surname><given-names>M. J.</given-names></name><name><surname>Zuzarte</surname><given-names>M.</given-names></name><name><surname>Alves-Silva</surname><given-names>J. M.</given-names></name><name><surname>Cavaleiro</surname><given-names>C.</given-names></name><name><surname>Cruz</surname><given-names>M. T.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Unveiling the antifungal potential of two Iberian thyme essential oils: effect on <italic>C. albicans</italic> germ tube and preformed biofilms.</article-title>
<source><italic>Front. Microbiol.</italic></source>
<volume>10</volume>:<issue>446</issue>. <pub-id pub-id-type="doi">10.3389/fphar.2019.00446</pub-id>
<?supplied-pmid 31130859?><pub-id pub-id-type="pmid">31130859</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aneja</surname><given-names>B.</given-names></name><name><surname>Irfan</surname><given-names>M.</given-names></name><name><surname>Kapil</surname><given-names>C.</given-names></name><name><surname>Jairajpuri</surname><given-names>M. A.</given-names></name><name><surname>Maguire</surname><given-names>R.</given-names></name><name><surname>Kavanagh</surname><given-names>K.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Effect of novel triazole-amino acid hybrids on growth and virulence of Candida species: in vitro and in vivo studies.</article-title>
<source><italic>Org. Biomol. Chem.</italic></source>
<volume>14</volume>
<fpage>10599</fpage>&#x02013;<lpage>10619</lpage>. <pub-id pub-id-type="doi">10.1039/c6ob01718e</pub-id>
<?supplied-pmid 27735963?><pub-id pub-id-type="pmid">27735963</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aslanyan</surname><given-names>L.</given-names></name><name><surname>Sanchez</surname><given-names>D.</given-names></name><name><surname>Valdebenito</surname><given-names>S.</given-names></name><name><surname>Eugenin</surname><given-names>E.</given-names></name><name><surname>Ramos</surname><given-names>R.</given-names></name><name><surname>Martinez</surname><given-names>L.</given-names></name></person-group> (<year>2017</year>). <article-title>The crucial role of biofilms in <italic>Cryptococcus neoformans</italic> survival within macrophages and colonization of the central nervous system.</article-title>
<source><italic>J. Fungi</italic></source>
<volume>3</volume>:<issue>10</issue>. <pub-id pub-id-type="doi">10.3390/jof3010010</pub-id>
<?supplied-pmid 29371529?><pub-id pub-id-type="pmid">29371529</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aulner</surname><given-names>N.</given-names></name><name><surname>Danckaert</surname><given-names>A.</given-names></name><name><surname>Ihm</surname><given-names>J.</given-names></name><name><surname>Shum</surname><given-names>D.</given-names></name><name><surname>Shorte</surname><given-names>S. L.</given-names></name></person-group> (<year>2019</year>). <article-title>Next-generation phenotypic screening in early drug discovery for infectious diseases.</article-title>
<source><italic>Trends Parasitol.</italic></source>
<volume>35</volume>
<fpage>559</fpage>&#x02013;<lpage>570</lpage>. <pub-id pub-id-type="doi">10.1016/j.pt.2019.05.004</pub-id>
<?supplied-pmid 31176583?><pub-id pub-id-type="pmid">31176583</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barillo</surname><given-names>D. J.</given-names></name><name><surname>Marx</surname><given-names>D. E.</given-names></name></person-group> (<year>2014</year>). <article-title>Silver in medicine: a brief history BC 335 to present.</article-title>
<source><italic>Burns</italic></source>
<volume>40</volume>
<fpage>S3</fpage>&#x02013;<lpage>S8</lpage>. <pub-id pub-id-type="doi">10.1016/j.burns.2014.09.009</pub-id>
<?supplied-pmid 25418435?><pub-id pub-id-type="pmid">25418435</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Behbehani</surname><given-names>J.</given-names></name><name><surname>Shreaz</surname><given-names>S.</given-names></name><name><surname>Irshad</surname><given-names>M.</given-names></name><name><surname>Karched</surname><given-names>M.</given-names></name></person-group> (<year>2017</year>). <article-title>The natural compound magnolol affects growth, biofilm formation, and ultrastructure of oral Candida isolates.</article-title>
<source><italic>Microb. Pathog.</italic></source>
<volume>113</volume>
<fpage>209</fpage>&#x02013;<lpage>217</lpage>. <pub-id pub-id-type="doi">10.1016/j.micpath.2017.10.040</pub-id>
<?supplied-pmid 29074435?><pub-id pub-id-type="pmid">29074435</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ben-Ami</surname><given-names>R.</given-names></name><name><surname>Olshtain-Pops</surname><given-names>K.</given-names></name><name><surname>Krieger</surname><given-names>M.</given-names></name><name><surname>Oren</surname><given-names>I.</given-names></name><name><surname>Bishara</surname><given-names>J.</given-names></name><name><surname>Dan</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Antibiotic exposure as a risk factor for fluconazole-resistant Candida bloodstream infection.</article-title>
<source><italic>Antimicrob. Agents Chemother.</italic></source>
<volume>56</volume>
<fpage>2518</fpage>&#x02013;<lpage>2523</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.05947-11</pub-id>
<?supplied-pmid 22314534?><pub-id pub-id-type="pmid">22314534</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Berde</surname><given-names>C. V.</given-names></name><name><surname>Salvi</surname><given-names>S. P.</given-names></name><name><surname>Rawool</surname><given-names>P. P.</given-names></name><name><surname>Prathyusha</surname><given-names>A. M. V. N.</given-names></name><name><surname>Berde</surname><given-names>V. B.</given-names></name></person-group> (<year>2019</year>). &#x0201c;<article-title>Role of medicinal plants and endophytic bacteria of medicinal plants in inhibition of biofilm formation: interference in quorum sensing</article-title>,&#x0201d; in <source><italic>Implication of Quorum Sensing and Biofilm Formation in Medicine</italic></source>, <role>ed.</role>
<person-group person-group-type="editor"><name><surname>Bramhachari</surname><given-names>P.</given-names></name></person-group> (<publisher-loc>Singapore</publisher-loc>: <publisher-name>Springer</publisher-name>).</mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berger</surname><given-names>A.</given-names></name></person-group> (<year>2000</year>). <article-title>Science commentary: Th1 and Th2 responses: what are they?</article-title>
<source><italic>BMJ</italic></source>
<volume>321</volume>
<fpage>424</fpage>&#x02013;<lpage>424</lpage>. <pub-id pub-id-type="doi">10.1136/bmj.321.7258.424</pub-id>
<?supplied-pmid 10938051?><pub-id pub-id-type="pmid">10938051</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bink</surname><given-names>A.</given-names></name><name><surname>Kuchar&#x000ed;kov&#x000e1;</surname><given-names>S.</given-names></name><name><surname>Neirinck</surname><given-names>B.</given-names></name><name><surname>Vleugels</surname><given-names>J.</given-names></name><name><surname>Van Dijck</surname><given-names>P.</given-names></name><name><surname>Cammue</surname><given-names>B. P. A.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>The nonsteroidal antiinflammatory drug diclofenac potentiates the in vivo activity of caspofungin against <italic>Candida albicans</italic> biofilms.</article-title>
<source><italic>J. Infect. Dis.</italic></source>
<volume>206</volume>
<fpage>1790</fpage>&#x02013;<lpage>1797</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/jis594</pub-id>
<?supplied-pmid 22984120?><pub-id pub-id-type="pmid">22984120</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bongomin</surname><given-names>F.</given-names></name><name><surname>Gago</surname><given-names>S.</given-names></name><name><surname>Oladele</surname><given-names>R. O.</given-names></name><name><surname>Denning</surname><given-names>D. W.</given-names></name></person-group> (<year>2017</year>). <article-title>Global and multi-national prevalence of fungal diseases&#x02014;estimate precision.</article-title>
<source><italic>J. Fungi</italic></source>
<volume>3</volume>:<issue>57</issue>. <pub-id pub-id-type="doi">10.3390/jof3040057</pub-id>
<?supplied-pmid 29371573?><pub-id pub-id-type="pmid">29371573</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bookstaver</surname><given-names>P. B.</given-names></name><name><surname>Rokas</surname><given-names>K. E. E.</given-names></name><name><surname>Norris</surname><given-names>L. B.</given-names></name><name><surname>Edwards</surname><given-names>J. M.</given-names></name><name><surname>Sherertz</surname><given-names>R. J.</given-names></name></person-group> (<year>2013</year>). <article-title>Stability and compatibility of antimicrobial lock solutions.</article-title>
<source><italic>Am. J. Heal. Pharm.</italic></source>
<volume>70</volume>
<fpage>2185</fpage>&#x02013;<lpage>2198</lpage>. <pub-id pub-id-type="doi">10.2146/ajhp120119</pub-id>
<?supplied-pmid 24296841?><pub-id pub-id-type="pmid">24296841</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borghi</surname><given-names>E.</given-names></name><name><surname>Borgo</surname><given-names>F.</given-names></name><name><surname>Morace</surname><given-names>G.</given-names></name></person-group> (<year>2016</year>). <article-title>Fungal biofilms: update on resistance.</article-title>
<source><italic>Adv Exp Med Biol.</italic></source>
<volume>931</volume>
<fpage>37</fpage>&#x02013;<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1007/5584_2016_7</pub-id><pub-id pub-id-type="pmid">27115411</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borghi</surname><given-names>E.</given-names></name><name><surname>Morace</surname><given-names>G.</given-names></name><name><surname>Borgo</surname><given-names>F.</given-names></name><name><surname>Rajendran</surname><given-names>R.</given-names></name><name><surname>Sherry</surname><given-names>L.</given-names></name><name><surname>Nile</surname><given-names>C.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>New strategic insights into managing fungal biofilms.</article-title>
<source><italic>Front. Microbiol.</italic></source>
<volume>6</volume>:<issue>1077</issue>. <pub-id pub-id-type="doi">10.3389/fmicb.2015.01077</pub-id>
<?supplied-pmid 26500623?><pub-id pub-id-type="pmid">26500623</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Branzk</surname><given-names>N.</given-names></name><name><surname>Papayannopoulos</surname><given-names>V.</given-names></name></person-group> (<year>2013</year>). <article-title>Molecular mechanisms regulating NETosis in infection and disease.</article-title>
<source><italic>Semin. Immunopathol.</italic></source>
<volume>35</volume>
<fpage>513</fpage>&#x02013;<lpage>530</lpage>. <pub-id pub-id-type="doi">10.1007/s00281-013-0384-6</pub-id>
<?supplied-pmid 23732507?><pub-id pub-id-type="pmid">23732507</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cadicamo</surname><given-names>C. D.</given-names></name><name><surname>Mortier</surname><given-names>J.</given-names></name><name><surname>Wolber</surname><given-names>G.</given-names></name><name><surname>Hell</surname><given-names>M.</given-names></name><name><surname>Heinrich</surname><given-names>I. E.</given-names></name><name><surname>Michel</surname><given-names>D.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Design, synthesis, inhibition studies, and molecular modeling of pepstatin analogues addressing different secreted aspartic proteinases of <italic>Candida albicans</italic>.</article-title>
<source><italic>Biochem. Pharmacol.</italic></source>
<volume>85</volume>
<fpage>881</fpage>&#x02013;<lpage>887</lpage>. <pub-id pub-id-type="doi">10.1016/j.bcp.2012.12.008</pub-id>
<?supplied-pmid 23262278?><pub-id pub-id-type="pmid">23262278</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carradori</surname><given-names>S.</given-names></name><name><surname>Chimenti</surname><given-names>P.</given-names></name><name><surname>Fazzari</surname><given-names>M.</given-names></name><name><surname>Granese</surname><given-names>A.</given-names></name><name><surname>Angiolella</surname><given-names>L.</given-names></name></person-group> (<year>2016</year>). <article-title>Antimicrobial activity, synergism and inhibition of germ tube formation by <italic>Crocus sativus</italic>-derived compounds against <italic>Candida</italic> spp.</article-title>
<source><italic>J. Enzyme Inhib. Med. Chem.</italic></source>
<volume>31</volume>
<fpage>189</fpage>&#x02013;<lpage>193</lpage>. <pub-id pub-id-type="doi">10.1080/14756366.2016.1180596</pub-id>
<?supplied-pmid 27160150?><pub-id pub-id-type="pmid">27160150</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cavalheiro</surname><given-names>M.</given-names></name><name><surname>Teixeira</surname><given-names>M. C.</given-names></name></person-group> (<year>2018</year>). <article-title>Candida biofilms: threats, challenges, and promising strategies.</article-title>
<source><italic>Front. Med.</italic></source>
<volume>5</volume>:<issue>28</issue>. <pub-id pub-id-type="doi">10.3389/fmed.2018.00028</pub-id>
<?supplied-pmid 29487851?><pub-id pub-id-type="pmid">29487851</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaffin</surname><given-names>W. L.</given-names></name><name><surname>L&#x000f3;pez-Ribot</surname><given-names>J. L.</given-names></name><name><surname>Casanova</surname><given-names>M.</given-names></name><name><surname>Gozalbo</surname><given-names>D.</given-names></name><name><surname>Mart&#x000ed;nez</surname><given-names>J. P.</given-names></name></person-group> (<year>1998</year>). <article-title>Cell wall and secreted proteins of <italic>Candida albicans</italic>: identification, function, and expression.</article-title>
<source><italic>Microbiol. Mol. Biol. Rev.</italic></source>
<volume>62</volume>
<fpage>130</fpage>&#x02013;<lpage>180</lpage>. <pub-id pub-id-type="doi">10.1128/mmbr.62.1.130-180.1998</pub-id><pub-id pub-id-type="pmid">9529890</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chandra</surname><given-names>J.</given-names></name><name><surname>Patel</surname><given-names>J. D.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Zhou</surname><given-names>G.</given-names></name><name><surname>Mukherjee</surname><given-names>P. K.</given-names></name><name><surname>Mccormick</surname><given-names>T. S.</given-names></name><etal/></person-group> (<year>2005</year>). <article-title>Modification of surface properties of biomaterials influences the ability of <italic>Candida albicans</italic> to form biofilms.</article-title>
<source><italic>Appl. Environ. Microbiol.</italic></source>
<volume>71</volume>
<fpage>8795</fpage>&#x02013;<lpage>8801</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.71.12.8795</pub-id><pub-id pub-id-type="pmid">16332875</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chavez-Dozal</surname><given-names>A. A.</given-names></name><name><surname>Lown</surname><given-names>L.</given-names></name><name><surname>Jahng</surname><given-names>M.</given-names></name><name><surname>Walraven</surname><given-names>C. J.</given-names></name><name><surname>Lee</surname><given-names>S. A.</given-names></name></person-group> (<year>2014</year>). <article-title>In vitro analysis of finasteride activity against candida albicans urinary biofilm formation and filamentation.</article-title>
<source><italic>Antimicrob. Agents Chemother.</italic></source>
<volume>58</volume>
<fpage>5855</fpage>&#x02013;<lpage>5862</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.03137-14</pub-id>
<?supplied-pmid 25049253?><pub-id pub-id-type="pmid">25049253</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Qu</surname><given-names>S.</given-names></name><name><surname>Mao</surname><given-names>Y.</given-names></name><name><surname>Peng</surname><given-names>X.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Cinnamaldehyde inhibits <italic>Candida albicans</italic> growth by causing apoptosis and its treatment on vulvovaginal candidiasis and oropharyngeal candidiasis.</article-title>
<source><italic>Appl. Microbiol. Biotechnol.</italic></source>
<volume>103</volume>
<fpage>9037</fpage>&#x02013;<lpage>9055</lpage>. <pub-id pub-id-type="doi">10.1007/s00253-019-10119-3</pub-id>
<?supplied-pmid 31659418?><pub-id pub-id-type="pmid">31659418</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chinnici</surname><given-names>J.</given-names></name><name><surname>Yerke</surname><given-names>L.</given-names></name><name><surname>Tsou</surname><given-names>C.</given-names></name><name><surname>Busarajan</surname><given-names>S.</given-names></name><name><surname>Mancuso</surname><given-names>R.</given-names></name><name><surname>Sadhak</surname><given-names>N. D.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title><italic>Candida albicans</italic> cell wall integrity transcription factors regulate polymicrobial biofilm formation with <italic>Streptococcus gordonii</italic>.</article-title>
<source><italic>PeerJ</italic></source>
<volume>7</volume>:<issue>e7870</issue>. <pub-id pub-id-type="doi">10.7717/peerj.7870</pub-id>
<?supplied-pmid 31616604?><pub-id pub-id-type="pmid">31616604</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coleman</surname><given-names>J. J.</given-names></name><name><surname>Okoli</surname><given-names>I.</given-names></name><name><surname>Tegos</surname><given-names>G. P.</given-names></name><name><surname>Holson</surname><given-names>E. B.</given-names></name><name><surname>Wagner</surname><given-names>F. F.</given-names></name><name><surname>Hamblin</surname><given-names>M. R.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Characterization of plant-derived saponin natural products against <italic>Candida albicans</italic>.</article-title>
<source><italic>ACS Chem. Biol.</italic></source>
<volume>5</volume>
<fpage>321</fpage>&#x02013;<lpage>332</lpage>. <pub-id pub-id-type="doi">10.1021/cb900243b</pub-id>
<?supplied-pmid 20099897?><pub-id pub-id-type="pmid">20099897</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cordeiro</surname><given-names>R. A.</given-names></name><name><surname>Macedo</surname><given-names>R. B.</given-names></name><name><surname>Teixeira</surname><given-names>C. E. C.</given-names></name><name><surname>Marques</surname><given-names>F. J. F.</given-names></name><name><surname>Bandeira</surname><given-names>T. J. P. G.</given-names></name><name><surname>Moreira</surname><given-names>J. L. B.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>The calcineurin inhibitor cyclosporin A exhibits synergism with antifungals against <italic>Candida parapsilosis</italic> species complex.</article-title>
<source><italic>J. Med. Microbiol.</italic></source>
<volume>63(Pt 7)</volume>
<fpage>936</fpage>&#x02013;<lpage>944</lpage>. <pub-id pub-id-type="doi">10.1099/jmm.0.073478-0</pub-id>
<?supplied-pmid 24722799?><pub-id pub-id-type="pmid">24722799</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cretton</surname><given-names>S.</given-names></name><name><surname>Dorsaz</surname><given-names>S.</given-names></name><name><surname>Azzollini</surname><given-names>A.</given-names></name><name><surname>Favre-godal</surname><given-names>Q.</given-names></name><name><surname>Marcourt</surname><given-names>L.</given-names></name><name><surname>Ebrahimi</surname><given-names>S. N.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Antifungal quinoline alkaloids from <italic>Waltheria indica</italic>.</article-title>
<source><italic>J. Nat. Prod.</italic></source>
<volume>79</volume>
<fpage>300</fpage>&#x02013;<lpage>307</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jnatprod.5b00896</pub-id>
<?supplied-pmid 26848627?><pub-id pub-id-type="pmid">26848627</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dahal</surname><given-names>G. P.</given-names></name><name><surname>Launder</surname><given-names>D.</given-names></name><name><surname>McKeone</surname><given-names>K. M. M.</given-names></name><name><surname>Hunter</surname><given-names>J. P.</given-names></name><name><surname>Conti</surname><given-names>H. R.</given-names></name><name><surname>Viola</surname><given-names>R. E.</given-names></name></person-group> (<year>2020</year>). <article-title>Aspartate semialdehyde dehydrogenase inhibition suppresses the growth of the pathogenic fungus <italic>Candida albicans</italic>.</article-title>
<source><italic>Drug Dev. Res.</italic></source>
<volume>81</volume>
<fpage>736</fpage>&#x02013;<lpage>744</lpage>. <pub-id pub-id-type="doi">10.1002/ddr.21682</pub-id>
<?supplied-pmid 32383780?><pub-id pub-id-type="pmid">32383780</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dahal</surname><given-names>G. P.</given-names></name><name><surname>Viola</surname><given-names>R. E.</given-names></name></person-group> (<year>2018</year>). <article-title>A fragment library screening approach to identify selective inhibitors against an essential fungal enzyme.</article-title>
<source><italic>SLAS Discov.</italic></source>
<volume>23</volume>
<fpage>520</fpage>&#x02013;<lpage>531</lpage>. <pub-id pub-id-type="doi">10.1177/2472555218767844</pub-id>
<?supplied-pmid 29608391?><pub-id pub-id-type="pmid">29608391</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Castro</surname><given-names>R. D.</given-names></name><name><surname>de Souza</surname><given-names>T. M.</given-names></name><name><surname>Bezerra</surname><given-names>L. M.</given-names></name><name><surname>Ferreira</surname><given-names>G. L.</given-names></name><name><surname>Costa</surname><given-names>E. M.</given-names></name><name><surname>Cavalcanti</surname><given-names>A. L.</given-names></name></person-group> (<year>2015</year>). <article-title>Antifungal activity and mode of action of thymol and its synergism with nystatin against <italic>Candida</italic> species involved with infections in the oral cavity: an in vitro study.</article-title>
<source><italic>BMC Complement. Altern. Med.</italic></source>
<volume>15</volume>:<issue>417</issue>. <pub-id pub-id-type="doi">10.1186/s12906-015-0947-2</pub-id>
<?supplied-pmid 26601661?><pub-id pub-id-type="pmid">26601661</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Cremer</surname><given-names>K.</given-names></name><name><surname>Lanckacker</surname><given-names>E.</given-names></name><name><surname>Cools</surname><given-names>T. L.</given-names></name><name><surname>Bax</surname><given-names>M.</given-names></name><name><surname>De Brucker</surname><given-names>K.</given-names></name><name><surname>Cos</surname><given-names>P.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Artemisinins, new miconazole potentiators resulting in increased activity against <italic>Candida albicans</italic> biofilms.</article-title>
<source><italic>Antimicrob. Agents Chemother.</italic></source>
<volume>59</volume>
<fpage>421</fpage>&#x02013;<lpage>426</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.04229-14</pub-id>
<?supplied-pmid 25367916?><pub-id pub-id-type="pmid">25367916</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delattin</surname><given-names>N.</given-names></name><name><surname>De Brucker</surname><given-names>K.</given-names></name><name><surname>Vandamme</surname><given-names>K.</given-names></name><name><surname>Meert</surname><given-names>E.</given-names></name><name><surname>Marchand</surname><given-names>A.</given-names></name><name><surname>Chaltin</surname><given-names>P.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Repurposing as a means to increase the activity of amphotericin B and caspofungin against <italic>Candida albicans</italic> biofilms.</article-title>
<source><italic>J. Antimicrob. Chemother.</italic></source>
<volume>69</volume>
<fpage>1035</fpage>&#x02013;<lpage>1044</lpage>. <pub-id pub-id-type="doi">10.1093/jac/dkt449</pub-id>
<?supplied-pmid 24284780?><pub-id pub-id-type="pmid">24284780</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Demuyser</surname><given-names>L.</given-names></name><name><surname>Jabra-Rizk</surname><given-names>M. A.</given-names></name><name><surname>van Dijck</surname><given-names>P.</given-names></name></person-group> (<year>2014</year>). <article-title>Microbial cell surface proteins and secreted metabolites involved in multispecies biofilms.</article-title>
<source><italic>Pathog. Dis.</italic></source>
<volume>70</volume>
<fpage>219</fpage>&#x02013;<lpage>230</lpage>. <pub-id pub-id-type="doi">10.1111/2049-632X.12123</pub-id>
<?supplied-pmid 24376219?><pub-id pub-id-type="pmid">24376219</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di&#x0017e;ov&#x000e1;</surname><given-names>S.</given-names></name><name><surname>Bujd&#x000e1;kov&#x000e1;</surname><given-names>H.</given-names></name></person-group> (<year>2017</year>). <article-title>Properties and role of the quorum sensing molecule farnesol in relation to the yeast <italic>Candida albicans</italic>.</article-title>
<source><italic>Pharmazie</italic></source>
<volume>72</volume>
<fpage>307</fpage>&#x02013;<lpage>312</lpage>. <pub-id pub-id-type="doi">10.1691/ph.2017.6174</pub-id>
<?supplied-pmid 29442016?><pub-id pub-id-type="pmid">29442016</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Douglas</surname><given-names>L. J.</given-names></name></person-group> (<year>2002</year>). <article-title>Medical importance of biofilms in <italic>Candida</italic> infections.</article-title>
<source><italic>Rev. Iberoam. Micol.</italic></source>
<volume>19</volume>
<fpage>139</fpage>&#x02212;<lpage>143</lpage>.<pub-id pub-id-type="pmid">12825991</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Douglas</surname><given-names>L. J.</given-names></name></person-group> (<year>2003</year>). <article-title>Candida biofilms and their role in infection.</article-title>
<source><italic>Trends Microbiol.</italic></source>
<volume>11</volume>
<fpage>30</fpage>&#x02013;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1016/S0966-842X(02)00002-1</pub-id><pub-id pub-id-type="pmid">12526852</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Endo</surname><given-names>E. H.</given-names></name><name><surname>Cortez</surname><given-names>D. A.</given-names></name><name><surname>Ueda-Nakamura</surname><given-names>T.</given-names></name><name><surname>Nakamura</surname><given-names>C. V.</given-names></name><name><surname>Prado</surname><given-names>B.</given-names></name><name><surname>Filho</surname><given-names>D.</given-names></name></person-group> (<year>2010</year>). <article-title>Potent antifungal activity of extracts and pure compound isolated from pomegranate peels and synergism with fluconazole against <italic>Candida albicans</italic>.</article-title>
<source><italic>Res. Microbiol.</italic></source>
<volume>161</volume>
<fpage>534</fpage>&#x02013;<lpage>540</lpage>. <pub-id pub-id-type="doi">10.1016/j.resmic.2010.05.002</pub-id>
<?supplied-pmid 20541606?><pub-id pub-id-type="pmid">20541606</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erb-Downward</surname><given-names>J. R.</given-names></name><name><surname>Noverr</surname><given-names>M. C.</given-names></name></person-group> (<year>2007</year>). <article-title>Characterization of prostaglandin E2 production by <italic>Candida albicans</italic>.</article-title>
<source><italic>Infect. Immun.</italic></source>
<volume>75</volume>
<fpage>3498</fpage>&#x02013;<lpage>3505</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.00232-07</pub-id>
<?supplied-pmid 17470538?><pub-id pub-id-type="pmid">17470538</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evensen</surname><given-names>N. A.</given-names></name><name><surname>Braun</surname><given-names>P. C.</given-names></name></person-group> (<year>2009</year>). <article-title>The effects of tea polyphenols on <italic>Candida albicans</italic>?: inhibition of biofilm formation and proteasome inactivation.</article-title>
<source><italic>Can. J. Microbiol.</italic></source>
<volume>55</volume>
<fpage>1033</fpage>&#x02013;<lpage>1039</lpage>. <pub-id pub-id-type="doi">10.1139/W09-058</pub-id>
<?supplied-pmid 19898545?><pub-id pub-id-type="pmid">19898545</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Favre-Godal</surname><given-names>Q.</given-names></name><name><surname>Dorsaz</surname><given-names>S.</given-names></name><name><surname>Queiroz</surname><given-names>E. F.</given-names></name><name><surname>Marcourt</surname><given-names>L.</given-names></name><name><surname>Ebrahimi</surname><given-names>S. N.</given-names></name><name><surname>Allard</surname><given-names>P-M.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Anti- candida cassane-type diterpenoids from the root bark of swartzia simplex.</article-title>
<source><italic>J. Nat. Prod.</italic></source>
<volume>78</volume>
<fpage>2994</fpage>&#x02013;<lpage>3004</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jnatprod.5b00744</pub-id>
<?supplied-pmid 26654828?><pub-id pub-id-type="pmid">26654828</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fazly</surname><given-names>A.</given-names></name><name><surname>Jain</surname><given-names>C.</given-names></name><name><surname>Dehner</surname><given-names>A. C.</given-names></name><name><surname>Issi</surname><given-names>L.</given-names></name><name><surname>Lilly</surname><given-names>E. A.</given-names></name><name><surname>Ali</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Chemical screening identifies filastatin, a small molecule inhibitor of <italic>Candida albicans</italic> adhesion, morphogenesis, and pathogenesis.</article-title>
<source><italic>Proc. Natl. Acad. Sci. U.S.A.</italic></source>
<volume>110</volume>
<fpage>13594</fpage>&#x02013;<lpage>13599</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1305982110</pub-id>
<?supplied-pmid 23904484?><pub-id pub-id-type="pmid">23904484</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feldman</surname><given-names>M.</given-names></name><name><surname>Al-Quntar</surname><given-names>A.</given-names></name><name><surname>Polacheck</surname><given-names>I.</given-names></name><name><surname>Friedman</surname><given-names>M.</given-names></name><name><surname>Steinberg</surname><given-names>D.</given-names></name></person-group> (<year>2014</year>). <article-title>Therapeutic potential of thiazolidinedione-8 as an antibiofilm agent against <italic>Candida albicans</italic>.</article-title>
<source><italic>PLoS One</italic></source>
<volume>9</volume>:<issue>e93225</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0093225</pub-id>
<?supplied-pmid 24796422?><pub-id pub-id-type="pmid">24796422</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finkel</surname><given-names>J. S.</given-names></name><name><surname>Mitchell</surname><given-names>A. P.</given-names></name></person-group> (<year>2011</year>). <article-title>Genetic control of <italic>Candida Albicans</italic> biofilm development.</article-title>
<source><italic>Nat. Rev. Microbiol.</italic></source>
<volume>9</volume>
<fpage>109</fpage>&#x02013;<lpage>118</lpage>. <pub-id pub-id-type="doi">10.1109/isdrs.2005.1596138</pub-id><pub-id pub-id-type="pmid">21189476</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fleming</surname><given-names>D.</given-names></name><name><surname>Chahin</surname><given-names>L.</given-names></name><name><surname>Rumbaugh</surname><given-names>K.</given-names></name></person-group> (<year>2017</year>). <article-title>Glycoside hydrolases degrade polymicrobial bacterial biofilms in wounds.</article-title>
<source><italic>Antimicrob. Agents Chemother.</italic></source>
<volume>61</volume>:<issue>e01998-16</issue>. <pub-id pub-id-type="doi">10.1128/AAC.01998-16</pub-id>
<?supplied-pmid 27872074?><pub-id pub-id-type="pmid">27872074</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fourie</surname><given-names>R.</given-names></name><name><surname>Ells</surname><given-names>R.</given-names></name><name><surname>Swart</surname><given-names>C. W.</given-names></name><name><surname>Sebolai</surname><given-names>O. M.</given-names></name><name><surname>Albertyn</surname><given-names>J.</given-names></name><name><surname>Pohl</surname><given-names>C. H.</given-names></name></person-group> (<year>2016</year>). <article-title><italic>Candida albicans</italic> and <italic>Pseudomonas aeruginosa</italic> interaction, with focus on the role of eicosanoids.</article-title>
<source><italic>Front. Physiol.</italic></source>
<volume>7</volume>:<issue>64</issue>. <pub-id pub-id-type="doi">10.3389/fphys.2016.00064</pub-id>
<?supplied-pmid 26955357?><pub-id pub-id-type="pmid">26955357</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia</surname><given-names>C.</given-names></name><name><surname>Burgain</surname><given-names>A.</given-names></name><name><surname>Chaillot</surname><given-names>J.</given-names></name><name><surname>Pic</surname><given-names>&#x000c9;</given-names></name><name><surname>Khemiri</surname><given-names>I.</given-names></name><name><surname>Sellam</surname><given-names>A.</given-names></name></person-group> (<year>2018</year>). <article-title>A phenotypic small-molecule screen identifies halogenated salicylanilides as inhibitors of fungal morphogenesis, biofilm formation and host cell invasion.</article-title>
<source><italic>Sci. Rep.</italic></source>
<volume>8</volume>:<issue>11559</issue>. <pub-id pub-id-type="doi">10.1038/s41598-018-29973-8</pub-id>
<?supplied-pmid 30068935?><pub-id pub-id-type="pmid">30068935</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Golipour</surname><given-names>F.</given-names></name><name><surname>Habibipour</surname><given-names>R.</given-names></name><name><surname>Moradihaghgou</surname><given-names>L.</given-names></name></person-group> (<year>2019</year>). <article-title>Investigating effects of superparamagnetic iron oxide nanoparticles on <italic>Candida albicans</italic> biofilm formation.</article-title>
<source><italic>Med. Lab. J.</italic></source>
<volume>13</volume>
<fpage>44</fpage>&#x02013;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.29252/mlj.13.6.44</pub-id>
<?supplied-pmid 30186992?><pub-id pub-id-type="pmid">30186992</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gondim</surname><given-names>B. L. C.</given-names></name><name><surname>Castellano</surname><given-names>L. R. C.</given-names></name><name><surname>de Castro</surname><given-names>R. D.</given-names></name><name><surname>Machado</surname><given-names>G.</given-names></name><name><surname>Carlo</surname><given-names>H. L.</given-names></name><name><surname>Valen&#x000e7;a</surname><given-names>A. M. G.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Effect of chitosan nanoparticles on the inhibition of <italic>Candida</italic> spp. biofilm on denture base surface.</article-title>
<source><italic>Arch. Oral Biol.</italic></source>
<volume>94</volume>
<fpage>99</fpage>&#x02013;<lpage>107</lpage>. <pub-id pub-id-type="doi">10.1016/j.archoralbio.2018.07.004</pub-id>
<?supplied-pmid 30015218?><pub-id pub-id-type="pmid">30015218</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grald</surname><given-names>A.</given-names></name><name><surname>Yargosz</surname><given-names>P.</given-names></name><name><surname>Case</surname><given-names>S.</given-names></name><name><surname>Shea</surname><given-names>K.</given-names></name><name><surname>Johnson</surname><given-names>D. I.</given-names></name></person-group> (<year>2012</year>). <article-title>Small-molecule inhibitors of biofilm formation in laboratory and clinical isolates of <italic>Candida albicans</italic>.</article-title>
<source><italic>J. Med. Microbiol.</italic></source>
<volume>61</volume>
<fpage>109</fpage>&#x02013;<lpage>114</lpage>. <pub-id pub-id-type="doi">10.1099/jmm.0.034124-0</pub-id>
<?supplied-pmid 21903824?><pub-id pub-id-type="pmid">21903824</pub-id></mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gristina</surname><given-names>A. G.</given-names></name><name><surname>Naylor</surname><given-names>P.</given-names></name><name><surname>Myrvik</surname><given-names>Q.</given-names></name></person-group> (<year>1988</year>). <article-title>Infections from biomaterials and implants: a race for the surface.</article-title>
<source><italic>Med. Prog. Technol.</italic></source>
<volume>14</volume>
<fpage>205</fpage>&#x02013;<lpage>224</lpage>.<pub-id pub-id-type="pmid">2978593</pub-id></mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guisbiers</surname><given-names>G.</given-names></name><name><surname>Lara</surname><given-names>H. H.</given-names></name><name><surname>Mendoza-Cruz</surname><given-names>R.</given-names></name><name><surname>Naranjo</surname><given-names>G.</given-names></name><name><surname>Vincent</surname><given-names>B. A.</given-names></name><name><surname>Peralta</surname><given-names>X. G.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Inhibition of Candida albicans biofilm by pure selenium nanoparticles synthesized by pulsed laser ablation in liquids.</article-title>
<source><italic>Nanomed. Nanotechnol. Biol. Med.</italic></source>
<volume>13</volume>
<fpage>1095</fpage>&#x02013;<lpage>1103</lpage>. <pub-id pub-id-type="doi">10.1016/j.nano.2016.10.011</pub-id>
<?supplied-pmid 27793789?><pub-id pub-id-type="pmid">27793789</pub-id></mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gulati</surname><given-names>M.</given-names></name><name><surname>Nobile</surname><given-names>C. J.</given-names></name></person-group> (<year>2016</year>). <article-title><italic>Candida albicans</italic> biofilms: development, regulation, and molecular mechanisms.</article-title>
<source><italic>Microbes Infect.</italic></source>
<volume>18</volume>
<fpage>310</fpage>&#x02013;<lpage>321</lpage>. <pub-id pub-id-type="doi">10.1016/j.micinf.2016.01.002</pub-id>
<?supplied-pmid 26806384?><pub-id pub-id-type="pmid">26806384</pub-id></mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haghighi</surname><given-names>F.</given-names></name><name><surname>Mohammadi</surname><given-names>S. R.</given-names></name><name><surname>Mohammadi</surname><given-names>P.</given-names></name><name><surname>Hosseinkhani</surname><given-names>S.</given-names></name><name><surname>Shidpour</surname><given-names>R.</given-names></name></person-group> (<year>2013</year>). <article-title>Antifungal Activity of TiO 2 nanoparticles and EDTA on <italic>Candida albicans</italic> biofilms.</article-title>
<source><italic>Orig. Artic. Infect. Epidemiol. Med.</italic></source>
<volume>1</volume>
<fpage>33</fpage>&#x02013;<lpage>38</lpage>.</mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harriott</surname><given-names>M. M.</given-names></name><name><surname>Noverr</surname><given-names>M. C.</given-names></name></person-group> (<year>2010</year>). <article-title>Ability of <italic>Candida albicans</italic> mutants to induce <italic>Staphylococcus aureus</italic> vancomycin resistance during polymicrobial biofilm formation.</article-title>
<source><italic>Antimicrob. Agents Chemother.</italic></source>
<volume>54</volume>
<fpage>3746</fpage>&#x02013;<lpage>3755</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.00573-10</pub-id>
<?supplied-pmid 20566760?><pub-id pub-id-type="pmid">20566760</pub-id></mixed-citation></ref><ref id="B60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hawser</surname><given-names>S. P.</given-names></name><name><surname>Douglas</surname><given-names>L. J.</given-names></name></person-group> (<year>1995</year>). <article-title>Resistance of <italic>Candida albicans</italic> biofilms to antifungal agents in vitro.</article-title>
<source><italic>Antimicrob. Agents Chemother.</italic></source>
<volume>39</volume>
<fpage>2128</fpage>&#x02013;<lpage>2131</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.39.9.2128</pub-id>
<?supplied-pmid 8540729?><pub-id pub-id-type="pmid">8540729</pub-id></mixed-citation></ref><ref id="B61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hendry</surname><given-names>E. R.</given-names></name><name><surname>Worthington</surname><given-names>T.</given-names></name><name><surname>Conway</surname><given-names>B. R.</given-names></name><name><surname>Lambert</surname><given-names>P. A.</given-names></name></person-group> (<year>2009</year>). <article-title>Antimicrobial efficacy of eucalyptus oil and 1,8-cineole alone and in combination with chlorhexidine digluconate against microorganisms grown in planktonic and biofilm cultures.</article-title>
<source><italic>J. Antimicrob. Chemother.</italic></source>
<volume>64</volume>
<fpage>1219</fpage>&#x02013;<lpage>1225</lpage>. <pub-id pub-id-type="doi">10.1093/jac/dkp362</pub-id>
<?supplied-pmid 19837714?><pub-id pub-id-type="pmid">19837714</pub-id></mixed-citation></ref><ref id="B62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hernandez-Delgadillo</surname><given-names>R.</given-names></name><name><surname>Velasco-Arias, Martinez-Sanmiguel, Diaz</surname><given-names>D.</given-names></name><name><surname>Zumeta-Dub&#x000e9;</surname><given-names>I.</given-names></name><name><surname>Cabral-Romero</surname><given-names>C.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Bismuth oxide aqueous colloidal nanoparticles inhibit <italic>Candida albicans</italic> growth and biofilm formation.</article-title>
<source><italic>Int. J. Nanomed.</italic></source>
<volume>8</volume>
<fpage>1645</fpage>&#x02013;<lpage>1652</lpage>. <pub-id pub-id-type="doi">10.2147/IJN.S38708</pub-id>
<?supplied-pmid 23637533?><pub-id pub-id-type="pmid">23637533</pub-id></mixed-citation></ref><ref id="B63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holbrook</surname><given-names>S. Y. L.</given-names></name><name><surname>Garzan</surname><given-names>A.</given-names></name><name><surname>Dennis</surname><given-names>E. K.</given-names></name><name><surname>Shrestha</surname><given-names>S. K.</given-names></name><name><surname>Garneau-Tsodikova</surname><given-names>S.</given-names></name></person-group> (<year>2017</year>). <article-title>Repurposing antipsychotic drugs into antifungal agents: synergistic combinations of azoles and bromperidol derivatives in the treatment of various fungal infections.</article-title>
<source><italic>Eur. J. Med. Chem.</italic></source>
<volume>139</volume>
<fpage>12</fpage>&#x02013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmech.2017.07.030</pub-id>
<?supplied-pmid 28797882?><pub-id pub-id-type="pmid">28797882</pub-id></mixed-citation></ref><ref id="B64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hosseini</surname><given-names>S. S.</given-names></name><name><surname>Ghaemi</surname><given-names>E.</given-names></name><name><surname>Koohsar</surname><given-names>F.</given-names></name></person-group> (<year>2018</year>). <article-title>Influence of ZnO nanoparticles on <italic>Candida albicans</italic> isolates biofilm formed on the urinary catheter.</article-title>
<source><italic>Iran. J. Microbiol.</italic></source>
<volume>10</volume>
<fpage>424</fpage>&#x02013;<lpage>432</lpage>.<pub-id pub-id-type="pmid">30873271</pub-id></mixed-citation></ref><ref id="B65"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hwang</surname><given-names>I.</given-names></name><name><surname>Lee</surname><given-names>J.</given-names></name><name><surname>Hwang</surname><given-names>J. H.</given-names></name><name><surname>Kim</surname><given-names>K.</given-names></name><name><surname>Lee</surname><given-names>D. G.</given-names></name></person-group> (<year>2012</year>). <article-title>Silver nanoparticles induce apoptotic cell death in <italic>Candida albicans</italic> through the increase of hydroxyl radicals.</article-title>
<source><italic>FEBS J.</italic></source>
<volume>6</volume>
<fpage>1327</fpage>&#x02013;<lpage>1338</lpage>. <pub-id pub-id-type="doi">10.1111/j.1742-4658.2012.08527.x</pub-id>
<?supplied-pmid 22324978?><pub-id pub-id-type="pmid">22324978</pub-id></mixed-citation></ref><ref id="B66"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ing</surname><given-names>L. Y.</given-names></name><name><surname>Zin</surname><given-names>N. M.</given-names></name><name><surname>Sarwar</surname><given-names>A.</given-names></name><name><surname>Katas</surname><given-names>H.</given-names></name></person-group> (<year>2012</year>). <article-title>Antifungal activity of chitosan nanoparticles and correlation with their physical properties.</article-title>
<source><italic>Int. J. Biomater.</italic></source>
<volume>2012</volume>
<fpage>1</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1155/2012/632698</pub-id>
<?supplied-pmid 22829829?><pub-id pub-id-type="pmid">22829829</pub-id></mixed-citation></ref><ref id="B67"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janeczko</surname><given-names>M.</given-names></name><name><surname>Kubi&#x00144;ski</surname><given-names>K.</given-names></name><name><surname>Martyna</surname><given-names>A.</given-names></name><name><surname>Muzyczka</surname><given-names>A.</given-names></name><name><surname>Boguszewska-Czubara</surname><given-names>A.</given-names></name><name><surname>Czernik</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>1,4-Naphthoquinone derivatives potently suppress <italic>Candida albicans</italic> growth, inhibit formation of hyphae and show no toxicity toward zebrafish embryos.</article-title>
<source><italic>J. Med. Microbiol.</italic></source>
<volume>67</volume>
<fpage>598</fpage>&#x02013;<lpage>609</lpage>. <pub-id pub-id-type="doi">10.1099/jmm.0.000700</pub-id>
<?supplied-pmid 29461185?><pub-id pub-id-type="pmid">29461185</pub-id></mixed-citation></ref><ref id="B68"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janeczko</surname><given-names>M.</given-names></name><name><surname>Mas&#x00142;yk</surname><given-names>M.</given-names></name><name><surname>Kubi&#x00144;ski</surname><given-names>K.</given-names></name><name><surname>Golczyk</surname><given-names>H.</given-names></name></person-group> (<year>2017</year>). <article-title>Emodin, a natural inhibitor of protein kinase CK2, suppresses growth, hyphal development, and biofilm formation of <italic>Candida albicans</italic>.</article-title>
<source><italic>Yeast</italic></source>
<volume>34</volume>
<fpage>253</fpage>&#x02013;<lpage>265</lpage>. <pub-id pub-id-type="doi">10.1002/yea.3230</pub-id>
<?supplied-pmid 28181315?><pub-id pub-id-type="pmid">28181315</pub-id></mixed-citation></ref><ref id="B69"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ji</surname><given-names>C.</given-names></name><name><surname>Liu</surname><given-names>N.</given-names></name><name><surname>Tu</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Han</surname><given-names>G.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Drug repurposing of haloperidol: discovery of new benzocyclane derivatives as potent antifungal agents against Cryptococcosis and Candidiasis.</article-title>
<source><italic>ACS Infect. Dis.</italic></source>
<volume>6</volume>
<fpage>768</fpage>&#x02013;<lpage>786</lpage>. <pub-id pub-id-type="doi">10.1021/acsinfecdis.9b00197</pub-id>
<?supplied-pmid 31550886?><pub-id pub-id-type="pmid">31550886</pub-id></mixed-citation></ref><ref id="B70"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname><given-names>W.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Li</surname><given-names>G.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Wei</surname><given-names>J.</given-names></name></person-group> (<year>2016</year>). <article-title>The calcineruin inhibitor cyclosporine a synergistically enhances the susceptibility of <italic>Candida albicans</italic> biofilms to fluconazole by multiple mechanisms.</article-title>
<source><italic>BMC Microbiol.</italic></source>
<volume>16</volume>:<issue>113</issue>. <pub-id pub-id-type="doi">10.1186/s12866-016-0728-1</pub-id>
<?supplied-pmid 27316338?><pub-id pub-id-type="pmid">27316338</pub-id></mixed-citation></ref><ref id="B71"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>C. J.</given-names></name><name><surname>Cabezas-Olcoz</surname><given-names>J.</given-names></name><name><surname>Kernien</surname><given-names>J. F.</given-names></name><name><surname>Wang</surname><given-names>S. X.</given-names></name><name><surname>Beebe</surname><given-names>D. J.</given-names></name><name><surname>Huttenlocher</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>The extracellular matrix of <italic>Candida albicans</italic> biofilms impairs formation of neutrophil extracellular traps.</article-title>
<source><italic>PLoS Pathog.</italic></source>
<volume>12</volume>:<issue>e1005884</issue>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1005884</pub-id>
<?supplied-pmid 27622514?><pub-id pub-id-type="pmid">27622514</pub-id></mixed-citation></ref><ref id="B72"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>C. J.</given-names></name><name><surname>Kernien</surname><given-names>J. F.</given-names></name><name><surname>Hoyer</surname><given-names>A. R.</given-names></name><name><surname>Nett</surname><given-names>J. E.</given-names></name></person-group> (<year>2017</year>). <article-title>Mechanisms involved in the triggering of neutrophil extracellular traps (NETs) by <italic>Candida glabrata</italic> during planktonic and biofilm growth.</article-title>
<source><italic>Sci. Rep.</italic></source>
<volume>7</volume>:<issue>13065</issue>. <pub-id pub-id-type="doi">10.1038/s41598-017-13588-6</pub-id>
<?supplied-pmid 29026191?><pub-id pub-id-type="pmid">29026191</pub-id></mixed-citation></ref><ref id="B73"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Juin</surname><given-names>C.</given-names></name><name><surname>Perrin</surname><given-names>F.</given-names></name><name><surname>Puy</surname><given-names>T.</given-names></name><name><surname>Mollichella</surname><given-names>M. L.</given-names></name><name><surname>Girardot</surname><given-names>M.</given-names></name><name><surname>Costa</surname><given-names>D.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Anti-biofilm activity of a semi-synthetic molecule obtained from resveratrol against <italic>Candida albicans</italic> biofilm.</article-title>
<source><italic>Med. Mycol.</italic></source>
<volume>58</volume>
<fpage>530</fpage>&#x02013;<lpage>542</lpage>. <pub-id pub-id-type="doi">10.1093/mmy/myz087</pub-id>
<?supplied-pmid 31504755?><pub-id pub-id-type="pmid">31504755</pub-id></mixed-citation></ref><ref id="B74"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Justo</surname><given-names>J. A.</given-names></name><name><surname>Bookstaver</surname><given-names>P. B.</given-names></name></person-group> (<year>2014</year>). <article-title>Antibiotic lock therapy: review of technique and logistical challenges.</article-title>
<source><italic>Infect. Drug Resist.</italic></source>
<volume>7</volume>
<fpage>343</fpage>&#x02013;<lpage>363</lpage>. <pub-id pub-id-type="doi">10.2147/IDR.S51388</pub-id>
<?supplied-pmid 25548523?><pub-id pub-id-type="pmid">25548523</pub-id></mixed-citation></ref><ref id="B75"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaplan</surname><given-names>J. B.</given-names></name></person-group> (<year>2014</year>). <article-title>Biofilm matrix-degrading enzymes.</article-title>
<source><italic>Methods Mol. Biol.</italic></source>
<volume>1147</volume>
<fpage>203</fpage>&#x02013;<lpage>213</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-4939-0467-9_14</pub-id><pub-id pub-id-type="pmid">24664835</pub-id></mixed-citation></ref><ref id="B76"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaur</surname><given-names>R.</given-names></name><name><surname>Goyal</surname><given-names>R.</given-names></name><name><surname>Dhakad</surname><given-names>M. S.</given-names></name><name><surname>Bhalla</surname><given-names>P.</given-names></name><name><surname>Kumar</surname><given-names>R.</given-names></name></person-group> (<year>2014</year>). <article-title>Epidemiology and virulence determinants including biofilm profile of candida infections in an ICU in a tertiary hospital in india.</article-title>
<source><italic>J. Mycol.</italic></source>
<volume>27</volume>
<fpage>171</fpage>&#x02013;<lpage>172</lpage>.</mixed-citation></ref><ref id="B77"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keniya</surname><given-names>M. V.</given-names></name><name><surname>Fleischer</surname><given-names>E.</given-names></name><name><surname>Klinger</surname><given-names>A.</given-names></name><name><surname>Cannon</surname><given-names>R. D.</given-names></name><name><surname>Monk</surname><given-names>B. C.</given-names></name></person-group> (<year>2015</year>). <article-title>Inhibitors of the <italic>Candida albicans</italic> major facilitator superfamily transporter Mdr1p responsible for fluconazole resistance.</article-title>
<source><italic>PLoS One</italic></source>
<volume>10</volume>:<issue>e0126350</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0126350</pub-id>
<?supplied-pmid 25951180?><pub-id pub-id-type="pmid">25951180</pub-id></mixed-citation></ref><ref id="B78"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kojic</surname><given-names>E. M.</given-names></name><name><surname>Darouiche</surname><given-names>R. O.</given-names></name></person-group> (<year>2004</year>). <article-title>Candida infections of medical devices.</article-title>
<source><italic>Clin. Microbiol. Rev.</italic></source>
<volume>17</volume>
<fpage>255</fpage>&#x02013;<lpage>267</lpage>. <pub-id pub-id-type="doi">10.1128/CMR.17.2.255-267.2004</pub-id>
<?supplied-pmid 15084500?><pub-id pub-id-type="pmid">15084500</pub-id></mixed-citation></ref><ref id="B79"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kong</surname><given-names>F.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Han</surname><given-names>R.</given-names></name><name><surname>Ji</surname><given-names>S.</given-names></name><name><surname>Yue</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Antifungal activity of magnesium oxide nanoparticles: effect on the growth and key virulence factors of <italic>Candida albicans</italic>.</article-title>
<source><italic>Mycopathologia</italic></source>
<volume>185</volume>
<fpage>485</fpage>&#x02013;<lpage>494</lpage>. <pub-id pub-id-type="doi">10.1007/s11046-020-00446-9</pub-id>
<?supplied-pmid 32328890?><pub-id pub-id-type="pmid">32328890</pub-id></mixed-citation></ref><ref id="B80"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kothari</surname><given-names>A.</given-names></name><name><surname>Sagar</surname><given-names>V.</given-names></name></person-group> (<year>2009</year>). <article-title>Epidemiology of candida bloodstream infections in a tertiary care institute in India.</article-title>
<source><italic>Indian J. Med. Microbiol.</italic></source>
<volume>27</volume>:<issue>171</issue>. <pub-id pub-id-type="doi">10.4103/0255-0857.49440</pub-id>
<?supplied-pmid 19384050?><pub-id pub-id-type="pmid">19384050</pub-id></mixed-citation></ref><ref id="B81"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LaFleur</surname><given-names>M. D.</given-names></name><name><surname>Lucumi</surname><given-names>E.</given-names></name><name><surname>Napper</surname><given-names>A. D.</given-names></name><name><surname>Diamond</surname><given-names>S. L.</given-names></name><name><surname>Lewis</surname><given-names>K.</given-names></name></person-group> (<year>2011</year>). <article-title>Novel high-throughput screen against <italic>Candida albicans</italic> identifies antifungal potentiators and agents effective against biofilms.</article-title>
<source><italic>J. Antimicrob. Chemother.</italic></source>
<volume>66</volume>
<fpage>820</fpage>&#x02013;<lpage>826</lpage>. <pub-id pub-id-type="doi">10.1093/jac/dkq530</pub-id>
<?supplied-pmid 21393183?><pub-id pub-id-type="pmid">21393183</pub-id></mixed-citation></ref><ref id="B82"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lara</surname><given-names>H. H.</given-names></name><name><surname>Ixtepan-Turrent</surname><given-names>L.</given-names></name><name><surname>Yacaman</surname><given-names>M. J.</given-names></name><name><surname>Lopez-Ribot</surname><given-names>J.</given-names></name></person-group> (<year>2020</year>). <article-title>Inhibition of <italic>Candida auris</italic> bio film formation on medical and environmental surfaces by silver nanoparticles.</article-title>
<source><italic>ACS Appl. Mater. Interfaces</italic></source>
<volume>12</volume>
<fpage>21183</fpage>&#x02013;<lpage>21191</lpage>. <pub-id pub-id-type="doi">10.1021/acsami.9b20708</pub-id>
<?supplied-pmid 31944650?><pub-id pub-id-type="pmid">31944650</pub-id></mixed-citation></ref><ref id="B83"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lara</surname><given-names>H. H.</given-names></name><name><surname>Romero-Urbina</surname><given-names>D. G.</given-names></name><name><surname>Pierce</surname><given-names>C.</given-names></name><name><surname>Lopez-Ribot</surname><given-names>J. L.</given-names></name><name><surname>Arellano-Jim&#x000e9;nez</surname><given-names>M. J.</given-names></name><name><surname>Jose-Yacaman</surname><given-names>M.</given-names></name></person-group> (<year>2015</year>). <article-title>Effect of silver nanoparticles on <italic>Candida albicans</italic> biofilms?: an ultrastructural study.</article-title>
<source><italic>J. Nanobiotechnol.</italic></source>
<volume>13</volume>:<issue>91</issue>. <pub-id pub-id-type="doi">10.1186/s12951-015-0147-8</pub-id>
<?supplied-pmid 26666378?><pub-id pub-id-type="pmid">26666378</pub-id></mixed-citation></ref><ref id="B84"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J.</given-names></name><name><surname>Lee</surname><given-names>D. G.</given-names></name></person-group> (<year>2015</year>). <article-title>Novel antifungal mechanism of resveratrol: apoptosis inducer in <italic>Candida albicans</italic>.</article-title>
<source><italic>Curr. Microbiol.</italic></source>
<volume>70</volume>
<fpage>383</fpage>&#x02013;<lpage>389</lpage>. <pub-id pub-id-type="doi">10.1007/s00284-014-0734-1</pub-id>
<?supplied-pmid 25413604?><pub-id pub-id-type="pmid">25413604</pub-id></mixed-citation></ref><ref id="B85"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J.-H.</given-names></name><name><surname>Kim</surname><given-names>Y. G.</given-names></name><name><surname>Khadke</surname><given-names>S. K.</given-names></name><name><surname>Yamano</surname><given-names>A.</given-names></name><name><surname>Watanabe</surname><given-names>A.</given-names></name><name><surname>Lee</surname><given-names>J.</given-names></name></person-group> (<year>2019</year>). <article-title>Inhibition of biofilm formation by <italic>Candida albicans</italic> and polymicrobial microorganisms by nepodin via hyphal-growth suppression.</article-title>
<source><italic>ACS Infect. Dis.</italic></source>
<volume>5</volume>
<fpage>1177</fpage>&#x02013;<lpage>1187</lpage>. <pub-id pub-id-type="doi">10.1021/acsinfecdis.9b00033</pub-id>
<?supplied-pmid 31055910?><pub-id pub-id-type="pmid">31055910</pub-id></mixed-citation></ref><ref id="B86"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Ma</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Guo</surname><given-names>F.</given-names></name><name><surname>Ren</surname><given-names>L.</given-names></name><name><surname>Yang</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>In vivo inhibitory effect on the biofilm formation of <italic>Candida albicans</italic> by liverwort derived Riccardin D.</article-title>
<source><italic>PLoS One</italic></source>
<volume>7</volume>:<issue>e35543</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0035543</pub-id>
<?supplied-pmid 22545115?><pub-id pub-id-type="pmid">22545115</pub-id></mixed-citation></ref><ref id="B87"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>Yu</surname><given-names>C.</given-names></name><name><surname>Li</surname><given-names>T.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Sun</surname><given-names>S.</given-names></name></person-group> (<year>2016</year>). <article-title>Potential antifungal targets against a candida biofilm based on an enzyme in the arachidonic acid cascade-a review.</article-title>
<source><italic>Front. Microbiol.</italic></source>
<volume>7</volume>:<issue>1925</issue>. <pub-id pub-id-type="doi">10.3389/fmicb.2016.01925</pub-id>
<?supplied-pmid 27999568?><pub-id pub-id-type="pmid">27999568</pub-id></mixed-citation></ref><ref id="B88"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lockhart</surname><given-names>S. R.</given-names></name></person-group> (<year>2014</year>). <article-title>Current epidemiology of candida infection.</article-title>
<source><italic>Clin. Microbiol. Newsl.</italic></source>
<volume>36</volume>
<fpage>131</fpage>&#x02013;<lpage>136</lpage>. <pub-id pub-id-type="doi">10.1016/j.clinmicnews.2014.08.001</pub-id></mixed-citation></ref><ref id="B89"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lohse</surname><given-names>M. B.</given-names></name><name><surname>Gulati</surname><given-names>M.</given-names></name><name><surname>Johnson</surname><given-names>A. D.</given-names></name><name><surname>Nobile</surname><given-names>C. J.</given-names></name></person-group> (<year>2018</year>). <article-title>Development and regulation of single-and multi-species <italic>Candida albicans</italic> biofilms.</article-title>
<source><italic>Nat. Rev. Microbiol.</italic></source>
<volume>16</volume>
<fpage>19</fpage>&#x02013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1038/nrmicro.2017.107</pub-id>
<?supplied-pmid 29062072?><pub-id pub-id-type="pmid">29062072</pub-id></mixed-citation></ref><ref id="B90"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Longhi</surname><given-names>C.</given-names></name><name><surname>Santos</surname><given-names>J. P.</given-names></name><name><surname>Morey</surname><given-names>A. T.</given-names></name><name><surname>Marcato</surname><given-names>P. D.</given-names></name><name><surname>Duran</surname><given-names>N.</given-names></name><name><surname>Pinge-filho</surname><given-names>P.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Combination of fluconazole with silver nanoparticles produced by <italic>Fusarium oxysporum</italic> improves antifungal effect against planktonic cells and biofilm of drug-resistant <italic>Candida albicans</italic>.</article-title>
<source><italic>Med. Mycol.</italic></source>
<volume>54</volume>
<fpage>428</fpage>&#x02013;<lpage>432</lpage>. <pub-id pub-id-type="doi">10.1093/mmy/myv036</pub-id>
<?supplied-pmid 26092103?><pub-id pub-id-type="pmid">26092103</pub-id></mixed-citation></ref><ref id="B91"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magi</surname><given-names>G.</given-names></name><name><surname>Marini</surname><given-names>E.</given-names></name><name><surname>Facinelli</surname><given-names>B.</given-names></name></person-group> (<year>2015</year>). <article-title>Antimicrobial activity of essential oils and carvacrol, and synergy of carvacrol and erythromycin, against clinical, erythromycin-resistant Group A Streptococci.</article-title>
<source><italic>Front. Microbiol.</italic></source>
<volume>6</volume>:<issue>165</issue>. <pub-id pub-id-type="doi">10.3389/fmicb.2015.00165</pub-id>
<?supplied-pmid 25784902?><pub-id pub-id-type="pmid">25784902</pub-id></mixed-citation></ref><ref id="B92"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mah</surname><given-names>T. F. C.</given-names></name><name><surname>O&#x02019;Toole</surname><given-names>G. A.</given-names></name></person-group> (<year>2001</year>). <article-title>Mechanisms of biofilm resistance to antimicrobial agents.</article-title>
<source><italic>Trends Microbiol.</italic></source>
<volume>9</volume>
<fpage>34</fpage>&#x02013;<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1016/S0966-842X(00)01913-2</pub-id><pub-id pub-id-type="pmid">11166241</pub-id></mixed-citation></ref><ref id="B93"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahamuni-Badiger</surname><given-names>P. P.</given-names></name><name><surname>Patil</surname><given-names>P. M.</given-names></name><name><surname>Badiger</surname><given-names>M. V.</given-names></name><name><surname>Patel</surname><given-names>P. R.</given-names></name><name><surname>Thorat- Gadgil</surname><given-names>B. S.</given-names></name><name><surname>Pandit</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Biofilm formation to inhibition: role of zinc oxide-based nanoparticles.</article-title>
<source><italic>Mater. Sci. Eng. C</italic></source>
<volume>108</volume>:<issue>110319</issue>. <pub-id pub-id-type="doi">10.1016/j.msec.2019.110319</pub-id>
<?supplied-pmid 31923962?><pub-id pub-id-type="pmid">31923962</pub-id></mixed-citation></ref><ref id="B94"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mamouei</surname><given-names>Z.</given-names></name><name><surname>Alqarihi</surname><given-names>A.</given-names></name><name><surname>Singh</surname><given-names>S.</given-names></name><name><surname>Xu</surname><given-names>S.</given-names></name><name><surname>Mansour</surname><given-names>M. K.</given-names></name><name><surname>Ibrahim</surname><given-names>A. S.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Alexidine dihydrochloride has broad-spectrum activities against diverse fungal pathogens.</article-title>
<source><italic>mSphere</italic></source>
<volume>3</volume>:<issue>e00539-18</issue>. <pub-id pub-id-type="doi">10.1128/mSphere.00539-18</pub-id>
<?supplied-pmid 30381356?><pub-id pub-id-type="pmid">30381356</pub-id></mixed-citation></ref><ref id="B95"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manoharan</surname><given-names>R. K.</given-names></name><name><surname>Lee</surname><given-names>J.-H.</given-names></name><name><surname>Kim</surname><given-names>Y.-G.</given-names></name><name><surname>Kim</surname><given-names>S.-I.</given-names></name><name><surname>Lee</surname><given-names>J.</given-names></name></person-group> (<year>2017a</year>). <article-title>Inhibitory effects of the essential oils &#x003b1;-longipinene and linalool on biofilm formation and hyphal growth of <italic>Candida albicans</italic>.</article-title>
<source><italic>Biofouling</italic></source>
<volume>33</volume>
<fpage>143</fpage>&#x02013;<lpage>155</lpage>. <pub-id pub-id-type="doi">10.1080/08927014.2017.1280731</pub-id>
<?supplied-pmid 28155334?><pub-id pub-id-type="pmid">28155334</pub-id></mixed-citation></ref><ref id="B96"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manoharan</surname><given-names>R. K.</given-names></name><name><surname>Lee</surname><given-names>J.-H.</given-names></name><name><surname>Kim</surname><given-names>Y.-G.</given-names></name><name><surname>Lee</surname><given-names>J.</given-names></name></person-group> (<year>2017b</year>). <article-title>Alizarin and chrysazin inhibit biofilm and hyphal formation by <italic>Candida albicans</italic>.</article-title>
<source><italic>Front. Cell. Infect. Microbiol.</italic></source>
<volume>7</volume>:<issue>447</issue>. <pub-id pub-id-type="doi">10.3389/fcimb.2017.00447</pub-id>
<?supplied-pmid 29085811?><pub-id pub-id-type="pmid">29085811</pub-id></mixed-citation></ref><ref id="B97"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marc</surname><given-names>G.</given-names></name><name><surname>Araniciu</surname><given-names>C.</given-names></name><name><surname>Oniga</surname><given-names>S. D.</given-names></name><name><surname>Vlase</surname><given-names>L.</given-names></name><name><surname>P&#x000ee;rnau</surname><given-names>A.</given-names></name><name><surname>Duma</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>New N-(oxazolylmethyl)-thiazolidinedione active against candida albicans biofilm: potential Als proteins inhibitors.</article-title>
<source><italic>Molecules</italic></source>
<volume>23</volume>:<issue>2522</issue>. <pub-id pub-id-type="doi">10.3390/molecules23102522</pub-id>
<?supplied-pmid 30279343?><pub-id pub-id-type="pmid">30279343</pub-id></mixed-citation></ref><ref id="B98"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marcos-Arias</surname><given-names>C.</given-names></name><name><surname>Eraso</surname><given-names>E.</given-names></name><name><surname>Madariaga</surname><given-names>L.</given-names></name><name><surname>Quind&#x000f3;s</surname><given-names>G.</given-names></name></person-group> (<year>2011</year>). <article-title>In vitro activities of natural products against oral Candida isolates from denture wearers.</article-title>
<source><italic>BMC Complement. Altern. Med.</italic></source>
<volume>11</volume>:<issue>119</issue>. <pub-id pub-id-type="doi">10.1186/1472-6882-11-119</pub-id>
<?supplied-pmid 22118215?><pub-id pub-id-type="pmid">22118215</pub-id></mixed-citation></ref><ref id="B99"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martins</surname><given-names>M.</given-names></name><name><surname>Uppuluri</surname><given-names>P.</given-names></name><name><surname>Thomas</surname><given-names>D. P.</given-names></name><name><surname>Cleary</surname><given-names>I. A.</given-names></name><name><surname>Henriques</surname><given-names>M.</given-names></name><name><surname>Lopez-Ribot</surname><given-names>J. L.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Presence of extracellular DNA in the <italic>Candida albicans</italic> biofilm matrix and its contribution to biofilms.</article-title>
<source><italic>Mycopathologia</italic></source>
<volume>169</volume>
<fpage>323</fpage>&#x02013;<lpage>331</lpage>. <pub-id pub-id-type="doi">10.1007/s11046-009-9264-y.Presence</pub-id></mixed-citation></ref><ref id="B100"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Math&#x000e9;</surname><given-names>L.</given-names></name><name><surname>Van Dijck</surname><given-names>P.</given-names></name></person-group> (<year>2013</year>). <article-title>Recent insights into <italic>Candida albicans</italic> biofilm resistance mechanisms.</article-title>
<source><italic>Curr. Genet.</italic></source>
<volume>59</volume>
<fpage>251</fpage>&#x02013;<lpage>264</lpage>. <pub-id pub-id-type="doi">10.1007/s00294-013-0400-3</pub-id>
<?supplied-pmid 23974350?><pub-id pub-id-type="pmid">23974350</pub-id></mixed-citation></ref><ref id="B101"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGeady</surname><given-names>P.</given-names></name><name><surname>Wansley</surname><given-names>D. L.</given-names></name><name><surname>Logan</surname><given-names>D. A.</given-names></name></person-group> (<year>2002</year>). <article-title>Carvone and perillaldehyde interfere with the serum-induced formation of filamentous structures in <italic>Candida albicans</italic> at substantially lower concentrations than those causing significant inhibition of growth.</article-title>
<source><italic>J. Nat. Prod.</italic></source>
<volume>65</volume>
<fpage>953</fpage>&#x02013;<lpage>955</lpage>. <pub-id pub-id-type="doi">10.1021/np010621l</pub-id>
<?supplied-pmid 12141851?><pub-id pub-id-type="pmid">12141851</pub-id></mixed-citation></ref><ref id="B102"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melo</surname><given-names>N. R.</given-names></name><name><surname>de, Abdrahman</surname><given-names>A.</given-names></name><name><surname>Greig</surname><given-names>C.</given-names></name><name><surname>Mukherjee</surname><given-names>K.</given-names></name><name><surname>Thornton</surname><given-names>C.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Myriocin significantly increases the mortality of a non-mammalian model host during Candida pathogenesis.</article-title>
<source><italic>PLoS One</italic></source>
<volume>8</volume>:<issue>e78905</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0078905</pub-id>
<?supplied-pmid 24260135?><pub-id pub-id-type="pmid">24260135</pub-id></mixed-citation></ref><ref id="B103"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Messier</surname><given-names>C.</given-names></name><name><surname>Grenier</surname><given-names>D.</given-names></name></person-group> (<year>2011</year>). <article-title>Effect of licorice compounds licochalcone A, glabridin and glycyrrhizic acid on growth and virulence properties of <italic>Candida albicans</italic>.</article-title>
<source><italic>Mycoses</italic></source>
<volume>54</volume>
<fpage>e801</fpage>&#x02013;<lpage>e806</lpage>. <pub-id pub-id-type="doi">10.1111/j.1439-0507.2011.02028.x</pub-id>
<?supplied-pmid 21615543?><pub-id pub-id-type="pmid">21615543</pub-id></mixed-citation></ref><ref id="B104"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michael</surname><given-names>C. A.</given-names></name><name><surname>Dominey-howes</surname><given-names>D.</given-names></name><name><surname>Labbate</surname><given-names>M.</given-names></name></person-group> (<year>2014</year>). <article-title>The antimicrobial resistance crisis?: causes, consequences, and management.</article-title>
<source><italic>Front. Public Health</italic></source>
<volume>2</volume>:<issue>145</issue>. <pub-id pub-id-type="doi">10.3389/fpubh.2014.00145</pub-id>
<?supplied-pmid 25279369?><pub-id pub-id-type="pmid">25279369</pub-id></mixed-citation></ref><ref id="B105"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Midkiff</surname><given-names>J.</given-names></name><name><surname>Borochoff-Porte</surname><given-names>N.</given-names></name><name><surname>White</surname><given-names>D.</given-names></name><name><surname>Johnson</surname><given-names>D. I.</given-names></name></person-group> (<year>2011</year>). <article-title>Small molecule inhibitors of the <italic>Candida albicans</italic> budded-to-hyphal transition act through multiple signaling pathways.</article-title>
<source><italic>PLoS On e</italic></source>
<volume>6</volume>:<issue>e25395</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0025395</pub-id>
<?supplied-pmid 21966518?><pub-id pub-id-type="pmid">21966518</pub-id></mixed-citation></ref><ref id="B106"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohammed</surname><given-names>M.</given-names></name><name><surname>Syeda</surname><given-names>J. T. M.</given-names></name><name><surname>Wasan</surname><given-names>K. M.</given-names></name><name><surname>Wasan</surname><given-names>E. K.</given-names></name></person-group> (<year>2017</year>). <article-title>An overview of chitosan nanoparticles and its application in non-parenteral drug delivery.</article-title>
<source><italic>Pharmaceutics</italic></source>
<volume>9</volume>:<issue>53</issue>. <pub-id pub-id-type="doi">10.3390/pharmaceutics9040053</pub-id>
<?supplied-pmid 29156634?><pub-id pub-id-type="pmid">29156634</pub-id></mixed-citation></ref><ref id="B107"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monteiro</surname><given-names>D. R.</given-names></name><name><surname>Feresin</surname><given-names>L. P.</given-names></name><name><surname>Arias</surname><given-names>L. S.</given-names></name><name><surname>Bar&#x000e3;o</surname><given-names>V. A. R.</given-names></name><name><surname>Barbosa</surname><given-names>D. B.</given-names></name><name><surname>Delbem</surname><given-names>A. C. B.</given-names></name></person-group> (<year>2015</year>). <article-title>Effect of tyrosol on adhesion of <italic>Candida albicans</italic> and <italic>Candida glabrata</italic> to acrylic surfaces.</article-title>
<source><italic>Med. Mycol.</italic></source>
<volume>53</volume>
<fpage>656</fpage>&#x02013;<lpage>665</lpage>. <pub-id pub-id-type="doi">10.1093/mmy/myv052</pub-id>
<?supplied-pmid 26162470?><pub-id pub-id-type="pmid">26162470</pub-id></mixed-citation></ref><ref id="B108"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monteiro</surname><given-names>D. R.</given-names></name><name><surname>Silva</surname><given-names>S.</given-names></name><name><surname>Negri</surname><given-names>M.</given-names></name><name><surname>Gorup</surname><given-names>L. F.</given-names></name><name><surname>de Camargo</surname><given-names>E. R.</given-names></name><name><surname>Oliveira</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Silver nanoparticles: influence of stabilizing agent and diameter on antifungal activity against <italic>Candida albicans</italic> and <italic>Candida glabrata</italic> biofilms.</article-title>
<source><italic>Lett. Appl. Microbiol.</italic></source>
<volume>54</volume>
<fpage>383</fpage>&#x02013;<lpage>391</lpage>. <pub-id pub-id-type="doi">10.1111/j.1472-765X.2012.03219.x</pub-id>
<?supplied-pmid 22313289?><pub-id pub-id-type="pmid">22313289</pub-id></mixed-citation></ref><ref id="B109"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moro</surname><given-names>I. J.</given-names></name><name><surname>Gondo</surname><given-names>G. D. G. A.</given-names></name><name><surname>Pierri</surname><given-names>E. G.</given-names></name><name><surname>Rodrigues Pietro</surname><given-names>C. L.</given-names></name><name><surname>Pienna Soares</surname><given-names>C.</given-names></name><name><surname>Pergentino de Sousa</surname><given-names>D.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Evaluation of antimicrobial, cytotoxic and chemopreventive activities of carvone and its derivatives.</article-title>
<source><italic>Braz. J. Pharm. Sci.</italic></source>
<volume>53</volume>
<fpage>1</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1590/s2175-97902017000400076</pub-id></mixed-citation></ref><ref id="B110"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nani</surname><given-names>B. D.</given-names></name><name><surname>Sardi</surname><given-names>J. C. O.</given-names></name><name><surname>Lazarini</surname><given-names>J. G.</given-names></name><name><surname>Silva</surname><given-names>D. R.</given-names></name><name><surname>Massariolli</surname><given-names>A. P.</given-names></name><name><surname>Cunha</surname><given-names>T. M.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Anti-inflammatory and anti- candida effects of brazilian organic propolis, a promising source of bioactive molecules and functional food.</article-title>
<source><italic>J. Agric. Food Chem.</italic></source>
<volume>68</volume>
<fpage>2861</fpage>&#x02013;<lpage>2871</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jafc.8b07304</pub-id>
<?supplied-pmid 31369255?><pub-id pub-id-type="pmid">31369255</pub-id></mixed-citation></ref><ref id="B111"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nett</surname><given-names>J. E.</given-names></name><name><surname>Crawford</surname><given-names>K.</given-names></name><name><surname>Marchillo</surname><given-names>K.</given-names></name><name><surname>Andes</surname><given-names>D. R.</given-names></name></person-group> (<year>2010</year>). <article-title>Role of Fks1p and matrix glucan in <italic>Candida albicans</italic> biofilm resistance to an echinocandin, pyrimidine, and polyene.</article-title>
<source><italic>Antimicrob. Agents Chemother.</italic></source>
<volume>54</volume>
<fpage>3505</fpage>&#x02013;<lpage>3508</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.00227-10</pub-id>
<?supplied-pmid 20516280?><pub-id pub-id-type="pmid">20516280</pub-id></mixed-citation></ref><ref id="B112"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nett</surname><given-names>J. E.</given-names></name><name><surname>Sanchez</surname><given-names>H.</given-names></name><name><surname>Cain</surname><given-names>M. T.</given-names></name><name><surname>Ross</surname><given-names>K. M.</given-names></name><name><surname>Andes</surname><given-names>D. R.</given-names></name></person-group> (<year>2011</year>). <article-title>Interface of <italic>Candida albicans</italic> biofilm matrix-associated drug resistance and cell wall integrity regulation.</article-title>
<source><italic>Eukaryot. Cell</italic></source>
<volume>10</volume>
<fpage>1660</fpage>&#x02013;<lpage>1669</lpage>. <pub-id pub-id-type="doi">10.1128/EC.05126-11</pub-id>
<?supplied-pmid 21666076?><pub-id pub-id-type="pmid">21666076</pub-id></mixed-citation></ref><ref id="B113"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niu</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>R.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Carvacrol induces candida albicans apoptosis associated With Ca2+/Calcineurin pathway.</article-title>
<source><italic>Front. Cell. Infect. Microbiol.</italic></source>
<volume>10</volume>:<issue>192</issue>. <pub-id pub-id-type="doi">10.3389/fcimb.2020.00192</pub-id>
<?supplied-pmid 32426298?><pub-id pub-id-type="pmid">32426298</pub-id></mixed-citation></ref><ref id="B114"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nobile</surname><given-names>C. J.</given-names></name><name><surname>Fox</surname><given-names>E. P.</given-names></name><name><surname>Nett</surname><given-names>J. E.</given-names></name><name><surname>Sorrells</surname><given-names>T. R.</given-names></name><name><surname>Mitrovich</surname><given-names>Q. M.</given-names></name><name><surname>Hernday</surname><given-names>A. D.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>A recently evolved transcriptional network controls biofilm development in <italic>Candida albicans</italic>.</article-title>
<source><italic>Cell</italic></source>
<volume>148</volume>
<fpage>126</fpage>&#x02013;<lpage>138</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2011.10.048</pub-id>
<?supplied-pmid 22265407?><pub-id pub-id-type="pmid">22265407</pub-id></mixed-citation></ref><ref id="B115"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Norris</surname><given-names>L. A. B.</given-names></name><name><surname>Kablaoui</surname><given-names>F.</given-names></name><name><surname>Brilhart</surname><given-names>M. K.</given-names></name><name><surname>Bookstaver</surname><given-names>P. B.</given-names></name></person-group> (<year>2017</year>). <article-title>Systematic review of antimicrobial lock therapy for prevention of central-line-associated bloodstream infections in adult and pediatric cancer patients.</article-title>
<source><italic>Int. J. Antimicrob. Agents</italic></source>
<volume>50</volume>
<fpage>308</fpage>&#x02013;<lpage>317</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijantimicag.2017.06.013</pub-id>
<?supplied-pmid 28689878?><pub-id pub-id-type="pmid">28689878</pub-id></mixed-citation></ref><ref id="B116"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noverr</surname><given-names>M. C.</given-names></name><name><surname>Huffnagle</surname><given-names>G. B.</given-names></name></person-group> (<year>2004</year>). <article-title>Regulation of <italic>Candida albicans</italic> morphogenesis by fatty acid metabolites.</article-title>
<source><italic>Infect. Immun.</italic></source>
<volume>72</volume>
<fpage>6206</fpage>&#x02013;<lpage>6210</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.72.11.6206-6210.2004</pub-id>
<?supplied-pmid 15501745?><pub-id pub-id-type="pmid">15501745</pub-id></mixed-citation></ref><ref id="B117"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Horo</surname><given-names>J. C.</given-names></name><name><surname>Silva</surname><given-names>G. L. M.</given-names></name><name><surname>Safdar</surname><given-names>N.</given-names></name></person-group> (<year>2011</year>). <article-title>Anti-infective locks for treatment of central line-associated bloodstream infection: a systematic review and meta-analysis.</article-title>
<source><italic>Am. J. Nephrol.</italic></source>
<volume>34</volume>
<fpage>415</fpage>&#x02013;<lpage>422</lpage>. <pub-id pub-id-type="doi">10.1159/000331262</pub-id>
<?supplied-pmid 21934302?><pub-id pub-id-type="pmid">21934302</pub-id></mixed-citation></ref><ref id="B118"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>&#x000d6;nc&#x000fc;</surname><given-names>S.</given-names></name></person-group> (<year>2014</year>). <article-title>Optimal dosage and dwell time of ethanol lock therapy on catheters infected with <italic>Candida species</italic>.</article-title>
<source><italic>Clin. Nutr.</italic></source>
<volume>33</volume>
<fpage>360</fpage>&#x02013;<lpage>362</lpage>. <pub-id pub-id-type="doi">10.1016/j.clnu.2013.04.014</pub-id>
<?supplied-pmid 23672805?><pub-id pub-id-type="pmid">23672805</pub-id></mixed-citation></ref><ref id="B119"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Padmavathi</surname><given-names>A. R.</given-names></name><name><surname>Das</surname><given-names>A.</given-names></name><name><surname>Priya</surname><given-names>A.</given-names></name><name><surname>Sushmitha</surname><given-names>T. J.</given-names></name><name><surname>Pandian</surname><given-names>S. K.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Impediment to growth and yeast-to-hyphae transition in <italic>Candida albicans</italic> by copper oxide nanoparticles.</article-title>
<source><italic>Biofouling</italic></source>
<volume>36</volume>
<fpage>56</fpage>&#x02013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1080/08927014.2020.1715371</pub-id>
<?supplied-pmid 31997658?><pub-id pub-id-type="pmid">31997658</pub-id></mixed-citation></ref><ref id="B120"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pammi</surname><given-names>M.</given-names></name><name><surname>Liang</surname><given-names>R.</given-names></name><name><surname>Hicks</surname><given-names>J.</given-names></name><name><surname>Mistretta</surname><given-names>T.-A.</given-names></name><name><surname>Versalovic</surname><given-names>J.</given-names></name></person-group> (<year>2013</year>). <article-title>Biofilm extracellular DNA enhances mixed species biofilms of Staphylococcus epidermidis and <italic>Candida albicans</italic>.</article-title>
<source><italic>BMC Microbiol.</italic></source>
<volume>13</volume>:<issue>257</issue>. <pub-id pub-id-type="doi">10.1186/1471-2180-13-257</pub-id>
<?supplied-pmid 24228850?><pub-id pub-id-type="pmid">24228850</pub-id></mixed-citation></ref><ref id="B121"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pappas</surname><given-names>P. G.</given-names></name><name><surname>Lionakis</surname><given-names>M. S.</given-names></name><name><surname>Arendrup</surname><given-names>M. C.</given-names></name><name><surname>Ostrosky-Zeichner</surname><given-names>L.</given-names></name><name><surname>Kullberg</surname><given-names>B. J.</given-names></name></person-group> (<year>2018</year>). <article-title>Invasive candidiasis.</article-title>
<source><italic>Nat. Rev. Dis. Prim.</italic></source>
<volume>4</volume>:<issue>18026</issue>. <pub-id pub-id-type="doi">10.1038/nrdp.2018.26</pub-id>
<?supplied-pmid 29749387?><pub-id pub-id-type="pmid">29749387</pub-id></mixed-citation></ref><ref id="B122"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perfect</surname><given-names>J. R.</given-names></name></person-group> (<year>2017</year>). <article-title>The antifungal pipeline: a reality check.</article-title>
<source><italic>Nat. Rev. Drug Discov.</italic></source>
<volume>16</volume>
<fpage>603</fpage>&#x02013;<lpage>616</lpage>. <pub-id pub-id-type="doi">10.1038/nrd.2017.46</pub-id>
<?supplied-pmid 28496146?><pub-id pub-id-type="pmid">28496146</pub-id></mixed-citation></ref><ref id="B123"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perlroth</surname><given-names>J.</given-names></name><name><surname>Choi</surname><given-names>B.</given-names></name><name><surname>Spellberg</surname><given-names>B.</given-names></name></person-group> (<year>2007</year>). <article-title>Nosocomial fungal infections: epidemiology, diagnosis, and treatment.</article-title>
<source><italic>Med. Mycol.</italic></source>
<volume>45</volume>
<fpage>321</fpage>&#x02013;<lpage>346</lpage>. <pub-id pub-id-type="doi">10.1080/13693780701218689</pub-id>
<?supplied-pmid 17510856?><pub-id pub-id-type="pmid">17510856</pub-id></mixed-citation></ref><ref id="B124"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfaller</surname><given-names>M. A.</given-names></name><name><surname>Diekema</surname><given-names>D. J.</given-names></name></person-group> (<year>2007</year>). <article-title>Epidemiology of invasive candidiasis: a persistent public health problem.</article-title>
<source><italic>Clin. Microbiol. Rev.</italic></source>
<volume>20</volume>
<fpage>133</fpage>&#x02013;<lpage>163</lpage>. <pub-id pub-id-type="doi">10.1128/CMR.00029-06</pub-id>
<?supplied-pmid 17223626?><pub-id pub-id-type="pmid">17223626</pub-id></mixed-citation></ref><ref id="B125"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pierce</surname><given-names>C. G.</given-names></name><name><surname>Chaturvedi</surname><given-names>A. K.</given-names></name><name><surname>Lazzell</surname><given-names>A. L.</given-names></name><name><surname>Powell</surname><given-names>A. T.</given-names></name><name><surname>Saville</surname><given-names>S. P.</given-names></name><name><surname>McHardy</surname><given-names>S. F.</given-names></name><etal/></person-group> (<year>2015a</year>). <article-title>A novel small molecule inhibitor of <italic>Candida albicans</italic> biofilm formation, filamentation and virulence with low potential for the development of resistance.</article-title>
<source><italic>npj Biofilms Microbiomes</italic></source>
<volume>1</volume>:<issue>15012</issue>. <pub-id pub-id-type="doi">10.1038/npjbiofilms.2015.12</pub-id>
<?supplied-pmid 26691764?><pub-id pub-id-type="pmid">26691764</pub-id></mixed-citation></ref><ref id="B126"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pierce</surname><given-names>C. G.</given-names></name><name><surname>Saville</surname><given-names>S. P.</given-names></name><name><surname>Lopez-Ribot</surname><given-names>J. L.</given-names></name></person-group> (<year>2014</year>). <article-title>High-content phenotypic screenings to identify inhibitors of <italic>Candida albicans</italic> biofilm formation and filamentation.</article-title>
<source><italic>Pathog. Dis.</italic></source>
<volume>70</volume>
<fpage>423</fpage>&#x02013;<lpage>431</lpage>. <pub-id pub-id-type="doi">10.1111/2049-632X.12161</pub-id>
<?supplied-pmid 24623598?><pub-id pub-id-type="pmid">24623598</pub-id></mixed-citation></ref><ref id="B127"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pierce</surname><given-names>C. G.</given-names></name><name><surname>Srinivasan</surname><given-names>A.</given-names></name><name><surname>Ramasubramanian</surname><given-names>A. K.</given-names></name><name><surname>L&#x000f3;pez-Ribot</surname><given-names>J. L.</given-names></name></person-group> (<year>2015b</year>). <article-title>From biology to drug development: new approaches to combat the threat of fungal biofilms.</article-title>
<source><italic>Microbiol. Spectr.</italic></source>
<volume>3</volume>
<fpage>1</fpage>&#x02013;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1128/microbiolspec.mb-0007-2014</pub-id>
<?supplied-pmid 26185082?><pub-id pub-id-type="pmid">26185082</pub-id></mixed-citation></ref><ref id="B128"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pleszczy&#x00144;ska</surname><given-names>M.</given-names></name><name><surname>Wiater</surname><given-names>A.</given-names></name><name><surname>Janczarek</surname><given-names>M.</given-names></name><name><surname>Szczodrak</surname><given-names>J.</given-names></name></person-group> (<year>2015</year>). <article-title>(1&#x02192;3)-&#x003b1;-d-Glucan hydrolases in dental biofilm prevention and control: a review.</article-title>
<source><italic>Int. J. Biol. Macromol.</italic></source>
<volume>79</volume>
<fpage>761</fpage>&#x02013;<lpage>778</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2015.05.052</pub-id>
<?supplied-pmid 26047901?><pub-id pub-id-type="pmid">26047901</pub-id></mixed-citation></ref><ref id="B129"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pristov</surname><given-names>K. E.</given-names></name><name><surname>Ghannoum</surname><given-names>M. A.</given-names></name></person-group> (<year>2019</year>). <article-title>Resistance of Candida to azoles and echinocandins worldwide.</article-title>
<source><italic>Clin. Microbiol. Infect.</italic></source>
<volume>25</volume>
<fpage>792</fpage>&#x02013;<lpage>798</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmi.2019.03.028</pub-id>
<?supplied-pmid 30965100?><pub-id pub-id-type="pmid">30965100</pub-id></mixed-citation></ref><ref id="B130"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qu</surname><given-names>S.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Tian</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Wang</surname><given-names>F.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Effect of perillaldehyde on prophylaxis and treatment of vaginal candidiasis in a murine model.</article-title>
<source><italic>Front. Microbiol.</italic></source>
<volume>10</volume>:<issue>1466</issue>. <pub-id pub-id-type="doi">10.3389/fmicb.2019.01466</pub-id>
<?supplied-pmid 31333606?><pub-id pub-id-type="pmid">31333606</pub-id></mixed-citation></ref><ref id="B131"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajasekharan</surname><given-names>S. K.</given-names></name><name><surname>Lee</surname><given-names>J.-H.</given-names></name><name><surname>Lee</surname><given-names>J.</given-names></name></person-group> (<year>2019</year>). <article-title>Aripiprazole repurposed as an inhibitor of biofilm formation and sterol biosynthesis in multidrug-resistant <italic>Candida albicans</italic>.</article-title>
<source><italic>Int. J. Antimicrob. Agents</italic></source>
<volume>54</volume>
<fpage>518</fpage>&#x02013;<lpage>523</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijantimicag.2019.05.016</pub-id>
<?supplied-pmid 31173863?><pub-id pub-id-type="pmid">31173863</pub-id></mixed-citation></ref><ref id="B132"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajendran</surname><given-names>R.</given-names></name><name><surname>Borghi</surname><given-names>E.</given-names></name><name><surname>Falleni</surname><given-names>M.</given-names></name><name><surname>Perdoni</surname><given-names>F.</given-names></name><name><surname>Tosi</surname><given-names>D.</given-names></name><name><surname>Lappin</surname><given-names>D. F.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Acetylcholine protects against <italic>Candida albicans</italic> infection by inhibiting biofilm formation and promoting hemocyte function in a galleria mellonella infection model.</article-title>
<source><italic>Eukaryot. Cell</italic></source>
<volume>14</volume>
<fpage>834</fpage>&#x02013;<lpage>844</lpage>. <pub-id pub-id-type="doi">10.1128/EC.00067-15</pub-id>
<?supplied-pmid 26092919?><pub-id pub-id-type="pmid">26092919</pub-id></mixed-citation></ref><ref id="B133"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajput</surname><given-names>S. B.</given-names></name><name><surname>Karuppayil</surname><given-names>S. M.</given-names></name></person-group> (<year>2013</year>). <article-title>Small molecules inhibit growth, viability and ergosterol biosynthesis in <italic>Candida albicans</italic>.</article-title>
<source><italic>Springerplus</italic></source>
<volume>2</volume>
<issue>26</issue>.</mixed-citation></ref><ref id="B134"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramage</surname><given-names>G.</given-names></name><name><surname>Mart&#x000ed;nez</surname><given-names>J. P.</given-names></name><name><surname>L&#x000f3;pez-Ribot</surname><given-names>J. L.</given-names></name></person-group> (<year>2006</year>). <article-title>Candida biofilms on implanted biomaterials: a clinically significant problem.</article-title>
<source><italic>FEMS Yeast Res.</italic></source>
<volume>6</volume>
<fpage>979</fpage>&#x02013;<lpage>986</lpage>. <pub-id pub-id-type="doi">10.1111/j.1567-1364.2006.00117.x</pub-id>
<?supplied-pmid 17042747?><pub-id pub-id-type="pmid">17042747</pub-id></mixed-citation></ref><ref id="B135"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramage</surname><given-names>G.</given-names></name><name><surname>Robertson</surname><given-names>S. N.</given-names></name><name><surname>Williams</surname><given-names>C.</given-names></name></person-group> (<year>2014</year>). <article-title>Strength in numbers: antifungal strategies against fungal biofilms.</article-title>
<source><italic>Int. J. Antimicrob. Agents</italic></source>
<volume>43</volume>
<fpage>114</fpage>&#x02013;<lpage>120</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijantimicag.2013.10.023</pub-id>
<?supplied-pmid 24359842?><pub-id pub-id-type="pmid">24359842</pub-id></mixed-citation></ref><ref id="B136"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramage</surname><given-names>G.</given-names></name><name><surname>Saville</surname><given-names>S. P.</given-names></name><name><surname>Wickes</surname><given-names>B. L.</given-names></name><name><surname>Lo&#x000ec;pez-Ribot</surname><given-names>J. L.</given-names></name></person-group> (<year>2002</year>). <article-title>Inhibition of <italic>Candida albicans</italic> biofilm formation by farnesol, a quorum-sensing molecule.</article-title>
<source><italic>Appl. Environ. Microbiol.</italic></source>
<fpage>5459</fpage>&#x02013;<lpage>5463</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.68.11.5459-5463.2002</pub-id>
<?supplied-pmid 12406738?><pub-id pub-id-type="pmid">12406738</pub-id></mixed-citation></ref><ref id="B137"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rasool</surname><given-names>U.</given-names></name></person-group> (<year>2019</year>). <article-title>Effect of biosynthesized copper nanoparticles (CUNPS) on the growth and biofilm formation of fluconazole-resistant <italic>Candida albicans</italic>.</article-title>
<source><italic>J. Microbiol. Biotechnol. Food Sci.</italic></source>
<volume>9</volume>
<fpage>21</fpage>&#x02013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.15414/jmbfs.2019.9.1.21-24</pub-id></mixed-citation></ref><ref id="B138"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raut</surname><given-names>J. S.</given-names></name><name><surname>Shinde</surname><given-names>R. B.</given-names></name><name><surname>Chauhan</surname><given-names>N. M.</given-names></name><name><surname>Mohan Karuppayil</surname><given-names>S.</given-names></name></person-group> (<year>2013</year>). <article-title>Terpenoids of plant origin inhibit morphogenesis, adhesion, and biofilm formation by <italic>Candida albicans</italic>.</article-title>
<source><italic>Biofouling</italic></source>
<volume>29</volume>
<fpage>87</fpage>&#x02013;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1080/08927014.2012.749398</pub-id>
<?supplied-pmid 23216018?><pub-id pub-id-type="pmid">23216018</pub-id></mixed-citation></ref><ref id="B139"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richardson</surname><given-names>M.</given-names></name><name><surname>Rautemaa-Richardson</surname><given-names>R.</given-names></name></person-group> (<year>2019</year>). <article-title>Exposure to aspergillus in home and healthcare facilities&#x02019; water environments: focus on biofilms.</article-title>
<source><italic>Microorganisms</italic></source>
<volume>7</volume>:<issue>7</issue>. <pub-id pub-id-type="doi">10.3390/microorganisms7010007</pub-id>
<?supplied-pmid 30621244?><pub-id pub-id-type="pmid">30621244</pub-id></mixed-citation></ref><ref id="B140"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romo</surname><given-names>J. A.</given-names></name><name><surname>Pierce</surname><given-names>C. G.</given-names></name><name><surname>Chaturvedi</surname><given-names>A. K.</given-names></name><name><surname>Lazzell</surname><given-names>A. L.</given-names></name><name><surname>McHardy</surname><given-names>S. F.</given-names></name><name><surname>Saville</surname><given-names>S. P.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Development of anti-virulence approaches for candidiasis via a novel series of small-molecule inhibitors of <italic>Candida albicans</italic> filamentation.</article-title>
<source><italic>mBio</italic></source>
<volume>8</volume>:<issue>e01991-17</issue>. <pub-id pub-id-type="doi">10.1128/mBio.01991-17</pub-id>
<?supplied-pmid 29208749?><pub-id pub-id-type="pmid">29208749</pub-id></mixed-citation></ref><ref id="B141"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romo</surname><given-names>J. A.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Cai</surname><given-names>H.</given-names></name><name><surname>Kadosh</surname><given-names>D.</given-names></name><name><surname>Koehler</surname><given-names>J. R.</given-names></name><name><surname>Saville</surname><given-names>S. P.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Global transcriptomic analysis of the <italic>Candida albicans</italic> response to treatment with a novel inhibitor of filamentation.</article-title>
<source><italic>mSphere</italic></source>
<volume>4</volume>:<issue>e00620-19</issue>. <pub-id pub-id-type="doi">10.1128/mSphere.00620-19</pub-id>
<?supplied-pmid 31511371?><pub-id pub-id-type="pmid">31511371</pub-id></mixed-citation></ref><ref id="B142"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sagatova</surname><given-names>A. A.</given-names></name><name><surname>Keniya</surname><given-names>M. V.</given-names></name><name><surname>Wilson</surname><given-names>R. K.</given-names></name><name><surname>Sabherwal</surname><given-names>M.</given-names></name><name><surname>Tyndall</surname><given-names>J. D. A.</given-names></name><name><surname>Monk</surname><given-names>B. C.</given-names></name></person-group> (<year>2016</year>). <article-title>Triazole resistance mediated by mutations of a conserved active site tyrosine in fungal lanosterol 14&#x003b1;-demethylase.</article-title>
<source><italic>Sci. Rep.</italic></source>
<volume>6</volume>:<issue>26213</issue>. <pub-id pub-id-type="doi">10.1038/srep26213</pub-id>
<?supplied-pmid 27188873?><pub-id pub-id-type="pmid">27188873</pub-id></mixed-citation></ref><ref id="B143"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sajjad</surname><given-names>M.</given-names></name><name><surname>Khan</surname><given-names>A.</given-names></name><name><surname>Ahmad</surname><given-names>I.</given-names></name></person-group> (<year>2012</year>). <article-title>Biofilm inhibition by <italic>Cymbopogon citratus</italic> and <italic>Syzygium aromaticum</italic> essential oils in the strains of <italic>Candida albicans</italic>.</article-title>
<source><italic>J. Ethnopharmacol.</italic></source>
<volume>140</volume>
<fpage>416</fpage>&#x02013;<lpage>423</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2012.01.045</pub-id>
<?supplied-pmid 22326355?><pub-id pub-id-type="pmid">22326355</pub-id></mixed-citation></ref><ref id="B144"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sebaa</surname><given-names>S.</given-names></name><name><surname>Boucherit-Otmani</surname><given-names>Z.</given-names></name><name><surname>Courtois</surname><given-names>P.</given-names></name></person-group> (<year>2019</year>). <article-title>Effects of tyrosol and farnesol on <italic>Candida albicans</italic> biofilm.</article-title>
<source><italic>Mol. Med. Rep.</italic></source>
<volume>19</volume>
<fpage>3201</fpage>&#x02013;<lpage>3209</lpage>. <pub-id pub-id-type="doi">10.3892/mmr.2019.9981</pub-id>
<?supplied-pmid 30816484?><pub-id pub-id-type="pmid">30816484</pub-id></mixed-citation></ref><ref id="B145"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seddighi</surname><given-names>N. S.</given-names></name><name><surname>Salari</surname><given-names>S.</given-names></name><name><surname>Izadi</surname><given-names>A. R.</given-names></name></person-group> (<year>2017</year>). <article-title>Evaluation of antifungal effect of iron&#x02212;oxide nanoparticles against different <italic>Candida</italic> species.</article-title>
<source><italic>IET Nanobiotechnol.</italic></source>
<volume>11</volume>
<fpage>883</fpage>&#x02013;<lpage>888</lpage>. <pub-id pub-id-type="doi">10.1049/iet-nbt.2017.0025</pub-id></mixed-citation></ref><ref id="B146"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>M.</given-names></name><name><surname>Prasad</surname><given-names>R.</given-names></name></person-group> (<year>2011</year>). <article-title>The quorum-sensing molecule farnesol is a modulator of drug efflux mediated by ABC multidrug transporters and synergizes with drugs in <italic>Candida albicans</italic>.</article-title>
<source><italic>Antimicrob. Agents Chemother.</italic></source>
<volume>55</volume>
<fpage>4834</fpage>&#x02013;<lpage>4843</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.00344-11</pub-id>
<?supplied-pmid 21768514?><pub-id pub-id-type="pmid">21768514</pub-id></mixed-citation></ref><ref id="B147"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>Y.</given-names></name><name><surname>Khan</surname><given-names>L. A.</given-names></name><name><surname>Manzoor</surname><given-names>N.</given-names></name></person-group> (<year>2016</year>). <article-title>Anti-Candida activity of geraniol involves disruption of cell membrane integrity and function.</article-title>
<source><italic>J. Mycol. M&#x000e9;dicale</italic></source>
<volume>26</volume>
<fpage>244</fpage>&#x02013;<lpage>254</lpage>. <pub-id pub-id-type="doi">10.1016/j.mycmed.2016.04.004</pub-id>
<?supplied-pmid 27554866?><pub-id pub-id-type="pmid">27554866</pub-id></mixed-citation></ref><ref id="B148"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sherry</surname><given-names>L.</given-names></name><name><surname>Jose</surname><given-names>A.</given-names></name><name><surname>Murray</surname><given-names>C.</given-names></name><name><surname>Williams</surname><given-names>C.</given-names></name><name><surname>Jones</surname><given-names>B.</given-names></name><name><surname>Millington</surname><given-names>O.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Carbohydrate derived fulvic acid: an in vitro investigation of a novel membrane active antiseptic agent against <italic>Candida albicans</italic> biofilms.</article-title>
<source><italic>Front. Microbiol.</italic></source>
<volume>3</volume>:<issue>116</issue>. <pub-id pub-id-type="doi">10.3389/fmicb.2012.00116</pub-id>
<?supplied-pmid 22479260?><pub-id pub-id-type="pmid">22479260</pub-id></mixed-citation></ref><ref id="B149"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Shukla</surname><given-names>A. K.</given-names></name></person-group> (<year>2020</year>). <source><italic>Nanoparticles and Their Biomedical Applications.</italic></source>
<publisher-loc>Basingstoke</publisher-loc>: <publisher-name>Springer Nature</publisher-name>.</mixed-citation></ref><ref id="B150"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siles</surname><given-names>S. A.</given-names></name><name><surname>Srinivasan</surname><given-names>A.</given-names></name><name><surname>Pierce</surname><given-names>C. G.</given-names></name><name><surname>Lopez-Ribot</surname><given-names>J. L.</given-names></name><name><surname>Ramasubramanian</surname><given-names>A. K.</given-names></name></person-group> (<year>2013</year>). <article-title>High-throughput screening of a collection of known pharmacologically active small compounds for identification of <italic>Candida albicans</italic> biofilm inhibitors.</article-title>
<source><italic>Antimicrob. Agents Chemother.</italic></source>
<volume>57</volume>
<fpage>3681</fpage>&#x02013;<lpage>3687</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.00680-13</pub-id>
<?supplied-pmid 23689719?><pub-id pub-id-type="pmid">23689719</pub-id></mixed-citation></ref><ref id="B151"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>F.</given-names></name><name><surname>Ferreira</surname><given-names>S.</given-names></name><name><surname>Duarte</surname><given-names>A.</given-names></name><name><surname>Mendonc</surname><given-names>D. I.</given-names></name><name><surname>Domingues</surname><given-names>F. C.</given-names></name></person-group> (<year>2011</year>). <article-title>Phytomedicine antifungal activity of <italic>Coriandrum sativum</italic> essential oil, its mode of action against Candida species and potential synergism with amphotericin B.</article-title>
<source><italic>Phytomedicine</italic></source>
<volume>19</volume>
<fpage>42</fpage>&#x02013;<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1016/j.phymed.2011.06.033</pub-id>
<?supplied-pmid 21788125?><pub-id pub-id-type="pmid">21788125</pub-id></mixed-citation></ref><ref id="B152"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>S.</given-names></name><name><surname>Rodrigues</surname><given-names>C. F.</given-names></name><name><surname>Ara&#x000fa;jo</surname><given-names>D.</given-names></name><name><surname>Rodrigues</surname><given-names>M. E.</given-names></name><name><surname>Henriques</surname><given-names>M.</given-names></name></person-group> (<year>2017</year>). <article-title>Candida species biofilms&#x02019; antifungal resistance.</article-title>
<source><italic>J. Fungi</italic></source>
<volume>3</volume>:<issue>8</issue>. <pub-id pub-id-type="doi">10.3390/jof3010008</pub-id>
<?supplied-pmid 29371527?><pub-id pub-id-type="pmid">29371527</pub-id></mixed-citation></ref><ref id="B153"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simsek</surname><given-names>M.</given-names></name><name><surname>Duman</surname><given-names>R.</given-names></name></person-group> (<year>2017</year>). <article-title>Investigation of effect of 1,8-cineole on antimicrobial activity of chlorhexidine gluconate.</article-title>
<source><italic>Pharmacognosy Res.</italic></source>
<volume>9</volume>:<issue>234</issue>. <pub-id pub-id-type="doi">10.4103/0974-8490.210329</pub-id>
<?supplied-pmid 28827963?><pub-id pub-id-type="pmid">28827963</pub-id></mixed-citation></ref><ref id="B154"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soll</surname><given-names>D. R.</given-names></name><name><surname>Daniels</surname><given-names>K. J.</given-names></name></person-group> (<year>2016</year>). <article-title>Plasticity of <italic>Candida albicans</italic> biofilms.</article-title>
<source><italic>Microbiol. Mol. Biol. Rev.</italic></source>
<volume>80</volume>
<fpage>565</fpage>&#x02013;<lpage>595</lpage>. <pub-id pub-id-type="doi">10.1128/mmbr.00068-15</pub-id>
<?supplied-pmid 27250770?><pub-id pub-id-type="pmid">27250770</pub-id></mixed-citation></ref><ref id="B155"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spampinato</surname><given-names>C.</given-names></name><name><surname>Leonardi</surname><given-names>D.</given-names></name></person-group> (<year>2013</year>). <article-title><italic>Candida</italic> infections, causes, targets, and resistance mechanisms: traditional and alternative antifungal agents.</article-title>
<source><italic>Biomed Res. Int.</italic></source>
<volume>204237</volume>. <pub-id pub-id-type="doi">10.1155/2013/204237</pub-id>
<?supplied-pmid 23878798?><pub-id pub-id-type="pmid">23878798</pub-id></mixed-citation></ref><ref id="B156"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spormann</surname><given-names>A. M.</given-names></name><name><surname>Thormann</surname><given-names>K.</given-names></name><name><surname>Saville</surname><given-names>R.</given-names></name><name><surname>Shukla</surname><given-names>S.</given-names></name><name><surname>Entcheva</surname><given-names>P.</given-names></name></person-group> (<year>2004</year>). <article-title>Microbial biofilms.</article-title>
<source><italic>Nanoscale Technol. Biol. Syst.</italic></source>
<fpage>341</fpage>&#x02013;<lpage>357</lpage>. <pub-id pub-id-type="doi">10.1201/9780203500224</pub-id></mixed-citation></ref><ref id="B157"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>H.</given-names></name><name><surname>Han</surname><given-names>L.</given-names></name><name><surname>Huang</surname><given-names>X.</given-names></name></person-group> (<year>2018</year>). <article-title>Potential targets for the development of new antifungal drugs.</article-title>
<source><italic>J. Antibiot.</italic></source>
<volume>71</volume>
<fpage>978</fpage>&#x02013;<lpage>991</lpage>. <pub-id pub-id-type="doi">10.1038/s41429-018-0100-9</pub-id>
<?supplied-pmid 30242283?><pub-id pub-id-type="pmid">30242283</pub-id></mixed-citation></ref><ref id="B158"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subbiahdoss</surname><given-names>G.</given-names></name><name><surname>Pidhatika</surname><given-names>B.</given-names></name><name><surname>Coullerez</surname><given-names>G.</given-names></name><name><surname>Charnley</surname><given-names>M.</given-names></name><name><surname>Kuijer</surname><given-names>R.</given-names></name><name><surname>van der Mei</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Bacterial biofilm formation versus mammalian cell growth on titanium-based mono- and bi-functional coating.</article-title>
<source><italic>Eur. Cells Mater.</italic></source>
<volume>19</volume>
<fpage>205</fpage>&#x02013;<lpage>213</lpage>. <pub-id pub-id-type="doi">10.22203/ecm.v019a20</pub-id>
<?supplied-pmid 20467966?><pub-id pub-id-type="pmid">20467966</pub-id></mixed-citation></ref><ref id="B159"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>B.</given-names></name><name><surname>Zhang</surname><given-names>M.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Hu</surname><given-names>Q.</given-names></name><name><surname>Zheng</surname><given-names>H.</given-names></name><name><surname>Chang</surname><given-names>W.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Synthesis of riccardin D derivatives as potent antimicrobial agents.</article-title>
<source><italic>Bioorg. Med. Chem. Lett.</italic></source>
<volume>26</volume>
<fpage>3617</fpage>&#x02013;<lpage>3620</lpage>. <pub-id pub-id-type="doi">10.1016/j.bmcl.2016.06.006</pub-id>
<?supplied-pmid 27297569?><pub-id pub-id-type="pmid">27297569</pub-id></mixed-citation></ref><ref id="B160"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>L.</given-names></name><name><surname>Liao</surname><given-names>K.</given-names></name><name><surname>Wang</surname><given-names>D.</given-names></name></person-group> (<year>2015</year>). <article-title>Effects of magnolol and honokiol on adhesion, yeast-hyphal transition, and formation of biofilm by <italic>Candida albicans</italic>.</article-title>
<source><italic>PLoS One</italic></source>
<volume>10</volume>:<issue>e0117695</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0117695</pub-id>
<?supplied-pmid 25710475?><pub-id pub-id-type="pmid">25710475</pub-id></mixed-citation></ref><ref id="B161"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>L.</given-names></name><name><surname>Liao</surname><given-names>K.</given-names></name><name><surname>Wang</surname><given-names>D.</given-names></name></person-group> (<year>2017</year>). <article-title>Honokiol induces superoxide production by targeting mitochondrial respiratory chain complex I in <italic>Candida albicans</italic>.</article-title>
<source><italic>PLoS One</italic></source>
<volume>12</volume>:<issue>e0184003</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0184003</pub-id>
<?supplied-pmid 28854218?><pub-id pub-id-type="pmid">28854218</pub-id></mixed-citation></ref><ref id="B162"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taff</surname><given-names>H. T.</given-names></name><name><surname>Mitchell</surname><given-names>K. F.</given-names></name><name><surname>Edward</surname><given-names>J. A.</given-names></name><name><surname>Andes</surname><given-names>D. R.</given-names></name></person-group> (<year>2013</year>). <article-title>Mechanisms of Candida biofilm drug resistance.</article-title>
<source><italic>Fut. Microbiol.</italic></source>
<volume>8</volume>
<fpage>1325</fpage>&#x02013;<lpage>1337</lpage>. <pub-id pub-id-type="doi">10.2217/fmb.13.101</pub-id>
<?supplied-pmid 24059922?><pub-id pub-id-type="pmid">24059922</pub-id></mixed-citation></ref><ref id="B163"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Talsma</surname><given-names>S. S.</given-names></name></person-group> (<year>2007</year>). <article-title>Biofilms on medical devices.</article-title>
<source><italic>Home Healthc. Nurse</italic></source>
<volume>25</volume>
<fpage>589</fpage>&#x02013;<lpage>594</lpage>. <pub-id pub-id-type="doi">10.1097/01.NHH.0000296117.87061.14</pub-id><pub-id pub-id-type="pmid">18049256</pub-id></mixed-citation></ref><ref id="B164"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ten Cate</surname><given-names>J. M.</given-names></name><name><surname>Klis</surname><given-names>F. M.</given-names></name><name><surname>Pereira-Cenci</surname><given-names>T.</given-names></name><name><surname>Crielaard</surname><given-names>W.</given-names></name><name><surname>De Groot</surname><given-names>P. W. J.</given-names></name></person-group> (<year>2009</year>). <article-title>Molecular and cellular mechanisms that lead to Candida biofilm formation.</article-title>
<source><italic>J. Dent. Res.</italic></source>
<volume>88</volume>
<fpage>105</fpage>&#x02013;<lpage>115</lpage>. <pub-id pub-id-type="doi">10.1177/0022034508329273</pub-id>
<?supplied-pmid 19278980?><pub-id pub-id-type="pmid">19278980</pub-id></mixed-citation></ref><ref id="B165"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thakre</surname><given-names>A.</given-names></name><name><surname>Jadhav</surname><given-names>V.</given-names></name><name><surname>Kazi</surname><given-names>R.</given-names></name><name><surname>Shelar</surname><given-names>A.</given-names></name><name><surname>Patil</surname><given-names>R.</given-names></name><name><surname>Kharat</surname><given-names>K.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Oxidative stress induced by piperine leads to apoptosis in <italic>Candida albicans</italic>.</article-title>
<source><italic>Med. Mycol.</italic></source>
<volume>59</volume>:<issue>myaa058</issue>. <pub-id pub-id-type="doi">10.1093/mmy/myaa058</pub-id>
<?supplied-pmid 32658959?><pub-id pub-id-type="pmid">32658959</pub-id></mixed-citation></ref><ref id="B166"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thangamani</surname><given-names>S.</given-names></name><name><surname>Eldesouky</surname><given-names>H. E.</given-names></name><name><surname>Mohammad</surname><given-names>H.</given-names></name><name><surname>Pascuzzi</surname><given-names>P. E.</given-names></name><name><surname>Avramova</surname><given-names>L.</given-names></name><name><surname>Hazbun</surname><given-names>T. R.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Ebselen exerts antifungal activity by regulating glutathione (GSH) and reactive oxygen species (ROS) production in fungal cells.</article-title>
<source><italic>Biochim. Biophys. Acta Gen. Subj.</italic></source>
<volume>1861</volume>
<fpage>3002</fpage>&#x02013;<lpage>3010</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbagen.2016.09.029</pub-id>
<?supplied-pmid 27712973?><pub-id pub-id-type="pmid">27712973</pub-id></mixed-citation></ref><ref id="B167"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>H.</given-names></name><name><surname>Qu</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Lu</surname><given-names>Z.</given-names></name><name><surname>Zhang</surname><given-names>M.</given-names></name><name><surname>Gan</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Calcium and oxidative stress mediate perillaldehyde-induced apoptosis in <italic>Candida albicans</italic>.</article-title>
<source><italic>Appl. Microbiol. Biotechnol.</italic></source>
<volume>101</volume>
<fpage>3335</fpage>&#x02013;<lpage>3345</lpage>. <pub-id pub-id-type="doi">10.1007/s00253-017-8146-3</pub-id>
<?supplied-pmid 28224196?><pub-id pub-id-type="pmid">28224196</pub-id></mixed-citation></ref><ref id="B168"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toenjes</surname><given-names>K. A.</given-names></name><name><surname>Munsee</surname><given-names>S. M.</given-names></name><name><surname>Ibrahim</surname><given-names>A. S.</given-names></name><name><surname>Jeffrey</surname><given-names>R.</given-names></name><name><surname>Edwards</surname><given-names>J. E.</given-names></name><name><surname>Johnson</surname><given-names>D. I.</given-names></name></person-group> (<year>2005</year>). <article-title>Small-molecule inhibitors of the budded-to-hyphal-form transition in the pathogenic yeast <italic>Candida albicans</italic>.</article-title>
<source><italic>Antimicrob. Agents Chemother.</italic></source>
<volume>49</volume>
<fpage>963</fpage>&#x02013;<lpage>972</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.49.3.963-972.2005</pub-id>
<?supplied-pmid 15728890?><pub-id pub-id-type="pmid">15728890</pub-id></mixed-citation></ref><ref id="B169"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Truong</surname><given-names>T.</given-names></name><name><surname>Suriyanarayanan</surname><given-names>T.</given-names></name><name><surname>Zeng</surname><given-names>G.</given-names></name><name><surname>Le</surname><given-names>T. D.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name></person-group> (<year>2018</year>). <article-title>Use of haploid model of <italic>Candida albicans</italic> to uncover mechanism of action of a novel antifungal agent.</article-title>
<source><italic>Front. Cell Infect. Microbiol.</italic></source>
<volume>8</volume>:<issue>164</issue>. <pub-id pub-id-type="doi">10.3389/fcimb.2018.00164</pub-id>
<?supplied-pmid 29938200?><pub-id pub-id-type="pmid">29938200</pub-id></mixed-citation></ref><ref id="B170"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsui</surname><given-names>C.</given-names></name><name><surname>Kong</surname><given-names>E. F.</given-names></name><name><surname>Jabra-Rizk</surname><given-names>M. A.</given-names></name></person-group> (<year>2016</year>). <article-title>Pathogenesis of <italic>Candida albicans</italic> biofilm.</article-title>
<source><italic>Pathog. Dis.</italic></source>
<volume>74</volume>:<issue>ftw018</issue>. <pub-id pub-id-type="doi">10.1093/femspd/ftw018</pub-id>
<?supplied-pmid 26960943?><pub-id pub-id-type="pmid">26960943</pub-id></mixed-citation></ref><ref id="B171"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uppuluri</surname><given-names>P.</given-names></name><name><surname>Nett</surname><given-names>J.</given-names></name><name><surname>Heitman</surname><given-names>J.</given-names></name><name><surname>Andes</surname><given-names>D.</given-names></name></person-group> (<year>2008</year>). <article-title>Synergistic effect of calcineurin inhibitors and fluconazole against <italic>Candida albicans</italic> biofilms.</article-title>
<source><italic>Antimicrob. Agents Chemother.</italic></source>
<volume>52</volume>
<fpage>1127</fpage>&#x02013;<lpage>1132</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.01397-07</pub-id>
<?supplied-pmid 18180354?><pub-id pub-id-type="pmid">18180354</pub-id></mixed-citation></ref><ref id="B172"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veerapandian</surname><given-names>R.</given-names></name><name><surname>Vediyappan</surname><given-names>G.</given-names></name></person-group> (<year>2019</year>). <article-title>Gymnemic acids inhibit adhesive nanofibrillar mediated <italic>Streptococcus gordonii</italic>&#x02013;<italic>Candida albicans</italic> mono-species and dual-species biofilms.</article-title>
<source><italic>Front. Microbiol.</italic></source>
<volume>10</volume>:<issue>2328</issue>. <pub-id pub-id-type="doi">10.3389/fmicb.2019.02328</pub-id>
<?supplied-pmid 31681200?><pub-id pub-id-type="pmid">31681200</pub-id></mixed-citation></ref><ref id="B173"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vila</surname><given-names>T.</given-names></name><name><surname>Lopez-Ribot</surname><given-names>J. L.</given-names></name></person-group> (<year>2017</year>). <article-title>Screening the pathogen box for identification of <italic>Candida albicans</italic> biofilm inhibitors.</article-title>
<source><italic>Antimicrob. Agents Chemother.</italic></source>
<volume>61</volume>:<issue>e02006-16</issue>. <pub-id pub-id-type="doi">10.1128/AAC.02006-16</pub-id>
<?supplied-pmid 27795383?><pub-id pub-id-type="pmid">27795383</pub-id></mixed-citation></ref><ref id="B174"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wall</surname><given-names>G.</given-names></name><name><surname>Chaturvedi</surname><given-names>A. K.</given-names></name><name><surname>Wormley</surname><given-names>F. L.</given-names></name><name><surname>Wiederhold</surname><given-names>N. P.</given-names></name><name><surname>Patterson</surname><given-names>H. P.</given-names></name><name><surname>Patterson</surname><given-names>T. F.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Screening a repurposing library for inhibitors of multidrug-resistant <italic>Candida auris</italic> identifies ebselen as a repositionable candidate for antifungal drug development.</article-title>
<source><italic>Antimicrob. Agents Chemother.</italic></source>
<volume>62</volume>:<issue>e01084-18</issue>. <pub-id pub-id-type="doi">10.1128/AAC.01084-18</pub-id>
<?supplied-pmid 30104269?><pub-id pub-id-type="pmid">30104269</pub-id></mixed-citation></ref><ref id="B175"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>B.</given-names></name><name><surname>You</surname><given-names>J.</given-names></name><name><surname>King</surname><given-names>J. B.</given-names></name><name><surname>Cai</surname><given-names>S.</given-names></name><name><surname>Park</surname><given-names>E.</given-names></name><name><surname>Powell</surname><given-names>D. R.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Polyketide glycosides from <italic>Bionectria ochroleuca</italic> inhibit candida albicans bio film formation.</article-title>
<source><italic>J. Nat. Prod.</italic></source>
<volume>77</volume>
<fpage>2273</fpage>&#x02013;<lpage>2279</lpage>.<pub-id pub-id-type="pmid">25302529</pub-id></mixed-citation></ref><ref id="B176"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>You</surname><given-names>J.</given-names></name><name><surname>King</surname><given-names>J. B.</given-names></name><name><surname>Powell</surname><given-names>D. R.</given-names></name><name><surname>Cichewicz</surname><given-names>R. H.</given-names></name></person-group> (<year>2012</year>). <article-title>Waikialoid A suppresses hyphal morphogenesis and inhibits biofilm development in pathogenic <italic>Candida albicans</italic>.</article-title>
<source><italic>J. Nat. Prod.</italic></source>
<volume>75</volume>
<fpage>707</fpage>&#x02013;<lpage>715</lpage>. <pub-id pub-id-type="doi">10.1021/np2009994</pub-id>
<?supplied-pmid 22400916?><pub-id pub-id-type="pmid">22400916</pub-id></mixed-citation></ref><ref id="B177"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>G.</given-names></name><name><surname>Xu</surname><given-names>X.</given-names></name><name><surname>Wu</surname><given-names>C. D.</given-names></name></person-group> (<year>2011</year>). <article-title>In vitro synergism between berberine and miconazole against planktonic and biofilm <italic>Candida</italic> cultures.</article-title>
<source><italic>Arch. Oral Biol.</italic></source>
<volume>56</volume>
<fpage>565</fpage>&#x02013;<lpage>572</lpage>. <pub-id pub-id-type="doi">10.1016/j.archoralbio.2010.11.021</pub-id>
<?supplied-pmid 21272859?><pub-id pub-id-type="pmid">21272859</pub-id></mixed-citation></ref><ref id="B178"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>C.</given-names></name><name><surname>Rajendran</surname><given-names>R.</given-names></name><name><surname>Ramage</surname><given-names>G.</given-names></name></person-group> (<year>2016</year>). <article-title>Aspergillus biofilms in human disease.</article-title>
<source><italic>Adv. Exp. Med. Biol.</italic></source>
<volume>931</volume>
<fpage>1</fpage>&#x02013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1007/5584_2016_4</pub-id><pub-id pub-id-type="pmid">27271678</pub-id></mixed-citation></ref><ref id="B179"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>D. W.</given-names></name><name><surname>Jordan</surname><given-names>R. P. C.</given-names></name><name><surname>Wei</surname><given-names>X.-Q.</given-names></name><name><surname>Alves</surname><given-names>C. T.</given-names></name><name><surname>Wise</surname><given-names>M. P.</given-names></name><name><surname>Wilson</surname><given-names>M. J.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Interactions of <italic>Candida albicans</italic> with host epithelial surfaces.</article-title>
<source><italic>J. Oral Microbiol.</italic></source>
<volume>5</volume>
<issue>22434</issue>. <pub-id pub-id-type="doi">10.3402/jom.v5i0.22434</pub-id>
<?supplied-pmid 24155995?><pub-id pub-id-type="pmid">24155995</pub-id></mixed-citation></ref><ref id="B180"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>S. S. W.</given-names></name><name><surname>Kao</surname><given-names>R. Y. T.</given-names></name><name><surname>Yuen</surname><given-names>K. Y.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>D.</given-names></name><name><surname>Samaranayake</surname><given-names>L. P.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>In vitro and in vivo activity of a novel antifungal small molecule against <italic>Candida Infections</italic>.</article-title>
<source><italic>PLoS One</italic></source>
<volume>9</volume>:<issue>e85836</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0085836</pub-id>
<?supplied-pmid 24465737?><pub-id pub-id-type="pmid">24465737</pub-id></mixed-citation></ref><ref id="B181"><mixed-citation publication-type="journal"><collab>World Health Organisation [WHO]</collab> (<year>2019</year>). <source><italic>New Report Calls for Urgent Action to Avert Antimicrobial Resistance Crisis.</italic></source> Available online at: <ext-link ext-link-type="uri" xlink:href="https://www.who.int/news/item/29-04-2019-new-report-calls-for-urgent-action-to-avert-antimicrobial-resistance-crisis">https://www.who.int/news/item/29-04-2019-new-report-calls-for-urgent-action-to-avert-antimicrobial-resistance-crisis</ext-link>
<comment>(accessed March 16, 2021)</comment>.</mixed-citation></ref><ref id="B182"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>N.</given-names></name><name><surname>Dong</surname><given-names>G.</given-names></name><name><surname>Sheng</surname><given-names>C.</given-names></name></person-group> (<year>2017</year>). <article-title>Tackling fungal resistance by biofilm inhibitors.</article-title>
<source><italic>J. Med. Chem.</italic></source>
<volume>60</volume>
<fpage>2193</fpage>&#x02013;<lpage>2211</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jmedchem.6b01203</pub-id>
<?supplied-pmid 28051303?><pub-id pub-id-type="pmid">28051303</pub-id></mixed-citation></ref><ref id="B183"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yapar</surname><given-names>N.</given-names></name></person-group> (<year>2014</year>). <article-title>Epidemiology and risk factors for invasive candidiasis.</article-title>
<source><italic>Ther. Clin. Risk Manag.</italic></source>
<volume>10</volume>
<fpage>95</fpage>&#x02013;<lpage>105</lpage>. <pub-id pub-id-type="doi">10.2147/TCRM.S40160</pub-id>
<?supplied-pmid 24611015?><pub-id pub-id-type="pmid">24611015</pub-id></mixed-citation></ref><ref id="B184"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>You</surname><given-names>J.</given-names></name><name><surname>Du</surname><given-names>L.</given-names></name><name><surname>King</surname><given-names>J. B.</given-names></name><name><surname>Hall</surname><given-names>B. E.</given-names></name><name><surname>Cichewicz</surname><given-names>R. H.</given-names></name></person-group> (<year>2013</year>). <article-title>Small-molecule suppressors of <italic>Candida albicans</italic> biofilm formation synergistically enhance the antifungal activity of Amphotericin B against clinical candida isolates.</article-title>
<source><italic>ACS Chem. Biol.</italic></source>
<volume>8</volume>
<fpage>840</fpage>&#x02013;<lpage>848</lpage>. <pub-id pub-id-type="doi">10.1021/cb400009f</pub-id>
<?supplied-pmid 23387427?><pub-id pub-id-type="pmid">23387427</pub-id></mixed-citation></ref><ref id="B185"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Youngsaye</surname><given-names>W.</given-names></name><name><surname>Vincent</surname><given-names>B.</given-names></name><name><surname>Hartland</surname><given-names>C. L.</given-names></name><name><surname>Morgan</surname><given-names>B. J.</given-names></name><name><surname>Buhrlage</surname><given-names>S. J.</given-names></name><name><surname>Johnston</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Piperazinyl quinolines as chemosensitizers to increase fluconazole susceptibility of <italic>Candida albicans</italic> clinical isolates.</article-title>
<source><italic>Bioorg. Med. Chem. Lett.</italic></source>
<volume>21</volume>
<fpage>5502</fpage>&#x02013;<lpage>5505</lpage>. <pub-id pub-id-type="doi">10.1016/j.bmcl.2011.06.105</pub-id>
<?supplied-pmid 21802942?><pub-id pub-id-type="pmid">21802942</pub-id></mixed-citation></ref><ref id="B186"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yousfi</surname><given-names>H.</given-names></name><name><surname>Cassagne</surname><given-names>C.</given-names></name><name><surname>Ranque</surname><given-names>S.</given-names></name><name><surname>Rolain</surname><given-names>J.-M.</given-names></name><name><surname>Bittar</surname><given-names>F.</given-names></name></person-group> (<year>2019</year>). <article-title>Repurposing of ribavirin as an adjunct therapy against invasive candida strains in an in vitro study.</article-title>
<source><italic>Antimicrob. Agents Chemother.</italic></source>
<volume>63</volume>:<issue>e00263-19</issue>. <pub-id pub-id-type="doi">10.1128/AAC.00263-19</pub-id>
<?supplied-pmid 31307986?><pub-id pub-id-type="pmid">31307986</pub-id></mixed-citation></ref><ref id="B187"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>L.-H.</given-names></name><name><surname>Wei</surname><given-names>X.</given-names></name><name><surname>Ma</surname><given-names>M.</given-names></name><name><surname>Chen</surname><given-names>X.-J.</given-names></name><name><surname>Xu</surname><given-names>S.-B.</given-names></name></person-group> (<year>2012</year>). <article-title>Possible inhibitory molecular mechanism of farnesol on the development of fluconazole resistance in <italic>Candida albicans</italic> biofilm.</article-title>
<source><italic>Antimicrob. Agents Chemother.</italic></source>
<volume>56</volume>
<fpage>770</fpage>&#x02013;<lpage>775</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.05290-11</pub-id>
<?supplied-pmid 22106223?><pub-id pub-id-type="pmid">22106223</pub-id></mixed-citation></ref><ref id="B188"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>Q.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>Inhibition of gold nanoparticles (AuNPs) on pathogenic biofilm formation and invasion to host cells.</article-title>
<source><italic>Sci. Rep.</italic></source>
<volume>6</volume>:<issue>26667</issue>. <pub-id pub-id-type="doi">10.1038/srep26667</pub-id>
<?supplied-pmid 27220400?><pub-id pub-id-type="pmid">27220400</pub-id></mixed-citation></ref><ref id="B189"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaki</surname><given-names>M.</given-names></name><name><surname>Oukhrib</surname><given-names>A.</given-names></name><name><surname>Hakmaoui</surname><given-names>A.</given-names></name><name><surname>El</surname></name><name><surname>Hiebel</surname><given-names>M.</given-names></name></person-group> (<year>2019</year>). <article-title>Synthesis of novel 1,2,3-triazole-substituted tomentosins.</article-title>
<source><italic>Zeitschrift f&#x000fc;r Naturforschung B</italic></source>
<volume>74</volume>
<fpage>273</fpage>&#x02013;<lpage>281</lpage>. <pub-id pub-id-type="doi">10.1515/znb-2018-0225</pub-id></mixed-citation></ref><ref id="B190"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>ElSohly</surname><given-names>H. N.</given-names></name><name><surname>Jacob</surname><given-names>M. R.</given-names></name><name><surname>Pasco</surname><given-names>D. S.</given-names></name><name><surname>Walker</surname><given-names>L. A.</given-names></name><name><surname>Clark</surname><given-names>A. M.</given-names></name></person-group> (<year>2002</year>). <article-title>Natural products inhibiting <italic>Candida albicans</italic> secreted aspartic proteases from <italic>Tovomita krukovii</italic>.</article-title>
<source><italic>Planta Med.</italic></source>
<volume>68</volume>
<fpage>49</fpage>&#x02013;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1055/s-2002-20049</pub-id>
<?supplied-pmid 11842327?><pub-id pub-id-type="pmid">11842327</pub-id></mixed-citation></ref></ref-list></back></article>